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ABSTRACT

Elucidating Mechanisms of Neurobehavioral Dysfunction in a
Rodent Model of Traumatic Brain Injury
Aric F. Logsdon
Neuropsychiatric symptoms and cognitive deficits are common among victims of a traumatic
brain injury (TBI), and currently, there are no effective treatments to improve outcome. We first
developed a clinically-relevant blast TBI model based on lung scaling parameters to elucidate
mechanisms of neuronal cell death. In order to discover effective treatments to improve outcome,
we had to validate our novel preclinical model of TBI. TBI is an external force that can cause
damage to the neurovascular unit (NVU), which can lead to secondary effects, cell death and
behavioral dysfunction. In our first study we observed that our model damaged the NVU,
increased neuronal cell death, and produced cognitive deficits in young adult Sprague-dawley
rats. The link between damage to the NVU and neurobehavioral dysfunction following TBI is
poorly understood. Recently secondary injury cascades, such as endoplasmic reticulum (ER)
stress and neuroinflammation, have been hypothesized to be early indicators for the development
of neurobehavioral dysfunction. Therefore, we examined the regional and temporal profile of
these secondary injury cascades using our validated rodent TBI model. We also measured
neurobehavioral dysfunction using a variety of functional assays at various time points post-TBI.
Tissues from brain regions associated with the behavioral sequelae of TBI were evaluated for
biochemical changes. Furthermore, we investigated the neurophysiological response in brain
slice recordings at various time points after TBI. We discovered that TBI produced spatial
memory deficits in the rats and altered synaptic firing rates in the hippocampus. In our next
study, we revealed a robust increase in markers of ER stress and neuroinflammation within the
frontal cortex after TBI. Interestingly, we observed impulsive-like behavior in rats after TBI,
which is indicative of damage to the frontal cortex. After characterization of the injury response,
we investigated the role of ER stress modulation in mediating secondary injury cascades and
neurobehavioral dysfunction following TBI. Salubrinal, an ER stress modulator, attenuated
markers of neuroinflammation and neuronal cell death. Most importantly, ER stress modulation
ameliorated impulsive-like behavior in rats after TBI. The final portion of this study was to
elucidate a link between ER stress and the development of Chronic Traumatic Encephalopathy
(CTE). We revealed a potential link between repetitive blast injury and neuropsychiatric
symptoms associated with CTE. Tau phosphorylation and aggregation are considered hallmarks
of CTE development. We observed an increase in marker of tau phosphorylation and
conformational change in rats exposed to repetitive blast. We also observed spatial memory
deficits and impulsive-like behavior after repetitive TBI. Together, these results suggest that
repetitive blast exposure may lead to tauopathy and the behavioral sequelae associated with CTE.
Future studies should aim to causally link secondary injury cascades to tauopathy in order to
elucidate new drug targets to improve patient outcome after TBI.
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Chapter One

Introduction
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LITERATURE REVIEW
ABSTRACT
Traumatic brain injury is acquired from an external force, which can inflict devastating
effects to the brain vasculature and neighboring neuronal cells. Disruption of vasculature is a
primary effect that can lead to a host of secondary injury cascades. The primary effects of neural
injury are rapidly occurring while secondary effects can be activated at later time points and may
be more amenable to targeting. Primary effects of brain injury include diffuse axonal shearing,
changes in blood brain barrier permeability, and brain contusions. These mechanical events,
especially changes to the BBB, can induce calcium perturbations within brain cells producing
secondary effects, which include cellular stress, inflammation, and apoptosis. These secondary
effects can be potentially targeted to preserve the tissue surviving the initial impact of TBI. In the
past, TBI research had focused on neurons without any regard for glial cells and the
cerebrovasculature. Now a greater emphasis is being placed on the vasculature and the
neurovascular unit following TBI. A paradigm shift in the importance of the vascular response to
injury has opened new avenues of drug treatment strategies for TBI. However, a connection
between the vascular response to TBI and the development of chronic disease has yet to be
elucidated. Long-term cognitive deficits are common amongst those sustaining severe or
multiple mild TBIs. Understanding the mechanisms of cellular responses following TBI is
important to prevent the development of neuropsychiatric symptoms. With appropriate
intervention following TBI, the vascular network can perhaps be maintained and the cellular
repair process possibly improved to aid in the recovery of cellular homeostasis.
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INTRODUCTION
Traumatic brain injury (TBI) represents an enormous societal burden both with regard to
prevalence/incidence and economic cost (initial treatment and long-term care due to high
morbidity), largely irrespective of initial injury mechanism. In fact, TBI is the leading cause of
trauma-related morbidity and mortality in developed countries, with over 55 million people
affected internationally (Bruns and Hauser, 2003). Interestingly, the mechanism of TBI
sustained is often related to the patient’s age with younger patients more likely suffering TBI as
the result of motor vehicle accidents, sports, or battlefield exposure to blast waves whereas the
elderly population is generally afflicted by falls (neurogenic or cardiogenic in origin). TBI is
also distributed bimodally with peak incidences between 15-24 years, and after 75 years of age.
Notably, after age 65, patients have increased mortality and worse functional outcome following
TBI (Susman et al., 2002). The most prominent cause of TBIs is motor vehicle collisions
(Dagher et al., 2010). Concussive injuries are also high amongst professional athletes and the
active military due to the high-risk for a neurotraumatic event to occur on the job (Guskiewicz et
al., 2003; Rigg and Mooney, 2011). These sub-populations should therefore be the focus for
future translational studies.
TBI is unique in that it is always acquired from an external force. One difficulty when
treating TBI patients is that we never know when, or how, a TBI will occur. Therefore, the
contribution of genetic predisposition and comorbidities to overall post-injury outcomes are hard
to ascertain. A valuable scale, called the Glasgow Coma Scale (GCS), is used to assess verbal,
motor, and eye-opening responses in order to classify TBI severity (Kay and Teasdale, 2001).
The score is based on a 15-point scale. Mild injury correlates with a score of 13+, moderate with
a score 9-12, and severe with a score of <8. Its clinical utility is mostly to help determine patient
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status in relation to intracerebral pressure (Balestreri et al., 2004). As such, the clinician can use
the score to determine the need for appropriate treatment or management. The values obtained
from the GCS help define the severity of TBI and allows clinicians to address the injury more
appropriately (Foreman et al., 2007). In addition, patients can display cognitive, emotional, and
sensory impairments following mild TBIs and even exhibit physical impairments following more
severe forms of TBI. Research now suggests that visible signs, or symptoms, of neurological
dysfunction from sports-related TBI may not develop for an extended period of time (Bailes et
al., 2013).
Imaging modalities have recently been used to detect some of the subtle injury changes
associated with TBI. Microdialysis in combination with nuclear magnetic resonance imaging was
used to determine that TBI patients have increased anaerobic metabolism dependent on the
pentose phosphate pathway (Jalloh et al., 2014). Diffusion tensor imaging has been used with
mixed success in detecting white track lesions following concussion (Shin et al., 2014).
Functional magnetic resonance imaging (fMRI) has been used to tease out differences in
Salience Network functioning following TBI indicative of failed cognitive control (Jilka et al.,
2014). In the clinic, Czosynka’s pressure reactivity index can be used to establish a dynamic
target for cerebral perfusion pressure (Depreitere et al., 2014). Another important consideration
is monitoring of cerebral blood flow to prevent the occurrence of ischemia following TBI.
Positron emission tomography, perfusion-weighted MRI, and the perfusion computed
tomography scan may be used for this endeavor (Rostami et al., 2014).
Two general forms of TBI exist: closed head injury and penetrating head injury (PeekAsa et al., 2001). TBI is grouped into three levels of severity: mild, moderate and severe
(Peskind et al., 2013). Further subclassification of injury is based on symptoms. Subconcussive
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injury can have no initial symptoms, concussive injury (acute) presents with cognitive,
emotional, and sleep symptoms, while juvenile head trauma syndrome presents with a lucid
interval and unconsciousness. Post-concussive syndrome involves concussive symptoms lasting
greater than 3 months, and chronic traumatic encephalopathy involves a several year symptom
free stage followed by onset of neuropsychiatric symptoms (McKee et al., 2014). Mild TBIs are
common and can go undetected with conventional screening tools, although balance tests and
cognitive measurements have been used with varied success rates (Harmon et al., 2013; Ruhe et
al., 2014). Typically, mild TBI leaves the subject conscious with mild symptoms; however,
rodent students have shown that secondary effects often lead to chronic deficits in cognition,
memory, and behavior (Hamm et al., 1992; Milman et al., 2005). Molecular mechanisms of the
secondary effects of mild and moderate TBI are being investigated due to the increased
awareness of how these effects contribute to chronic neuropsychiatric symptoms (Koponen et al.,
2002). Severe TBI is often life-threatening and requires immediate care. Fewer basic scientists
study severe TBI because its effects are more likely irreversible in both the short-term and the
long-term.
We have limited knowledge of what brain regions are most affected after a TBI, due to
the fact the injury can either be focal or diffuse depending on the type and severity. As such,
clinicians struggle with identifying which brain regions have been affected after injury. The
brain’s response to TBI is more often globally distributed with a vast number of dilated
perivascular spaces (Inglese et al., 2005). Pathologic changes are scattered throughout the brain
as well and are highly dependent on neuroinflammation as evident from gliosis (Streit et al.,
2004). With the many different forms of TBI, the diagnosis and treatment plans must be
adaptable and situational specific.
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To date, the primary focus of TBI research has been on neurons with little emphasis on
glial cells or the cerebrovasculature. Indeed, for this review, we identified 1030 published reports
that assess neurons, and only 326 reports that assessed other brain cell types, including 46 reports
on brain microvessels. The current skewing of research in TBI literature toward neurons is
understandable, given the underlying goal of protecting neurons and preserving brain function. A
neurocentric approach however has not resulted in successful translation of therapeutics in TBI
(Maas, 2001; Kabadi and Faden, 2014), or other models of neural injury (Korczyn, 2012). It is
clear other approaches are needed to be successful. Microvessel disruption plays a substantial
role in primary, secondary and chronic effects of TBI, and understanding the response of the
vascular system on brain trauma is critical to our ability to effectively treat brain trauma. As
such, it is clear other approaches are needed and this review deals with the response of all brain
cell types to trauma and focuses on the potential role of microvessel damage to neuronal loss and
dysfunction.
Forms of Traumatic Brain Injury
In human subjects, there are a number of causes of TBI and include motor vehicle
collisions, falls, sport-associated injuries, blast exposure, and shaken baby syndrome in infants
(Table 2)(Zhang et al., 2014b). Besides characterizing the injury based on a specific inciting
event, the injury can be described as open or closed head injury, focal or global injury, and
impact or blast in origin. Blast injury can be subdivided further into primary, secondary, tertiary,
or quaternary injury, a level of detail beyond the scope of this review but discussed in detail
elsewhere in the literature (Covey and Born, 2010; Yeh and Schecter, 2012). The different forms
of neurotrauma can further be classified based on clinical features through the GCS assessment,
pathological features through advanced imaging assessment, or a combination of the two.
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While numerous causes of neurotrauma exist, TBI is uniformly associated with both
primary and secondary injury mechanisms. The primary injury is induced instantaneously by the

application of external forces to the skull and associated brain tissue, depending on the form of
TBI. Impact TBI induces focal brain contusions (Sutton et al., 1993), while blast TBI globally
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shears axons (Raghupathi and Margulies, 2002) and damages brain microvessels (Abdul-Muneer
et al., 2013) (see Fig 1, Adapted from (Turner et al., 2013a)). The secondary injury follows the
primary injury temporally and rodent studies have shown it is associated with induction of
signaling cascades that alter metabolic, cellular and molecular events, ultimately leading to
alteration in cellular function and/or death (Rink et al., 1995). This period of secondary injury
can last from minutes to years and is mediated by biochemical processes that may be targeted by
and amenable to therapeutic development (Ramlackhansingh et al., 2011); whereas primary
injury can only be prevented (through safety devices, preventative measures, reduced exposure,
etc).
To improve understanding of TBI pathophysiology, as well as develop potential
therapeutic agents, an array of TBI models have been created and utilized. Some of the most
commonly utilized models include the fluid percussion models; variations of the impact
acceleration or weight drop models, the controlled cortical impact models, and variations of the
shock tube blast models. These models and others such as penetrating injury models are
reviewed in depth elsewhere (Albert-Weissenberger and Siren, 2010; Xiong et al., 2013; AngoaPerez et al., 2014; Zhang et al., 2014b). Importantly, TBI represents a highly heterogeneous
condition due to the various mechanisms involved and range in forces that are applied/sustained.
As such, it is unlikely that one model is adequate for all TBI research and consequently a multifaceted approach is likely required. This is reflected in the approach taken by oversight and
advisory groups in which consortiums have been formed to evaluate proposed therapeutics
across a range of models in search of identifying not only promising therapeutic candidates but
also the most appropriate scenarios in which to clinically test agents (Kochanek et al., 2011).
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Importantly, the diversity of pathophysiological processes involved in neurotrauma has
been increasingly recognized with recent studies investigating the role of non-neuronal cell
types, such as astrocytes and microglia in neurotrauma, as well as the role of the neurovascular
unit and associated blood-brain barrier (BBB). Emerging evidence with in vivo models has
implicated these cell types and the BBB in outcomes following neurotrauma, with a particular
emphasis on both microvascular and macroscopic components of vascular disruption (Jiang et
al., 1992; Pop and Badaut, 2011; McKee et al., 2013; Miyauchi et al., 2013; Yeoh et al., 2013;
Liao et al., 2014). This is particularly relevant clinically as macroscopic bleeds, such as epidural
and subdural hematomas, may be managed neurosurgically, and microvascular/microscopic
bleeds have been implicated in neurodegeneration associated with neurotrauma (Wilberger et al.,
1991; McKee et al., 2013).
Traumatic Brain Injury Effects on Neurons
Following TBI there are immediate primary effects and sub-acute secondary effects.
Primary effects to the brain from TBI cause damage to neurons, glia, and the vasculature (Table
3). Secondary effects to the brain from TBI include: inflammatory responses (Begum et al.,
2013), cellular stress (Farook et al., 2013), and apoptotic cascades (Clark et al., 1997). The
physical forces of TBI can shear axons (Raghupathi and Margulies, 2002), break down
plasmalemma (Cullen et al., 2011), and rupture brain microvessels (Arun et al., 2013). When an
axon is torn, or a cell membrane is broken from the external forces of TBI, the neurons can
rapidly depolarize and activate voltage gated Ca2+ channels; thereby, increasing intracellular
Ca2+ (Gurkoff et al., 2013). Appropriate modeling of the primary effects of TBI will enable
researchers to effectively study therapeutic options for the secondary effects.
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Axonal injury has emerged as one of the most important pathological features of TBI.
The rotational and acceleration/deceleration components of blast-induced TBI, commonly tears
axons apart leading to a robust gliosis response and axonal degeneration (Creed et al., 2011;
Goldstein et al., 2012; Li et al., 2013b). Axonal swelling and bulb formation are common
morphological hallmarks observed following TBI and contribute to decreased action potential
firing (DiLeonardi et al., 2009, 2012). Axonal injury is a result of TBI and is evident in the white
matter areas of the brain (Li et al., 2013c), and is the initial pathology in neurodegenerative
diseases (Adalbert et al., 2009). Injury to axons is present in all severities of TBI and may
represent a key hallmark of TBI for modeling purposes (Johnson et al., 2013b). Therefore,
defining the neurodegenerative mechanisms induced by axonal injury would allow us to better
model the injury and identify specific targets for neuroprotection.
The mechanical forces of brain trauma can also rupture microvessels (Abdul-Muneer et
al., 2013). Specifically, the traumatic force causes an intracranial pressure spike which causes
cerebral microvessels to burst (Arun et al., 2013). When an external force damages brain
microvessels they can release cytotoxic levels of iron into the brain parenchyma (Liu et al., 2013;
Nisenbaum et al., 2014). Iron promotes Ca2+-dependent mechanisms, which can stimulate cell
survival, or trigger cell death depending on severity and duration of iron exposure (Munoz et al.,
2006; Munoz et al., 2011). Ca2+-dependent mechanisms observed following TBI include the
unfolded protein response (Ron and Walter, 2007; Farook et al., 2013), proteasomal degradation
(Sano and Reed, 2013), autophagy (Bernales et al., 2006), apoptosis (Clark et al., 2000;
Nakagawa and Yuan, 2000), and neurodegeneration (Salminen et al., 2009). TBI-induced
intracellular Ca2+ increase also prompts reactive oxygen species (ROS) accumulation (Cho et al.,
2013), triggers neuroinflammatory cascades (Szmydynger-Chodobska et al., 2010), and can
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influence excitatory amino acids release (Shohami and Biegon, 2014). These secondary effects
could potentially be targeted for therapy and warrant further investigation.
Vascular Effects of Traumatic Brain Injury
The external forces of a TBI induce vascular damage with both the initial insult and the
ensuing secondary effects (Roth et al., 2014). It has been proposed that secondary effects can be
therapeutically treated because they are driven by pathogenic alterations to signal transduction
mechanisms. The vascular effects of TBI include vasospasms, hemorrhage, hypoxia
inflammation and BBB disruption. Determining how TBI leads to cell death will provide a better
understanding of the secondary effects and provide better therapeutic options. Targets could
include BBB restoration after injury, or even using the injury to advantageously deliver drugs
during a time window where the BBB is more permeable. This approach will allow
pharmacological investigation of mechanisms using drugs that do not easily cross the BBB.
Vasospasms, Subarachnoid Hemorrhage, Edema and Ischemic Hypoxia
Cerebral vasospasm can be a serious outcome of TBI due to the resulting cerebral hypoperfusion
(Izzy and Muehlschlegel, 2014). TBI can trigger molecular mechanisms that rapidly mediate
vascular tone (See Fig. 2) (Chen et al., 2013a). One such mechanism is the release of a potent
vasoconstrictor, endothelin-1, from damaged pericytes (Dore-Duffy et al., 2011; Paradis and
Zhang, 2013). Parenchymal contusions and fever increase the risk for vasospasm (Shahlaie et al.,
2011). Up to 68% of individuals with TBI experience short duration vasospasms (Kramer et al.,
2013), which are especially common in soldiers exposed to blast TBI (Alford et al., 2011).
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Vasospasms resulting from TBI can lead to ischemic episodes, energy depletion and cell
necrosis; in other words, an inability for brain cells to compensate for increased metabolic
functional overload (Ling et al., 2009). Vasospasms are frequently associated with recurrent

intracranial hypertension and subarachnoid hemorrhage (Razumovsky et al., 2013; Wilson and
Shankar, 2014). Blast TBI, in particular, can cause cerebral vasospasms that last for more than
30 days and are associated with altered mental status (Magnuson et al., 2012). Severe vasospasm
must be adequately treated to avoid permanent neurologic deficits or ischemic stroke (Bauer and
Rasmussen, 2014). CT angiography is the diagnostic gold standard for vasospasm (Sanelli et al.,
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2014). Endovascular treatment and vasodilator therapy have both proven to be successful
treatment approaches (Asakuno and Ishida, 2014; Kelman and Reavey-Cantwell, 2014).
Mild TBIs typically exhibit subdural hemorrhaging, while more severe TBIs can display
traumatic subarachnoid hemorrhage—increasing the likelihood of diffuse axonal injury, edema,
and skull fracture (Mata-Mbemba et al., 2014b). CT imaging is the gold standard for diagnosis of
subarachnoid hemorrhage severity (Mata-Mbemba et al., 2014a). The recent establishment of the
clinical course score has allowed for the improved monitoring of subarachnoid hemorrhage over
time (Brandner et al., 2014), and follow-up CT scans are only needed if new bleeding is a
concern (Rubino et al., 2014). TBI has the highest average years of potential life lost for all
neurological disorders partly due to traumatic subarachnoid hemorrhage (Rosenbaum et al.,
2014). Subarachnoid hemorrhage can lead to increased mortality, extended hospital stays, and
central diabetes insipidus (Hochstadter et al., 2014). Most importantly a likely complication of
subarachnoid hemorrhage is cerebral vasospasm (Faust et al., 2014). A common treatment option
for hemorrhagic change that infiltrates the ventricles is a ventriculostomy followed by
ventriculoperitoneal shunt placement (Chalouhi et al., 2014). In severe cases of TBI with
subarachnoid hemorrhage where herniation is anticipated, decompressive craniectomy can be
performed (Lazaridis and Czosnyka, 2012). Fortunately, most intracerebral hemorrhages are
minor and will resolve on their own with time (Levy et al., 2013).
Brain edema following TBI can cause serious complications by limiting brain oxygen
delivery and increasing intracranial pressure (Nirula et al., 2014). The pressure increase is more
common in children experiencing TBI than adults (Ewing-Cobbs et al., 2000) Hounsfield unit
values from brain CT mapped across an intracranial area can be used to accurately predict brain
edema following TBI in children (Kim et al., 2014). A new imaging modality, shear wave
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elastography, has also been tested in rodents and gives an accurate representation of edema (Xu
et al., 2014b).Ulinastatin, a serine protease inhibitor, is currently being investigated for reduction
of edema in rodents following TBI (Cui and Zhu, 2014). Decompressive craniectomies are
common in clinical practice (Nirula et al., 2014). Decompressive craniectomies can prevent the
intracranial pressure rise and potential herniation associated with edema (Bor-Seng-Shu et al.,
2013). Decompressive cranectomies are not without risk and a recent report showed 83% of
patients developed hygromas and 50% of patients developed aseptic bone resorption (Pechmann
et al., 2014). Continued work is necessary to find viable alternatives for the treatment of edema.
A primary complication of ischemic hypoxia following TBI is hemispheric hypodensity
(Foster et al., 2014). Ischemic hypoxia can cause the toxic release of hypoxia-inducible factor 1alpha (Schaible et al., 2014), leading to inflammatory cascades (Qutub and Popel, 2008).
Outcomes from the inflammatory cascade include axonal injury and central myelin damage (van
der Eerden et al., 2014). Point in time monitoring revealed that ~10% of TBI patients experience
some ischemic hypoxia (Padayachy et al., 2012). Ischemic hypoxia following TBI is associated
with poorer functional independence measures (Cullen et al., 2009). Applying techniques for
brain oxygen optimization in clinical care has produced the most successful treatment results
(Mangat, 2012). Continuous neurophysiologic recordings are imperative for appropriate patient
management (Amantini et al., 2012). In extreme circumstances, red blood cell transfusion may
be required (Kramer and Le Roux, 2012). Experimental treatment with mild hypothermia has
produced profound preclinical neuroprotection in a variety of TBI models (Fujita et al., 2012a;
Miyauchi et al., 2014) and initial human clinical trials (Lee et al., 2010) have proved promising.
Blood-brain Barrier Disruption: Neuroinflammation and Reactive Oxygen Species

14

The neurovascular unit can become damaged with TBI. The neurovascular unit controls
blood flow to the brain, nutrient delivery, and maintenance of BBB integrity (Hartmann et al.,
2014). The BBB is an anatomical structure that plays a key role in normal brain physiological
regulation. The BBB is composed in part of astrocyte podocytes, a basement membrane,
pericytes, and the endothelium connected with tight junction proteins. (Badaut and Bix, 2014).
With regard to TBI, little is known about the role of BBB disruption in disease pathology (Alves,
2014).
Neurovascular inflammation can lead to the formation of ROS (Abdul-Muneer et al.,
2014). Neuronal injury can occur when ROS exceeds the brain’s defense and clearance
mechanisms (Adibhatla and Hatcher, 2010). ROS are generated from mitochondrial damage as
well as the nicotinamide adenine dinucleotide phosphate-oxidase system at the plasma
membrane (Zhang et al., 2012). ROS can eventually contribute to disruption of the BBB, edema,
and neuroinflammation (Pun et al., 2009). ROS contribute to downregulation of tight junction
proteins at the microvessel interface (Abdul-Muneer et al., 2013). In addition, formation of ROS
ultimately triggers glial cell activation producing additive injury to the brain parenchyma (Roth
et al., 2014). Oxidative stress stimulates the release of inflammatory factors: interleukin-1beta,
tumor necrosis factor-alpha, and transforming growth factor-beta (Abdul-Muneer et al., 2014).
ROS also disrupt the vasculatures ability to self-regulate and constrict (DeWitt and Prough,
2009). Ultimately, ROS depression of cerebral metabolism can have long-term consequences
manifesting in chronic neurodegeneration and behavioral abnormalities (Tavazzi et al., 2005).
Proton therapy through use of hydrogen infused saline can limit the damage to endothelial cells
by preventing BBB disruption and the formation of ROS (Ji et al., 2012). Another means of
limiting oxidative stress is maintenance of mitochondrial homeostasis (Pandya et al., 2009).
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Uncoupling the mitochondrial oxygen cascade early following TBI has proved beneficial in
limiting ROS formation and calcium overload (Pandya et al., 2007). Cerebral microdialysis has
been proposed as a diagnostic test for detecting the concentration of free radicals within the brain
(Hillered et al., 2005).
BBB disruption is common amongst TBI patients. Approximately 44% of patients who
experience severe TBI have BBB breakdown (Ho et al., 2014). In addition to being effected by
ROS, BBB breakdown itself can lead to enhanced neuroinflammation and the formation of ROS
(See Fig. 3) (Abdul-Muneer et al., 2014). Damage to the BBB also leads to the release of
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neurotoxic proteins into the brain parenchyma (Helmy et al., 2011a; Helmy et al., 2011b).
Prolonged inflammation can eventually contribute to myelin loss (Glushakova et al., 2014).
Omega-3 supplementation in rodents can limit BBB breakdown by inhibiting matrix
metalloproteinase 9 activity (Russell et al., 2014). Targeting estrogen receptors may also be a
viable therapeutic target due to decreased BBB permeability following TBI in female rats (Asl et
al., 2013).
Tight junctions between endothelial cells maintain vascular integrity, but are often
sheared following TBI (Xu et al., 2014a). Blast TBI, in particular, causes a rapid blood pressure
spike leading to disruption of the tight junction proteins at the BBB (Yeoh et al., 2013).
Alternatively, astrogliosis can also lead to BBB modulation over time (Liu et al., 2014c).
Astrocytes support endothelial cell function at the neurovascular unit and direct control of
permeability (Molino et al., 2014). Astrocytes and neurons help support the basement membrane
surrounding the endothelial cells (Schiera et al., 2003). Podocytes from astrocytes contain
vascular endothelial growth factor, which can be released when the BBB is damaged (Saito et al.,
2011). The biomarker, pituitary adenylate cyclase activating polypeptide, offers promising
diagnostic potential for determining BBB disruption (Bukovics et al., 2014). Currently, digital
imaging quantification is the primary method of diagnosis (Biancardi et al., 2014).
Secondary Effects of Traumatic Brain Injury
Shortly after TBI, biochemical mechanisms assist in repairing cells that survive the
primary insults of TBI. On the other hand, those same mechanisms can cause injured cells to die
in order to preserve energy for other cells undergoing the energy-dependent repair process. The
brain plays a game of checks and balances (using energy as currency) to determine which
neuronal cells are worth saving after TBI. Programmed cell death, or apoptosis, is a necessary
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mechanism following neuronal injury and may be beneficial to the CNS. However, the resulting
effects from an apoptotic event can cause further damage within the brain through the process of
neuroinflammation (Abdul-Muneer et al., 2014).
Even after mild TBI neuronal apoptosis is evident around perivascular regions, indicative
of cerebral vascular injury (Abdul-Muneer et al., 2013). Brain damage from TBI was reported to
be associated with decreased mitochondrial membrane potential and increased release of
cytochrome C in rodents—both indicative of cellular apoptosis (Wang et al., 2014). Cleavedcaspase-3 and caspase-3 enzyme activity was reportedly increased in TBI animals versus control
(Clark et al., 2000). Models of TBI have also shown upregulation of caspase gene expression
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(Larner et al., 2004). These results indicate that caspase activity contributes to brain tissue loss,
and that caspase inhibition may prove to be an effective treatment strategy for TBI.
The secondary effects of TBI can be attenuated with therapeutic interventions given at
the right time following neurotrauma. The series of molecular, neurochemical, cellular, and
pathophysiological mechanisms resulting from TBI can be targeted with drug therapy designed
to manipulate the signaling mechanisms of various cellular and subcellular processes. The
secondary mechanisms of TBI include: neuroinflammation, oxidative stress, endoplasmic
reticulum (ER) stress, glutamate excitotoxicity, calpain processing, apoptosis and tau
hyperphosphorylation (see Fig. 4). The timing and duration of each event is dependent on the
type and severity of the TBI in question; therefore, each treatment strategy could be
individualized to the specific type of TBI. The aforementioned secondary mechanisms are
described in more detail below.
Endoplasmic Reticulum Stress, Excitotoxicity and Calpain Processing
TBI occurs over a very short duration, and is often mild in nature, compared to other
neural injuries. TBI often goes undetected and chronic deficits often take years to develop
(Omalu et al., 2011a; Omalu et al., 2011b). TBI harms neurons by perturbing Ca2+ homeostasis
in an energy-independent process. The damage done by TBI makes membranes more permeable
to Ca2+ and even to extracellular proteins (Arun et al., 2013). What is known is that neural injury,
in particular TBI, causes massive neuronal depolarization and a resulting large influx of Ca2+.
Cells which withstand the immediate physical injury from TBI, will have disrupted intracellular
Ca2+ levels and oxidative stress (Malhotra and Kaufman, 2007). As described previously,
oxidative stress can induce neuroinflammation, which is known to cause neuronal death and is
associated with chronic disease pathology (Cernak and Noble-Haeusslein, 2010).
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ER stress has been implicated in a variety of TBI models (Rubovitch et al., 2011a;
Farook et al., 2013; Begum et al., 2014). ER stress then triggers the unfolded protein response
(UPR) as an endogenous means of cellular repair. TBI-induced Ca2+ perturbations cause proteins
to unfold, and when the ER becomes overwhelmed and struggles to re-fold the unfolded proteins,
the UPR ensues (Larner et al., 2006). In the short-term, the UPR can promote cell survival
through three separate mechanisms: (1) attenuation of global protein translation, (2) upregulation
of stress response genes, and (3) degradation of unfolded proteins (Mori, 2000). Apoptosis and
neurodegeneration are the end-game consequence if ER stress and the UPR are prolonged
(Deniaud et al., 2008; Moreno et al., 2012). The UPR has only recently been addressed by TBI
investigators because of its new found link to neurodegeneration (Moreno et al., 2013). The
timing and duration of the UPR and how exactly it develops into a neurodegenerative phenotype
warrants further investigation.
Another secondary mechanism of TBI also involving calcium disruption is glutamate
signaling and the phenomenon known as excitotoxicity. TBI triggers a massive depolarization
which promotes excessive glutamate release (Katayama et al., 1990). This disrupted regulation in
glutamate signaling plays a role in the pathophysiology of TBI through the initiation of
secondary injury cascades (Bullock et al., 1998). High extracellular glutamate promotes high
levels of intracellular Ca2+ following TBI (Truettner et al., 2007). Secondary injury cascades
initiated by glutamate receptors and the disruption of Ca2+ homeostasis will activate calciumdependent proteases, disrupt energy-dependent processes, and produce oxidative stress (Faden et
al., 1989; Yi and Hazell, 2006). Using drug therapy to regulate glutamate release may help to
attenuate the secondary effects of TBI exposure.
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Loss of microvascular integrity and BBB compromise are often related to brain injuries
involving Ca2+ perturbations. In brain trauma models acute and sustained activation of the
calpain family of proteases has been implicated in neuronal death and TBI (Liu et al., 2014a).
Calpains are acutely activated following TBI within the injured hippocampus and frontal cortex
(Ringger et al., 2004). Calpain activation has been observed in degenerating dendrites and
atrophic neurons after TBI, providing evidence that calpain activation may participate in
neuronal loss after neurotrauma (Huh et al., 2006). Activation of Ca2+-dependent proteases, such
as calpain, is a predicted outcome of membrane depolarization and loss of Ca2+ homeostasis. Its
regulation of cytoskeletal dynamics contributes to plasticity (Greer et al., 2013) and is consistent
with injury deficits in axonal architecture and disruption of synaptic plasticity (Dapul et al.,
2013). Animals exposed to TBI can exhibit damaged axonal hillocks, suggesting detrimental
changes to their synaptic function (Baalman et al., 2013). Moreover, calpain-dependent
processes in TBI models have been suggested to attenuate overall electrophysiological responses
(Park et al., 2013) and invoke more neuronal death (Schafer et al., 2009).
Chronic Effects of Traumatic Brain Injury
Alteration of cerebral blood flow has been linked to delayed neuronal death in the
contusion penumbra (Engel et al., 2008). Hemorrhagic shock causes immediate reduction in
mean arterial pressure with continued apoptosis over time due to perpetual lack of perfusion
(Dennis et al., 2009). At extended time points TBI continues to cause disruption in the
autoregulation of cerebral vasculature (Pop and Badaut, 2011). A primary mechanism is
temporal changes in V1a vasopressin receptors (Szmydynger-Chodobska et al., 2004).
Vasopressin receptor stimulation contributes to cerebral edema that leads to increased
intracellular uptake of H2O from the blood (Marmarou et al., 2014). The disruption in vascular
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supply can contribute to perivascular nerve damage (Ueda et al., 2006). In addition, systemic
hypotension can contribute to chronic neurodegeneration (Long et al., 2009). Persistent
activation of calpain proteases is another mechanism by which persistent hypotension leads to
neuronal pathology (Newcomb et al., 1999). Calpains cleave the contractile components of
vascular smooth muscles inhibiting their ability to contract (Neuhof and Neuhof, 2014).
Not surprisingly, cerebral hypotension has been associated with neurodegenerative
diseases such as Alzheimer’s disease and Parkinson’s disease (Le Heron et al., 2014). A genetic
mutation in Neurogenic locus notch homolog protein 3 increases the risk for small vessel disease
following TBI and has been linked as well to Alzheimer’s disease (Marchesi, 2014).
Interestingly, microvasular defects may be linked to Alzheimer’s disease due to the increased
incidence of neurological disease in TBI patients (Dennis et al., 2009). Preventative treatment
approaches are limited, but a few experimental techniques appear promising. Closely regulated
hypothermia therapy can prevent chronic microvessel changes and contustion expansion (Zhong
et al., 2009), while compressing the internal jugular vein has also been shown to mitigate axonal
injury and vascular disruption (Smith et al., 2012; Turner et al., 2012b). Because TBI cannot be
predicted a post-injury therapy that mitigates the detrimental chronic effects is therefore needed.
Tau protein hyperphosphorylation and amyloid beta oligomers are well-known markers
of neurodegenerative disease. TBI has been shown to hyperphosphorylate tau protein (Goldstein
et al., 2012), and produce amyloid beta oligomers (Smith et al., 2003), through mechanisms that
are not completely understood. These neurodegenerative factors are activated immediately
following TBI and can advance profoundly over time (see Fig. 5). The cellular repair
mechanisms associated with these factors are more drawn out, and may contribute to
neurodegenerative disease progression and brain matter loss (Hoozemans et al., 2007; Scheper et
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al., 2011). Cortical tissue loss and white matter atrophy resulting from TBI are associated with
cognitive deficits (Huh et al., 2008). Cognitive deficits in rodents have been observed at chronic
time points following TBI (Petraglia et al., 2014c), indicating neurodegenerative disease
progression in rodent models of TBI. How the primary effects of TBI manifest into chronic
disease states is an area of ongoing investigation. The brains of professional athletes and military
veterans are currently being examined with new imaging modalities to discover underlying
causes behind neuropsychiatric symptoms such as post-traumatic stress disorder, chronic
traumatic encephalopathy, and Alzheimer’s disease (Small et al., 2013). Moving forward, TBI
research needs to emphasize vascular effects, glial responses and resulting neurodegeneration.
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Future Directions
Primary and secondary mechanisms of TBI are undergoing continued investigation. What
remain to be determined are the tertiary mechanisms that mark the transition from acute injury to
chronic neurodegeneration. Studying the broader role of cerebrovascular changes and how these
changes interact with neurons and glia must be carefully considered in future investigations.
Chronic mechanisms might very well deal with the vasoregulation of cerebral vessels and how
microvessels respond to inflammatory markers. In addition, the theory of ‘inflamm-aging’ is
likely to take precedence, because aged neurons and glia respond differently to injury-induced
stimuli. How these aged cells interact with concurrently aged and previously injured vascular
system has not been fully elucidated. Chronic disease states are subject to the effects of both agerelated comorbidities and aging itself.
Future studies must incorporate a broader approach utilizing more representative models.
Animal models of TBI have been developed, but therapeutics have not yet translated successfully
to the clinic. Therefore, an increasing need exists for the development of more clinically relevant
TBI models, and the use of advanced MRI and PET imaging to map the dynamics of brain injury
responses. This will enable us to devise more effective therapeutic interventions for the amenable
secondary effects. Further studies utilizing BBB compromise following TBI could be
advantageous for pharmaceutical researchers attempting to alter brain mechanisms. In addition,
the balance between protein phosphatases vs. kinases will need to be heavily investigated.
Marking the transition to amyloidopathy and/or tauopathy will provide important insight into
effective treatment windows. More importantly, understanding chronic mechanisms of injury
will allow a more tailored and individualized approach to patient care.
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Table 1.1: Forms of Traumatic Brain Injury
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Table 1.2: Neurotoxic Events in Traumatic Brain Injury
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OBJECTIVES

Study I: Validate neural injury in the rat model of traumatic brain injury over time

Blast-induced traumatic brain injury represents a leading cause of injury in modern warfare with
injury pathogenesis poorly understood. Preclinical models of blast injury remain poorly
standardized across laboratories and the clinical relevance unclear based upon pulmonary injury
scaling laws. Models capable of high peak overpressures with short durations may better
replicate clinical exposure when scaling principles are considered. In this work we demonstrate
a tabletop shock tube model capable of high peak overpressures of short duration. By varying the
thickness of the polyester membrane, peak overpressure could be controlled. Blast exposure was
shown to decrease total activity and histology revealed markers of neuronal degeneration,
increased glial activation, and Blood-brain barrier disruption. This work demonstrates one of the
first examples of blast-induced brain injury in the rodent when exposed to a blast wave scaled
from human exposure based on scaling principles derived from pulmonary injury lethality
curves.

Study II: Characterize traumatic brain injury in the rat by investigating primary injury
effects, secondary injury cascades, neurophysiology and neurobehavioral dysfunction

Traumatic brain injury resulting from blast exposure is the most common injury of military
combatants. Animal modeling of blast-induced traumatic brain injury has demonstrated severe
histopathological effects accompanied by loss of long-term synaptic plasticity and cognitive
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performance due to tissue damage. Here we use a scaled blast model that was specifically
developed to assess the neuropathological, neurophysiological, and biochemical effects of
exposure to blast forces not severe enough to cause overt physiological deficits or behavioral
changes. We find that mild blast exposure induces no observable macroscopic histological
effects, but instead causes microvascular injury, axonal damage, and neuroinflammation in
various brain regions including hippocampus. Hippocampal deficits in short term plasticity and
synaptic excitability were observed after mild blast exposure. Biochemical analysis revealed that
mild blast exposure invokes markers of excitotoxicity and neuronal injury in hippocampus. Thus
mild blast exposure causes subtle but deleterious neurological effects in the absence of major
behavioral deficits, suggesting that subclinical exposures to blast forces may initiate
neuropathology.

Study III: Investigate the effects of endoplasmic reticulum stress modulation on cellular
fate and impulsive-like behavior in rats exposed to traumatic brain injury

Neuronal injury following blast-induced traumatic brain injury increases the risk for
neuropsychiatric disorders, yet the pathophysiology remains poorly understood. Blood-brainbarrier disruption, endoplasmic reticulum stress, and apoptosis have all been implicated in
neurotrauma. Microvessel compromise is a primary effect of neurotrauma and is postulated to
cause subcellular secondary effects. What remains unclear is how these secondary effects progress
to personality disorders in humans exposed to head trauma. To investigate this we exposed male
rats to a clinically relevant traumatic brain injury model we have recently developed. The study
examined initial Blood-brain barrier disruption, endoplasmic reticulum stress mechanisms,
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apoptosis and impulsive-like behavior. The endoplasmic reticulum stress inhibitor, salubrinal, was
administered (1mg/kg i.p.) to investigate its’ effects on neuronal injury and impulsive-like
behavior associated with neurotrauma. Results would provide evidence that neurotrauma involves
endoplasmic reticulum stress and suggest a promising molecular target for the attenuation of
neuronal injury and amelioration of neuropsychiatric symptoms after neurotrauma.

Study IV: Investigate the effects of endoplasmic reticulum stress modulation on
neuroinflammation and risk-taking behavior in rats exposed to repetitive traumatic brain
injury

TBI is the leading cause of trauma related morbidity in the developed world. TBI has been
shown to trigger secondary injury cascades including endoplasmic reticulum stress, oxidative
stress, and neuroinflammation. The link between secondary injury cascades and behavioral
outcome following TBI is poorly understood and warrants further investigation. Using our
validated rodent blast TBI model, we examined the secondary injury cascades following single
injury and how these effects may contribute to risk-taking behavior after repetitive TBI. We
targeted these pathways with the cellular stress modulator, salubrinal, and investigated its role in
decreasing neuroinflammation and risk-taking behavior after blast injury. Overall, these results
would suggest a novel approach to treat neuroinflammation and neuropsychiatric symptoms
following neurotrauma.

Study VI: Model chronic traumatic encephalopathy in multiple models of traumatic brain
injury
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Chronic neurodegeneration following a history of neurotrauma is frequently associated
with neuropsychiatric and cognitive symptoms. In order to enhance understanding about the
underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model preclinical approach must be established to account for the different injury paradigms and
pathophysiologic mechanisms. We investigated the development of tau pathology and behavioral
changes using a multi-model and multi-institutional approach, comparing the pre-clinical results
to tauopathy patterns seen in post-mortem human samples from athletes diagnosed with chronic
traumatic encephalopathy (CTE). We utilized a scaled and validated blast-induced traumatic
brain injury model in rats and a modified pneumatic closed-head impact model in mice. Tau
hyperphosphorylation was evaluated by western blot and immunohistochemistry. Elevated plus
maze and Morris water maze were employed to measure impulsive-like behavior and cognitive
deficits respectively. This study provides a multi-model example of replicating tau and
behavioral changes in animals and provides a foundation for future investigation of CTE disease
pathophysiology and therapeutic development.

30

RATIONALE
Chronic traumatic encephalopathy (CTE) is a serious neuropsychological disease identified in a
growing number of soldiers and athletes exposed to repetitive traumatic brain injuries (TBIs).
This progressive neurodegenerative disease is distinguished neuropathologically by
neurofibrillary tau tangles with a predilection for perivascular and subcortical areas near reactive
astrocytes. The disease is currently diagnosed post-mortem by pathologic identification of the
neurofibrillary tangles. There is a need for pre-mortem diagnosis in an effort to understand
disease pathophysiology and to develop targeted treatments. In order to accomplish this
objective, it is necessary to discover the mechanistic link between acute neurotrauma and the
development of chronic neurodegenerative and neuropsychiatric disorders such as CTE. The role
of endoplasmic reticulum (ER) stress is important to investigate since protein kinase-like ER
kinase (PERK), a key marker of ER stress, is co-localized with hyperphosphorylated tau in
pretangle neurons. The long-term goal of this work is to understand how ER stress modulates
and/or causes the neurofibrillary tau tangles seen in CTE. The central hypothesis is that ER stress
contributes to the neuropathological findings of CTE, and that modulation of ER stress will
improve outcomes. The significance of this proposal is that by examining and manipulating ER
stress, a disease mechanism associated with tau hyperphosphorylation, we will aid in finding
diagnostic and therapeutic treatment options which will have a substantial impact on overall
understanding of acute brain injuries as well as chronic neurodegenerative diseases.
By understanding the role that ER stress plays in the progression of CTE, it will facilitate
the development of urgently needed diagnostics and therapeutics. New imaging modalities and
biomarkers specifically focused on the identification of ER stress proteins will potentially prove
to be an invaluable resource for diagnosing CTE following bTBI. In addition, ER stress
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modification using a drug such as salubrinal will not only provide an effective treatment option
but more importantly a preventative solution to mitigate CTE progression. The far reaching
implications of this proposed research will improve health outcomes and disease management
not only for CTE but also for related neurodegenerative diseases.Regardless of the time course of
activation mediated by the different arms of the ER stress pathway, the valuable information
obtained about the transition phase between cell survival and cell death will provide a strong line
of evidence for exactly when the process of neurodegeneration begins following blast injury.
Understanding the role of ER stress in bTBI will improve our ability to locate pharmacologic
targets to treat and ideally prevent CTE.
TBI has profound and measurable effects on cerebral vasculature. Due to the variable
expression of TBI in the hospital setting, as characterized by the Glasgow Coma Scale and
advanced imaging, individual treatment approaches are a necessity. Understanding complication
of TBI such as subarachnoid hemorrhage, vasospasm, and ischemia are necessary in appropriate
patient management. Mechanism of injury such as acceleration/deceleration, axonal damage, and
vascular disruption are also important to keep in mind. The most promising targets include
secondary injury cascades such as oxidative stress, neuroinflammation, and ER stress. Future
approaches may target chronic mechanisms involved in the development of neurodegenerative
disease. Better pre-clinical models are necessary to map more complex systems such as
glutamate toxicity and calpain mediated cell death. Moving forward, treatment of secondary
mechanisms affecting vascular dynamics is critical both acutely and chronically. Consideration
of age and comorbidities remains a constant factor in any form of neuronal injury.
Neurodegeneration and cellular apoptosis are common following TBI, but improved
management acutely can prevent the common sequelae of symptoms. In order for successful
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therapeutic options to translate to the clinic, TBI research needs to move away from the common
neurocentric approach and change focus towards vascular effects, glial responses and
neurodegeneration.
In summary, ER stress, and the UPR, is activated following TBI. The primary effects of
TBI can produce excess ROS, increased intracellular Ca2+ levels, and induce inflammation;
however, the timing, severity, and duration all vary from model to model. It is difficult to prevent
the immediate effects of TBI, but we can attempt to mitigate the secondary effects that follow.
Preventative therapies, mostly pharmacological agents, have been employed in pre-clinical
models of neural injury, but nothing has yet to successfully translate to the clinic. The approach
has been to mediate apoptosis and reduce neurodegeneration. However, the underlying link
between ER stress, apoptosis and neurodegeneration is not yet fully understood. Research is now
being focused on the most effective treatment strategies to suppress chronic effects resulting
from neural injury. Of particular importance is transferring preclinical success to effective
treatment options for human care. Evidence suggests that combining therapeutic options that
target multiple injury components at the ideal time window will be the most effective strategy
going forward.
Our expectations are that we will determine the role of ER stress in CTE development
and progression. Furthermore, we will show that appropriate manipulation of the ER stress
pathway will improve outcomes in preclinical study, thus justifying the need for further studies,
including those in a clinical population. The significance of this proposal is that by examining
and manipulating the mechanistic process of this disease we will aid in finding diagnostic and
therapeutic treatment options, which will have a substantial impact on overall understanding of
acute brain injuries as well as chronic neurodegenerative diseases.
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Chapter Two
Modeling clinically relevant blast parameters based on scaling
principles produces functional & histological deficits in rats

This work is published in Exp Neurol. 2013 Oct;248:520-9.
doi: 10.1016/j.expneurol.2013.07.008. Epub 2013 Jul 20. PMID: 23876514
Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ,
Gettens RT, Matsumoto RR, Huber JD, Rosen CL.
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ABSTRACT
Blast-induced traumatic brain injury represents a leading cause of injury in modern warfare
with injury pathogenesis poorly understood. Preclinical models of blast injury remain poorly
standardized across laboratories and the clinical relevance unclear based upon pulmonary injury
scaling laws. Models capable of high peak overpressures with short durations may better replicate
clinical exposure when scaling principles are considered. In this work we demonstrate a tabletop
shock tube model capable of high peak overpressures of short duration. By varying the thickness
of the polyester membrane, peak overpressure can be controlled. We used membranes with a
thickness of 0.003, 0.005, 0.007, and 0.010 inches to generate peak reflected overpressures of
31.47, 50.72, 72.05, and 90.10 PSI, respectively. Blast exposure was shown to decrease total
activity and produce neural degeneration as indicated by fluoro-jade B staining. Similarly, blast
exposure resulted in increased glial activation as indicated by an increase in the number of glial
fibrillary acidic protein expressing astrocytes compared to control within the corpus calllosum, the
region of greatest apparent injury following blast exposure. Similar findings were observed with
regards to activated microglia, some of which displayed phagocytic-like morphology within the
corpus callosum following blast exposure, particularly with higher peak overpressures.
Furthermore, hematoxylin and eosin staining showed the presence of red blood cells within the
parenchyma and red, swollen neurons following blast injury. Exposure to blast with 90.10 PSI
peak reflected overpressure resulted in immediate mortality associated with extensive intracranial
bleeding. This work demonstrates one of the first examples of blast-induced brain injury in the
rodent when exposed to a blast wave scaled from human exposure based on scaling principles
derived from pulmonary injury lethality curves.
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INTRODUCTION
Blast-induced traumatic brain injury has been described as the hallmark injury of modern
warfare (Elder and Cristian, 2009; Nakagawa et al., 2011) with ~25,000 members of the armed
services (U.S. and Coalition forces) injured or killed by explosive devices in Iraq and Afghanistan
conflicts in the past decade (Champion et al., 2009). The prevalence of blast exposure is associated
with an immense financial and societal burden with estimates of 13-22% of combat veterans
having sustained a traumatic brain injury (TBI) during time in service (Schneiderman et al., 2008;
Terrio et al., 2009; Panzer et al., 2012). Consequently, there is a clear clinical need for increased
understanding of blast injury pathogenesis and the development of improved therapeutics for the
treatment, or prevention, of blast-induced brain injury. Increasing efforts to study blast injury has
resulted in the propagation of numerous preclinical models of blast injury with the shock tube
representing the most widely used model type. Despite the extensive use of shock tube models,
model parameters such as size of the driver and driven sections, membrane material and thickness,
and gas used seem to vary across laboratories. As such, the shock waves produced vary
significantly in peak overpressure and duration.
Recent work by Panzer and colleagues has identified potential discrepancies between many
preclinical models and real-world recorded blast parameters with models often exposing small
rodents to long duration blasts (Panzer et al., 2012). Assuming the same scaling principles apply
as those discovered with regards to pulmonary blast injury, many current rodent models, in which
overpressure exposure durations frequently exceed 4 ms and in some cases as much as 10 ms or
more, may be subjecting animals to the equivalent of a human exposed to detonation of 27,000-kg
of TNT from over 70 m away (Panzer et al., 2012). In other words, many preclinical models may
be exposing animals to the equivalent of long-duration nuclear blasts in humans rather than the
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more common high explosive blasts (Bass et al., 2012). Therefore, a preclinical blast model
capable of delivering high peak overpressures over short durations may be of value, particularly
should similar scaling laws exist in brain, as is the case in pulmonary-based work.
In this work we demonstrate the ability to model blast injury with clinically relevant peak
overpressure and duration based on scaling laws from humans to rodents with a novel, tabletop
shock tube model. Furthermore, we show the ability to model blast injury of varying severity with
different PET membranes that result in reflected peak overpressures ranging from 31-90 PSI while
consistently being of short duration (< 3 ms). Animals exposed to blast-induced traumatic brain
injury across this range of pressures exhibit alterations in total activity as well as clear histological
changes as determined utilizing common markers of neural injury.

METHODS
Animals
All procedures involving live animals were approved by the Institutional Animal Care and
Use Committee of West Virginia University and were performed according to the principles of the
Guide for the Care and Use of Laboratory Animals. This worked used thirty 350 gram male
animals acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc.). Animals were acclimated
for 1 week prior to experimental use and were housed under 12-hour light/12-hour dark conditions
with food and water available ad libitum.
Design of Blast Model
A 4-piece, machined aluminum shock tube apparatus was constructed and driven using
compressed nitrogen gas.

The driver and driven sections were separated by clear mylar

membranes (Ridout Plastics Co.) of varying thickness (0.003”-0.010”) to achieve a range of peak
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overpressure exposures. A tapered design of the driver section (Figure 1) was included in an effort
to minimize wave reflection and alterations of the blast wave by the expansion wave. This feature
is similar in nature to blast tubes utilizing explosives in which the explosive is often detonated in
a conical or parabolic-shaped driver section. The driver section was kept short in length in an
effort to reduce the amount of gas required for membrane rupture and subsequent blast duration.
The overpressure duration and impulse are reduced as described previously due to the shortened
driver section (Bass et al., 2012). For additional details concerning design of the blast model,
please see Supplemental Information.
Blast Waveform Acquisition & Analysis
Shock wave pressures were detected using piezoelectric sensors (PCB Piezotronics) that
were placed in both reflected and incident positions at the exit of the shock tube (Figure 1). Data
was acquired and processed using the National Instruments input module (NI 9223) connected to
the National Instruments receiver USB chassis (CDAQ-9171). Signals were recorded using a
custom-designed Labview 12.0 program and the NI data acquisition system (National Instrument)
with a sampling rate of 500 kHz as described previously (Chavko et al., 2011; Ahlers et al., 2012).
Blast Exposure
Prior to blast exposure, animals were anesthetized by intraperitoneal injection of ketamine
(90 mg/kg; Webster Veterinary) and xylazine (5 mg/kg; Webster Veterinary). Animals were
oriented with the long axis of the animal perpendicular to the blast front. In other words, the blast
was delivered side-on to the head only as the thorax and abdomen were protected using rigid
shielding, creating an experimental setup (Figure 1) similar to that used by Shridharani and
colleagues (Shridharani et al., 2012). With the animal placed directly at the exit of the tube, the
effect of expansion waves on the planar conditions of the blast front is minimized as described by
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Bass and colleagues (Bass et al., 2012). Animals (n=38) were divided into the following groups:
control (n=10), 0.003 membrane blast exposure (n=6), 0.005 membrane blast exposure (n=10),
0.007 membrane blast exposure (n=9), and 0.010 membrane blast exposure (n=3). Immediately
following blast exposure, animals were returned to a holding cage equipped with a homeothermic
heating blanket equipped with a rectal thermometer to maintain body temperature at 37 C. Once
basic reflexes were restored, animals were returned to the home cage.
Total Activity Measurements
Animal activity was measured using an automated activity monitoring system (San Diego
Instruments). Rats were given 1 hour to acclimate to the testing room prior to initiation of testing.
Each testing chamber consisted of a 16 x 16 photobeam array surrounding a Plexiglass chamber
to record lateral movements. A separate 8 photobeam array to detect rearing activity was located
above the 16 x 16 array. Activity was quantified over a 30 minute period 24 hours post-blast
exposure with total activity, ambulatory, and fine activity reported based on default settings of the
data acquisition software (PAS, San Diego Instruments).
Histological Preparations
At 72 hours post-blast exposure, a total of 24 animals (6 control and 6 from each blast
exposure group) were anesthetized as described above and perfused transcardially with cold 0.9%
saline followed by 10% formalin for a total of ten minutes. The brain was then extracted and
placed into fresh 10% formalin for a minimum of 24 hours. After 24 hours of fixation, the brain
was blocked into sections and paraffin embedded as previous described (Turner et al., 2012c).
Briefly, tissues were processed using the Tissue-Tek VIP 5 automatic tissue processor (Sakura
Finatek) and embedded in paraffin using the Tissue-Tek TEC 5 embedding system (Sakura
Finatek). Tissues were sliced using a Leica RM2235 microtome (Leica Microsystems) and slices
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mounted on slides for staining. Standard protocols were utilized for staining with hematoxylin and
eosin (H&E), fluorojade-B (Millipore), which was used as a marker of neural degeneration, glial
fibrillary acidic protein (Dako), which was used as a marker of reactive astrocytes, and ionized
calcium binding adapter molecule (Wako), which was used as a marker of activated microglia.
Images were acquired from the S1BF region of the cortex, corpus callosum, striatum,
hippocampus, and cerebellum. Imaging was performed using a Zeiss Axio Imager 2 for all
brightfield and fluorescent images shown.
Histological Quantification
Stereology and the optical fractionator technique were used to quantify histological results
as previously described. (Schmitz and Hof, 2005; Smith et al., 2012; Turner et al., 2012b) Briefly,
a region of interest encompassing the corpus callosum was drawn at low power using an Olympus
AX70 microscope and StereoInvestigator software. The software then selected random 75-m
counting frames with a depth of 6 m, and the object of interest marked by an observed blinded to
treatment. The volume of the region of interest previously identified is then determined by the
software and the number of cells marked by the observer returned.
Quantitative real-time PCR
A total of 8 animals were used for quantitative real-time PCR and included 4 control
animals and 4 animals exposed to blast using the 0.005 membrane. Total RNA was extracted from
the brain tissue (cortex, striatum, hippocampus, and cerebellum) of saline perfused animals using
Trizol reagent (Invitrogen) according to the manufacturer’s instructions. Sample concentration
was determined by spectral absorption and the purity confirmed using a 260/280 ratio of 1.8-2.0.
Samples of cDNA were prepared via reverse transcription using commercially available kits
(Applied Biosystems). Sample reactions included MultiScribe TM Reverse Transcriptase and
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random primers, with thermal cycle conditions set as follows: step 1 at 25 C for 10 minutes, step
2 at 37 C for 120 minutes, step 3 at 85 C for 5 seconds, and step 4 at 4 C for 10 minutes. For
PCR amplification, TaqMan Universal PCR Master Mix and the following probes were obtained
from Applied Biosystems: 18s (Hs99999901_s1) for use as an endogenous control gene, GFAP
(Rn00566603_m1), and Iba-1 (Rn00574125_g1). The reaction mixture was prepared based on
manufacturer’s instructions and the following thermal cycling conditions used: initial holding at
50 C for 2 minutes to allow for optimal AmpErase UNG activity, followed by a first denaturing
step at 95 C for 10 minutes, then 45 cycles at 95 C for 15 seconds, and at 60 C for 1 minute.
Changes in gene expression were determined using the CT method and a threshold value of 0.2.
Threshold cycle values of each gene were normalized to 18s rRNA.
Data Analysis
Data were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc.). A one-way
ANOVA with posthoc Tukey’s was used to compare across control and various blast-exposed
groups. For gene expression work a student’s t-test was utilized for comparing control and the
blast-exposure group (0.005 membrane). A P < 0.05 was considered statistically significant for
all data analyzed.

RESULTS
Blast Model Design
The model is capable of producing a characteristic Friedlander-type blast across a range of
peak overpressures with short duration of exposure. The ideal blast wave in an open area, also
known as the Friedlander curve, consists of a near-instantaneous pressure rise followed by an
exponential decay of the overpressure (Bass et al., 2012). With all membranes tested utilizing the
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shock tube apparatus (Figure 2.1), ideal blast waves were obtained with a representative curve
shown (Figure 2.2a). Peak overpressure increased in a linear fashion with membrane thickness
with both reflected (r2 = 0.92) and incident (r2 = 0.93) sensor orientations allowing for the
simulation of multiple peak overpressures in the experiment (Figure 2.2b,c).
Injury Severity
High peak overpressure blast, even of short duration, is associated with high mortality and
extensive intracranial bleeds. While reflected pressures of 31.47  3.049 and 50.72  3.368 PSI
failed to produce any mortality, exposure to 72.05  1.212 PSI blast was associated with mortality
in 3 of 9 experimental animals (33%) while 90.10  1.030 PSI blast exposures produced mortality
in all 3 animals tested (100%). Surviving animals failed to exhibit large hematomas at 72 hours
post-blast (Figure 2.3a,b) but evidence of microvascular dysfunction and the potential for
intraparenchymal bleeds was present (Figure 2.3c,d). Animals exposed to survivable moderate
peak overpressures in this work did display small hematomas immediately following blast
exposure (Figure 2.3c), consistent with the work of Reneer and colleagues (Reneer et al., 2011).
Mortality was associated with the production of intracranial bleeds in the cortex, particularly on
the contrecoup side as well as in the brainstem (Figure 2.3e,f). Similar findings have been
observed utilizing explosives such as TNT in rat models in which animals placed in close range
exhibit increased mortality rates associated with brain contusions, lacerations, and hematomas
(Cheng et al., 2010).
Vascular Injury
Blast-induced brain injury results in the presence of intraparenchymal red blood cells,
swollen neurons, and activated microglia. To further examine the effect of blast exposure on neural
injury and microvascular dysfunction, particularly considering the presence of hematomas and
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parenchymal blood on gross examination, brain sections underwent hematoxylin and eosin (H&E)
staining. The intraparenchymal blood was confirmed with H&E staining and red blood cells have
clearly passed into the parenchyma and are no longer confined to the vasculature (Figure 2.4a).
Evidence of neural injury and swollen, red axons was apparent in some animals (Figure 2.4b). The
presence of red neurons indicates a potential anoxic/ischemic insult (de Lanerolle et al., 2011),
consistent with the presence of microvascular dysfunction observed following blast exposure
(Svetlov et al., 2012). The presence of activated microglia, capable of releasing an array of
inflammatory mediators, was also seen with blast exposure and prompted further investigation of
astro- and microgliosis.
Neurodegeneration
Neural degeneration occurs in a dose-response manner consistent with blast severity. Blastinduced brain injury resulted in increased neural degeneration measured using Fluoro-Jade B
staining in the S1BF region of the cortex on both the coup (F(3,23) = 47.03, P < 0.0001) and
contrecoup (F(3,23) = 110.7, P < 0.0001) sides when analyzed by one-way ANOVA (Figure 2.5ad).

Post hoc tests revealed that blast-induced brain injury produced increases in neural

degeneration compared to control at 31.47  3.049 PSI on the contrecoup side (q = 4.51, P < 0.05),
50.72  3.368 PSI on both coup (q = 10.29, P < 0.0001) and contrecoup (q = 13.69, P < 0.0001)
sides, and 72.05  1.212 PSI on both coup (q = 15.13, P < 0.001) and contrecoup (q = 23.76, P <
0.0001) sides (Figure 2.5e-f). Neural degeneration following blast exposure was also observed
within other brain regions including the striatum, hippocampus, cerebellum and regions
surrounding the corpus callosum (Supplemental Information).
Glial Reactivity
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Blast injured brains demonstrate increased glial activation with increasing peak overpressure. Reactive astrocytes, identified by GFAP staining, were elevated significantly within the
corpus callosum on the coup (F(3,23) = 26.08, P < 0.0001) and contrecoup (F(3,23) = 8.03, P <
0.001) sides of the brain following blast-induced neurotrauma, consistent with findings from other
blast injury models (Svetlov et al., 2012), when analyzed using one-way ANOVA (Figure 2.6a-d).
Post hoc tests showed that blast injury resulted in elevated astrocyte reactivity at 50.72  3.368
PSI on the contrecoup side (q = 5.13, P < 0.01) and at 72.05  1.212 PSI on both the coup (q =
11.28, P < 0.0001) and contrecoup (q = 6.03, P < 0.01) sides (Figure 2.6e-f).
Similar findings were observed concerning microglial activation, identified with Iba-1
staining, with increased levels of microglial activation relative to control on both coup (F(3,23) =
83.12, P < 0.0001) and contrecoup (F(3,23) = 25.37, P < 0.0001) sides (Figure 2.7a-d). Again,
although microglial presence was detected throughout the brain and appeared increased
throughout, microglial activation was most prominent throughout the corpus callosum and internal
capsule, consistent with other studies (de Lanerolle et al., 2011). Notably, microglia appeared
more rounded or amoeboid, typical of phagocytic microglia, within these white matter tracts
consistent with white matter damage observed in human subjects following trauma (Johnson et al.,
2013c). Previous reports in swine exposed to blast and assessed primarily at 2 weeks failed to
identify extensive microglial activation, a potential reason for the discrepancy between studies (de
Lanerolle et al., 2011). Post hoc tests revealed increased microglial activation following 31.47 
3.049 PSI blast on the contrecoup side (q = 4.71, P < 0.05), 50.72  3.368 PSI blast on both coup
(q = 8.37, P < 0.0001) and contrecoup (q = 7.85, P < 0.0001) sides, and 72.05  1.212 PSI blast on
both coup (q = 20.49, P < 0.0001) and contrecoup (q = 11.92, P < 0.0001) sides as well (Figure
2.7e-f). The clear neuroinflammatory response, characterized by a graded glial response based on
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peak overpressure exposure, observed in this work is consistent with findings by Cernak and
colleagues in which mild and moderate blast exposure produced increases in GFAP, as well as
ED1, a marker of microglia, at numerous time points (Cernak et al., 2011). Importantly, activated
microglia in other blast exposure studies have been associated with changes in neuron appearance
such as darkened dendrites (Kaur et al., 1995) and in vitro work has demonstrated a mild activation
of microglia following overpressure exposure with pulse duration altering microglial gene
expression (Kane et al., 2012).
Gene expression of GFAP (Figure 2.8a) was increased at 24 hours following blast exposure
in the cortex (t = 2.412, P < 0.05) but not in the striatum (t = 0.022, P > 0.05), hippocampus (t =
1.084, P > 0.05), or cerebellum (t = 0.634, P > 0.05). The lack of difference in GFAP gene
expression in regions outside of the cortex was in contrast to the visible differences seen in these
regions at 72 hours based on immunohistochemistry (Supplemental Information). The reason for
this discrepancy is not entirely clear but may be due to consideration of the entirety of brain
sections for gene expression studies when immunohistochemistry reveals findings largely located
at the interface of regions and the gray-white matter junction. Another possibility explaining the
discrepancy between immunohistochemical and gene expression findings is the time of analysis.
Only one time point for each assay was included and therefore, changes in gene expression could
have occurred rapidly following blast and already declined to baseline by 24 hours. No difference
in Iba-1 gene expression (Figure 2.8b) was detected in the cortex (t = 0427, P > 0.05), striatum (t
= 0.900, P > 0.05), hippocampus (t = 0.380, P > 0.05), or cerebellum (t = 0.448, P > 0.05),
consistent with immunohistochemical findings (Supplemental Information).
Locomotor Activity
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Blast-induced traumatic brain injury produces deficits in total activity regardless of
severity. Total activity of the experimental subjects was decreased at 24 hours post-blast in all
injured groups. The total activity level post-injury did not vary based on injury severity with all
injury groups demonstrating similar impairments (Figure 2.9a). The deficits in total activity
were due to a decrease in ambulatory activity associated with blast exposure (Figure 2.9b). Blast
exposure did not alter measures of fine activity (Figure 2.9c).

DISCUSSION
Efforts to model blast injury have been plagued by the lack of standardization across
laboratories and the appropriate scaling of blast parameters to the animal species used based on
data obtained from human studies. Preclinical studies are varied with regards to animal placement
within or outside of the shock tube, orientation to the blast front, protection of the thorax, and blast
parameters, namely peak overpressure and duration of exposure. Studies in soldiers revealed
common IED exposures producing blast injury result from detonation of 105-mm and 155-mm
artillery rounds at a distance of 5-10 meters. Use of the Conventional Weapons Effects Program
(CONWEP) (Hyde, 2004) allows for interpretation of these exposures in relation to blast wave
parameters with a peak overpressure of 50-1000 kPA (7.25-145.03 PSI) and an exposure duration
of 2-10 ms (Panzer et al., 2012). As such, utilizing these parameters and scaling appropriately to
preclinical animal species used may represent a more clinically relevant blast exposure and allow
for improved elucidation of blast-induced injury pathophysiology and evaluation of proposed
therapeutics.
The concept of scaling blast injury to animal models is based largely upon previous works
assessing pulmonary injury and primary blast survival across animal species. Richmond and
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colleagues identified, in various species, the effect of blast duration on lethality with longer
duration blasts requiring a lower peak overpressure to produce mortality when compared to short
duration blasts that required a significantly higher peak overpressure (Richmond et al., 1968). A
clear relationship between mass and blast parameters associated with lethality exists, particularly
with regards to the more clinically relevant short duration blast (Richmond et al., 1968). In fact,
classical work by Bowen and colleagues investigated pulmonary injury in relation to blast
exposure and created a model system in which scaling is based upon the height of burst divided
by the cubed root of the mass (Bowen et al., 1968). This has been simplified to an equation
utilizing the cubed root of the reference mass (human) divided by mass of the experimental subject
(Bass et al., 2012; Panzer et al., 2012; Shridharani et al., 2012). The scaling equations developed
have displayed significant utility in development of injury risk functions based upon the high level
of agreement with pre-existing experimental data concerning blast survival and injury risk. As
such, while scaling of blast injury and associated blast parameters based on subject weight has not
been related to neural injury (Park et al., 2011), scaling represents a logical step forward in more
closely replicating clinically relevant exposures in laboratory models (Panzer et al., 2012; Rafaels
et al., 2012; Risling and Davidsson, 2012).
To address the question of how scaling affects blast-induced brain injury a shock tube
capable of producing a range of peak overpressures with short durations was designed and utilized
within this work. Notably, the model produced clear neuropathological changes indicative of
neural degeneration and glial reactivity. These findings were consistent with work by Goldstein
and colleagues in which single-blast exposure produced neurodegenerative changes consistent
with chronic traumatic encephalopathy (CTE) (Goldstein et al., 2012) as well as other work
utilizing scaling principles (Shridharani et al., 2012). Similarly, neuropathological changes were
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observed throughout the cortex as previously described (Goldstein et al., 2012) but were most
prominent with the corpus callosum and internal capsule, consistent with previous findings in other
blast injury models (Park et al., 2011). It remains unclear why specific brain regions may be more
susceptible to blast-induced brain injury but one logical explanation is that of spallation. Spallation
refers to the interface-based disruption that occurs between tissues of different densities upon a
compression wave in the denser medium reflecting at the interface resulting in displacement and
fragmentation of the denser medium into the less dense medium (Cernak and Noble-Haeusslein,
2010; Covey and Born, 2010; Yeh and Schecter, 2012). Spalling has been identified as a leading
cause of endothelial injury and activation of microglia (Duckworth et al., 2012), consistent with
our findings. Similarly, endothelial damage results in a loss of tight junction integrity and
consequently the potential for increased blood-brain barrier permeability and microvascular injury
(Duckworth et al., 2012). Notably, increased BBB permeability has been found as late as one
month following blast-induced brain injury in a preclinical rodent model, indicating the presence
of lasting microvascular dysfunction (Rubovitch et al., 2011b). Furthermore, blast-induced BBB
disruption has been observed to occur more extensively on the contralateral side, as well as at
fluid-tissue interfaces such as that surrounding the lateral ventricles (Readnower et al., 2010),
consistent with the findings reported within this study in which the contralateral side was more
severely injured in comparison to the ipsilateral side based on standard markers of neural
degeneration, astrocyte reactivity, and microglial activation (Garman et al., 2011).
In addition to the neuropathological findings, the model utilized in this work produced
deficits in total activity at 24 hours post-blast, regardless of experimental group. How blast-injury
models affect behavioral functions in rodents is poorly understood but of clear interest based on
clinical findings associated with blast that include retrograde amnesia, confusion, loss of
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conscioussness, depression, post-traumatic stress disorder (PTSD), vertigo, balance disorders,
anxiety, apathy, and difficulty concentrating and performing executive functions (Taber et al.,
2006; Rubovitch et al., 2011b; Magnuson et al., 2012; Risling and Davidsson, 2012; Scheibel et
al., 2012). Previous reports have demonstrated impairment on the accelerating rotarod following
direct cranial blast injury (Kuehn et al., 2011) and on the balance beam following whole body blast
exposure (Ahlers et al., 2012) while others have shown that shielding of the torso prevents neural
injury and associated behavioral deficits following blast (Koliatsos et al., 2011). Cognitive
abilities, particularly reference memory, may also be impaired following blast injury. The latency
to find the platform using the Morris Water Maze may be related to and correlate with maximum
peak overpressure exposure (Saljo et al., 2011). Other hippocampal-based learning and memory
tasks such as the Barnes maze and Y-maze have also been utilized successfully in the study of
functional deficits induced post-injury with blast subjects performing significantly worse in both
acquisition and memory tasks (Koliatsos et al., 2011; Goldstein et al., 2012). The same can be
said of the passive avoidance task with animals showing anterograde memory deficits but not
retrograde amnesia following blast-induced brain injury (Ahlers et al., 2012). Previous studies
have also revealed deficits following whole-body blast injury by assessing memory and social
interaction through the social recognition memory test (Koliatsos et al., 2011). Evaluation of
cognitive abilities at 30 days post-blast in a mouse model has revealed persistent deficits in the
novel object recognition test as well (Rubovitch et al., 2011b). This serves as one functional test
capable of detecting sustained deficits following blast injury. Other assessments capable of
detecting neural injury in the chronic period following blast exposure include the accelerating
rotarod, active avoidance, and open field activity (Cernak et al., 2011). Furthermore, the novel
object recognition test appears exceptionally sensitive to neural dysfunction and memory
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impairments, even in the absence of histological changes following blast exposure as described by
Baalman, et al (Baalman et al., 2012). While the significance of these findings is unclear and how
these findings translate from one model to another, let alone to the clinical population, there is a
clear need for further studies in standardized, clinically-relevant models.
It is clear that future studies, in addition to understanding the effect of scaled blast
exposure on functional ability and behavior-related changes, need to better characterize the
inflammatory processes associated with blast exposure and how these relate to neural injury and
neurodegeneration. While it is unlikely blast exposure can be completely prevented, particularly
in civilians exposed to terrorist-type attacks, it may be possible to improve therapeutic options.
The need for improved therapeutics is particularly clear in the military in which evacuation of
blast-exposed troops is often delayed by hours to several days due to the nature of conflict. As
such, secondary responses within the brain often occur and may represent a potential target as
described previously (Dalle Lucca et al., 2012).

50

Figure 2.1. Experimental setup utilized in this work demonstrating the novel shock tube apparatus
for simulating blast-induced brain injury and data acquisition procedures. The shock tube utilizes
a tapered driver section to reduce wave reflection and alterations of the shock wave by the
expansion wave. The driver section was kept short to reduce the volume of gas required to produce
membrane rupture and therefore, reduced overpressure duration and impulse. The abdomen and
thorax of animals was protected using a rigid apparatus.
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Figure 2.2. A.) Sample shock wave recording (reflected sensor) representing a classical
Friedlander wave of short duration. B.) Peak reflected overpressure recorded as a function of
membrane thickness. C.) Peak incident overpressure recorded as a function of membrane
thickness.
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Figure 2.3. Gross examination of single blast-exposed brains. A.) Brain of a perfused control
animal, B.) 31.47  3.049 PSI (reflected) blast-exposed brain at 72 hours post-blast following
perfusion demonstrating no apparent hematomas or gross changes, C.) Presence of hematomas
and contusion immediately following exposure to 50.72  3.368 PSI (reflected) blast on the
contrecoup side, D.) At 72 hours post-blast, 72.05  1.212 PSI (reflected) blast exposure results in
the appearance of parenchymal blood and an overall husky appearance on the contrecoup side, E.)
Immediately following 90.10  1.030 PSI (reflected) blast, clear evidence of bleeds on the cortex,
and F.) Immediately following 90.10  1.030 (reflected) PSI blast, brainstem bleeds were apparent
and associated with mortality.
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Figure 2.4. Blast exposure, particularly at high peak overpressures, was associated with
microvascular damage and neural injury on H&E staining. A.) Presence of red blood cells within
the parenchyma at 72 hours following 72.05  1.212 PSI (reflected) blast. B.) Swollen, red neuron
at 72 hours following 72.05  1.212 (reflected) PSI blast. Red neurons typically are associated
with anoxic/ischemic injury indicating the presence of secondary damage, likely related to
microvascular dysfunction, following blast injury.
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Figure 2.5. Blast exposure produced neural degeneration within the S1BF region of the cortex at
72 hours post-exposure as indicated with fluoro-jade B staining. A.) 31.47  3.049 PSI (reflected)
blast on the coup side, B.) 50.72  3.368 PSI blast on the coup side, C.) 31.47  3.049 PSI blast
on the contrecoup side, and D.) 72.05  1.212 PSI blast on the contrecoup side. Quantification of
Fluoro-Jade B (FJB) positive neurons using stereology demonstrated a graded response based on
peak overpressure exposure in the S1BF region of the cortex on coup (F(3,23) = 47.03, P<0.0001)
and contrecoup (F(3,23) = 110.70, P<0.0001) sides (E and F, respectively). Post hoc analysis
showed that blast exposure resulted in increased neural degeneration relative to control with 31.47
 3.049 PSI on the contrecoup side (q = 4.51, P < 0.05), 50.72  3.368 PSI on both coup (q =
10.29, P < 0.0001) and contrecoup (q = 13.69, P < 0.0001) sides, and 72.05  1.212 PSI on both
coup (q = 15.13, P < 0.001) and contrecoup (q = 23.76, P < 0.0001) sides.
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Figure 2.6. Blast exposure produced extensive astrocyte reactivity within the corpus callosum at
72 hours post-exposure as indicated with glial fibrillary acidic protein (GFAP) staining. A.) 31.47
 3.049 PSI blast on the coup side, B.) 72.05  1.212 PSI blast on the coup side, C.) control (no
blast exposure) on the contrecoup side, and D.) 72.05  1.212 PSI blast on the contrecoup side.
Quantification of Glial Fibrillary Acidic Protein (GFAP) positive astrocytes using stereology
demonstrated a graded response based on peak overpressure exposure in the corpus callosum
on the coup (F(3,23) = 26.08, P<0.0001) and contrecoup (F(3,23) = 8.03, P<0.001) sides (E and F,
respectively). Post hoc analysis showed that blast exposure resulted in increased astrocyte
reactivity relative to control with 50.72  3.368 PSI on the contrecoup side (q = 5.13, P < 0.01)
and at 72.05  1.212 PSI on both the coup (q = 11.28, P < 0.0001) and contrecoup (q = 6.03, P <
0.01) sides.
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Figure 2.7. Blast exposure produced microglial changes within the corpus callosum at 72 hours
post-exposure as indicated with ionized calcium-binding adapter molecule 1 (Iba-1) staining. A.)
Control (no blast exposure) on the coup side, B.) 50.72  3.368 PSI blast on the coup side, C.)
31.47  3.049 PSI blast on the contrecoup side, and D.) 72.05  1.212 PSI blast on the contrecoup
side. Quantification of Ionized Calcium-binding Adapter Molecule 1 (Iba-1) positive microglia
using stereology demonstrated a graded response based on peak overpressure exposure in the
corpus callosum on the coup (F(3,23) = 83.12, P<0.0001) and contrecoup (F(3,23) = 25.37,
P<0.0001) sides (E and F, respectively). Post hoc analysis showed that blast exposure resulted in
increased microglial activation relative to control with 31.47  3.049 PSI blast on the contrecoup
side (q = 4.71, P < 0.05), 49 PSI blast on both coup (q = 8.37, P < 0.0001) and contrecoup (q =
7.85, P < 0.0001) sides, and 72.05  1.212 PSI blast on both coup (q = 20.49, P < 0.0001) and
contrecoup (q = 11.92, P < 0.0001) sides as well.
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Figure 2.8. Effect of 50.72 PSI blast exposure on gene expression at 24 hours post-injury. A.)
Gene expression of glial fibrillary acidic protein (GFAP) was increased within the cortex (t =
2.412, P < 0.05) but not in the striatum, hippocampus, or cerebellum. B.) Gene expression of
ionized calcium binding adapter molecule (Iba-1) was not changed within any of the brain regions
studied at 24 hours post-blast.
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Figure 2.9. Effect of blast exposure on total, ambulatory, and fine activity levels at 24 hours postinjury. A.) Total activity was significantly altered with blast exposure (F(3,23) = 6.55, P<0.05)
with post hoc analysis identifying a reduction relative to control with 31.47  3.049 PSI blast (q =
4.50, P<0.05), 50.72  3.368 PSI blast (q = 5.28, P<0.05), and 72.05  1.212 PSI blast (q = 5.40,
P<0.05). B.) Ambulatory activity was reduced with blast exposure (F(3,23) = 6.74, P<0.05) with
post hoc analysis identifying a reduction relative to control with 31.47  3.049 PSI blast (q = 4.59,
P<0.05), 50.72  3.368 PSI blast (q = 5.34, P<0.05), and 72.05  1.212 PSI blast (q = 5.47, P<0.05)
exposures. C.) Fine activity failed to demonstrate differences across any group comparisons
(F(3,23) = 0.17, P>0.05).
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Chapter Three

Characterization of neural injury and neurobehavioral dysfunction
in the rat after traumatic brain injury

This work is in preparation.
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ABSTRACT
Traumatic brain injury resulting from blast exposure is the most common injury of
military combatants. Animal modeling of blast-induced traumatic brain injury has demonstrated
severe histopathological effects accompanied by loss of long-term synaptic plasticity and
cognitive performance due to tissue damage. Here we use a scaled blast model that was
specifically developed to assess the neuropathological, neurophysiological, and biochemical
effects of exposure to blast forces not severe enough to cause overt physiological deficits or
behavioral changes. We find that mild blast exposure induces no observable macroscopic
histological effects, but instead causes microvascular injury, axonal damage, and
neuroinflammation in various brain regions including hippocampus. Hippocampal deficits in
short term plasticity and synaptic excitability were observed 7-days after mild blast exposure.
Biochemical analysis revealed that mild blast exposure invokes markers of excitotoxicity and
neuronal injury in hippocampus. Thus mild blast exposure causes subtle but deleterious
neurological effects in the absence of major behavioral deficits, suggesting that subclinical
exposures to blast forces may initiate neuropathology.
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INTRODUCTION
Blast-induced traumatic brain injury (bTBI) occurs when a shock wave penetrates the skull
and causes physical damage to neurons, glia and the vasculature. Explosion-derived shock waves
have made bTBI the hallmark injury of American combatants (Huber et al., 2013). Diagnosis of
bTBI is comorbid with increased incidence of neuropsychiatric disorders and long-term physical,
cognitive, behavioral, and emotional changes (Tompkins et al., 2013). Furthermore,
neurodegenerative disorders have been suggested as pathological outcomes of bTBI (Goldstein et
al., 2012; Miller, 2012). While strong blasts may cause severe and acute brain injury or death, it is
possible that exposure to mild forces result in delayed or more subtle effects. Thus, better
understanding of the time- and force intensity-dependent factors that contribute to blast-induced
pathophysiology is needed.
As animal models of bTBI have been developed over the past decade (Rubovitch et al.,
2011b; Elder et al., 2012; Goldstein et al., 2012; Turner et al., 2013b), studies of blast exposure
have descriptively characterized more overt pathological effects. Histopathology including
profound neuronal injury and neuroinflammation has been demonstrated in rodent models of bTBI
(de Lanerolle et al., 2011; Abdul-Muneer et al., 2013). Furthermore, bTBI has been suggested to
result in suppression of synaptic plasticity in rat hippocampus (Miyazaki et al., 1992; Li et al.,
2013a). Moreover, common biochemical and molecular mechanisms of brain injury have been
demonstrated in a variety of bTBI models (Goldstein et al., 2012; Kochanek et al., 2013; Sosa et
al., 2013; Turner et al., 2013b). Severe TBI elicits clear loss of neurological function, although the
subsequent behavioral effects of blast-exposure and their persistence remain controversial (Cernak
et al., 2001; Elder et al., 2012; Budde et al., 2013; Klemenhagen et al., 2013). While these more
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profound effects demonstrate the ability to accurately model severe bTBI, the threshold for
pathogenesis in response to mild force remains poorly defined.
Here we investigate the histological, functional, and biochemical effects caused by
exposure to mild blast. The results suggest that even mild blast forces may induce a variety of
deleterious effects, which may not be reflected in behavioral or lower resolution imaging
assessments. These results should inform the evaluations of patients exposed to mild or
asymptomatic blast forces and, hopefully, contribute to facilitation of improved recovery from
sub-concussive bTBI.

METHODS
Animals
All procedures involving animals were approved by the Institutional Animal Care and Use
Committee of West Virginia University and were performed according to the principles of the
Guide for the Care and Use of Laboratory Animals (IACUC protocol # 13-0708). Male SpragueDawley rats (n = 74) were acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc.,
Scottsdale, PA). At the time of blast exposure the rats were 12 weeks old and weighed ~300-350
g. Animals were acclimated for 1 week prior to experimental use and were housed under 12-hour
light/12-hour dark conditions with food and water available ad libitum.
Blast Exposure
Prior to blast exposure, animals were anesthetized with 4% isoflurane (Halocarbon, River
Edge, NJ). The blast was delivered to the right side of the head with the animal’s body oriented
perpendicular to the blast tube, and with the peripheral organs protected by a polyvinyl chloride
pipe shield. The animals were exposed to a mild blast (0.005” membrane; incident peak
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overpressure of ~15 psi.), which was suggested to cause neural injury but no mortality in previous
work (Turner et al., 2013b). Control subjects were placed in proximity to the blast paradigm but
were not subjected to blast force. Immediately following blast exposure, animals were returned to
a holding cage equipped with a homeothermic heating blanket equipped with a rectal thermometer
to maintain body temperature at 37˚C. Once basic reflexes were restored, animals were returned
to the home cage. For histological, neurophysiological, biochemical and behavioral paradigms,
analyses were conducted after post-blast intervals of 6 h, 1, 2, 3, or 7 days.
Neuropathology
Neuropathological studies were conducted at 1, 2, 3, or 7 d (n = 6), with a control group.
Animals were euthanized by CO2 asphyxiation and perfused transcardially with ice-cold 0.9%
saline followed by 10% formalin for a total of 10 min. The brains were then dissected and placed
in fresh 10% formalin for 72 h. Brains were then block-sectioned into 5 coronal slabs, paraffinembedded, and serially sectioned at 5 μm at Bregma level of 2.20, 1.00, -2.80, -7.30 and -11.30
mm. Standard protocols were utilized for staining with hematoxylin and eosin (H&E) (Fischer et
al., 2008), and Fluoro-Jade B (FJB, Millipore Corporation) (Schmued and Hopkins, 2000). For the
immunohistochemical analysis, paraffin-embedded sections were labeled with SMI-31 to detect
phosphorylated neurofilaments (1:500; Covance, Emeryville, CA), glial fibrillary acidic protein
(GFAP) to detect astrocyte activation (1:1200; Chemicon) and ionized Ca2+ binding adapter
molecule (Iba1) to detect microglial activation (1:1000; Wako) and visualized by
immunoperoxidase method (Sinclair et al., 1981). Briefly, 5 μm sections were deparaffinized,
subjected to microwave antigen retrieval (citrate buffer, pH 6.0), permeabilized with 0.3%
(vol/vol) Triton, quenched free of endogenous peroxidases, and blocked with a cocktail of normal
goat serums (2.5% (vol/vol) each) prior to overnight incubation of primary antibodies at 4°C.
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Bound primaries were detected by sequential incubation with biotinylated-secondary antisera and
streptavidinperoxidase. Diaminobenzidine chromagen was used to detect immunoperoxidase
signal (DAKO).
Neurophysiology
Neurophysiological studies were conducted on experimental and control rats 1, 3, or 7 d
post-blast (n = 6). Following rapid decapitation and dissection, brains were placed into ice-cold
solution (75 mM sucrose, 87 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7
mM MgCl2, 0.5 mM CaCl2 and 10 mM glucose), and transverse hippocampal slices (350 µm) were
prepared using a vibratome (Leica Microsystems Inc., VT1000S). Slices recovered in oxygenated
Kreb’s buffer (125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 1.1 mM MgCl2,
2 mM CaCl2 and 25 mM glucose) and maintained at 30˚C for 30 min before recording. A
Multiclamp 700A amplifier with a Digidata 1322 and pClamp 10 software (Axon, Molecular
devices, LLC) was used to for the electrophysiological recordings. Slices for recordings were
placed into a perfusion chamber on the upright microscope stage (Axioscop 2, Carl Zeiss, Inc).
The perfusion bath was maintained at 30˚C during the recordings (TC-324B Automatic
Temperature Controller, Warner Instruments Corporation). Field excitatory postsynaptic
potentials (fEPSP) from CA1 were evoked by square current pulses (0.1 ms) at 0.033 Hz with a
bipolar stimulation electrode (FHC, Bowdoinham, ME) placed at the Schaffer collaterals (~250300 µm) from the recording electrode. Results were obtained using a stimulus intensity to induce
50% of the maximal fEPSP slope, with the same intensity used to explore the paired pulse ratio
(PPR) at different intervals. The intensity was established through the input-output curve, the
maximal stimulation was considered when a population spike appeared in the fEPSP. A stable
baseline was recorded for at least 15 min prior to high frequency stimulation (HFS, 4 trains, 100
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Hz, 1 s duration, separated by 20 s). Long-term potentiation (LTP) was assessed for at least 60 min
after HFS. The time-course showing baselines and LTP is expressed as a percent of change from
the baseline fEPSP slope. The PPF plot was constructed by dividing the second fEPSP slope over
the first (fEPSP2/fEPSP1). The input-output curve was constructed by normalizing recordings for
each slice, assigning the maximal fiber volley amplitude (obtained with the maximal stimulation)
to the value of 1.0, and the plots were derived for the respective fEPSP slopes. All recordings were
taken in the absence of any drug. Data were analyzed with Clampfit 10 software (Axon, Molecular
devices, LLC). Prism 6 (GraphPad Software, Inc.) was used to make graphs and statistical analysis.
Immunoblotting
Brain dissection, tissue removal and lysate preparation, and immunoblotting were
performed as previously described (Sahin et al., 2004; Plattner et al., 2006). Rats (n ≤ 6) for
immunoblotting were sacrificed at 6 h, and 1, 2, 3 and 7 d post-blast exposure. Cell lysates from
hippocampal dissections were prepared and equal amounts of lysates were run on 7% acrylamide
gels or 10-20% gradient acrylamide gels. The blots were probed with the following antibodies:
p35/25 (Cell Signaling Technology; C64B10), α-Fodrin (cleaved spectrin) (Enzo Life Sciences;
BML FG6090), pTauT205 (Sigma; T 6694), total Tau (DAKO). Signal was detected with HRPconjugated secondary antibodies and enhanced chemiluminescence (GE Healthcare, Piscataway,
NJ). Images were analyzed using densitometry with background subtraction and ImageJ software
(NIH, Bethesda, MD). The resulting bands were normalized to GAPDH (10-20% gels), ß-tubulin
(7% gels), or total Tau.
Locomotion
All behavior was carried out with the experimenter blind to treatment groups. Locomotion
trials were conducted at 48 h post blast. Rats (n = 7) were left in their home cage surrounded by a
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PAS-Home Cage locomotor recording apparatus (San Diego Instruments, CA). The rats were left
to explore for 24 h and ambulatory, fine and total beam breaks were collected with Vision PASF
Software (San Diego Instruments). Ambulatory beam breaks were counted as the simultaneous
breaking of multiple beams within 0.2 s, and Fine beam breaks were counted as single beam breaks
at intervals greater than 0.2 s. The two forms of beam breaks were combined to compare total
beam breaks. The locomotion was subdivided into 24 bins of 1 h each.
Fear Conditioning
The fear conditioning behavioral paradigm used here was essentially as previously
described (Plattner, 2014). Rats (n = 7) were left to explore the conditioning box (Med Associates)
for 2 min, followed by a 30 s period with tone representation (90 dB, 10 kHz), which co-terminated
with a mild foot shock (2 s, 0.7 mA, constant current). Rats remained in the chamber 2 min after
shocking before returning to their home cage. Conditioning boxes were thoroughly cleaned after
each animal. To test context-dependent fear memory, rats were reintroduced 24 h post-shock into
the conditioning box for 5 min. Freezing responses (motionless except respirations) were recorded
using a 5 s interval time-sampling method. Control animals were subject to isoflurane exposure
(4%) on the same day as the bTBI rats.
Statistical Analysis
Data were analyzed using GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA). Oneway ANOVA with post-hoc Newman-Keuls multiple comparison tests were used to compare
across groups for the neurophysiological data. Student’s t-tests were used to compare behavioral
and immunoblot data. A p < 0.05 was considered statistically significant for all data analyzed.

RESULTS
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To study the threshold effects of bTBI it is important to define the relationship between
force intensity and injury severity in a general sense. Previously we characterized this relationship
with regard to general neuropathology and function using a scaled blast model that we developed
(Turner et al., 2013b). This study defined incident peak overpressure of 15 psi exposure as the
threshold for induction of neuropathological effects, consistent with those reported in other studies
(Goldstein et al., 2012; Mez et al., 2013; Sosa et al., 2013). Based on these findings we chose to
expose young adult male rats to a single threshold shock wave (Figure 3.1A). To assess effects
over relatively acute periods following blast exposure, delays including 6 h, and 1, 2, 3 and 7 d
were chosen (Figure 3.1B) for histology, neurophysiology, biochemical, and behavioral analyses.
Neuropathological effects of mild bTBI
Gross examination of postmortem brains from each time point following blast exposure
revealed no macroscopic evidence of contusion, necrosis, hematoma, hemorrhage, or focal tissue
damage (Figure 3.2A-C), confirming the force intensity used as mild or threshold. However
detailed microscopic examination showed a variety of notable deleterious effects in blast-exposed
rats. Small hemorrhagic foci, which showed the presence of the intraparenchymal red blood cells
(Figure 3.2D) and robust reactive astrogliosis (Figure 3.2E), were observed in the left corpus
collosum at 48 h post-blast and in the striatum at 72 h post-blast. Furthermore, the extravasation
of blood plasma was confirmed in a small number of venule- (Figure 3.2F) and arteriole-like
(Figure 3.2G) microvessels of the cerebral cortex or striatum at all time points post-blast. These
observations are consistent with a growing perception of the microvasculature as an important
target of bTBI research (Sajja et al., 2013).
Diffuse axonal injury, one of the primary neuropathological characteristics of TBI, was
observed at all time points post-blast. Phosphorylated neurofilament immunostaining was
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enhanced in the deep layer of cerebral cortex and lateral septal nucleus (Figure 3.2H), as well as
in the ventrolateral part of thalamus (Figure 3.2J), compared to control subjects (Figure 3.2I, K).
These effects were accompanied by beaded or irregularly swollen dystrophic axons (Figure 3.2L)
and axonal bulbs (Figure 3.2M). These malformations in axonal architecture denote potential
compromise in neuronal circuitry. Furthermore these effects may denote neurofilament
compaction or diffuse axonal injury which has been implicated in TBI neuropathogenesis
(Blennow et al., 2012).
As was observed above, the effects of blast on fine microvasculature and axonal structure
were accompanied by elevated reactive astrocytes and microglia throughout the cerebrum,
especially in the striatum, cortex, amygdala and hippocampus, as well as in the thalamus. Reactive
astrocytes were observed in a greater abundance in the cerebral cortex 72 h post-blast (Figure
3.2N), compared to control subjects (Figure 3.2O). Reactive microglia were also observed in
greater abundance in the striatum 72 h post-blast (Figure 3.2P), compared to control subjects
(Figure 3.2Q). In contrast, brainstem and cerebellum were relatively devoid of neuroinflammation.
The hippocampus is often the target of neurodegenerative pathology (Nagy et al., 1997),
and neurophysiological function of hippocampal circuitry is often related to cognitive performance
(Wiescholleck and Manahan-Vaughan, 2013b, a). Therefore, to better understand the effects of
mild blast exposure, and given the overall pathology observed in mild blast-exposed rats,
hippocampus pathology was examined. Postmortem coronal sections of hippocampus from each
time point post-blast were well preserved (Figure 3.3A). Furthermore, H&E staining showed no
signs of typical degenerating or ischemic neurons in the hippocampus following blast injury
(Figure 3.3B). FJB staining also showed no signs of neurodegeneration in the hippocampus of
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bTBI rats (Figure 3.3C). However, brains from bTBI rats showed other evidence of microscopic
neuropathology in the hippocampus.
For example, the hippocampal subfield CA3 exhibited intense immunoreactivity for
phosphorylated neurofilaments. SMI-31-immunoreactive. Staining displayed an accumulation of
phosphorylated neurofilaments in the cytoplasm of several pyramidal neurons (Figure 3.3D).
These effects were completely absent in control subjects (Figure 3.3E). A small number of mild
swollen dystrophic axons were observed in the CA1 stratum pyramidale (Figure 3.3F) or radiatum
at all time points post-blast. One axonal bulb was seen in the hippocampal hilus at 7 d post-blast
(Figure 3.3G). Brains subjected to bTBI also demonstrated obvious reactive astrogliosis and
microgliosis throughout the hippocampus. Reactive astrocytes were observed in a greater
abundance in the CA1 field 72 h post-blast (Figure 3.3H), compared to control subjects (Figure
3.3I). Reactive microglia were also observed in greater abundance in the CA1 subfield 72 h postblast (Figure 3.3J), compared to control subjects (Figure 3.3K). Thus neuropathological effects
observed in the hippocampus were consistent with the neuropathology observed in other brain
regions.
Neurophysiological effects of mild bTBI
To understand the physiological consequences of the neuropathology resulting from mild
blast-exposure, neurophysiological studies were conducted in acutely prepared hippocampal brain
slices. To assess hippocampal circuitry, functional LTP was assessed in the Schaffer collateralCA1 circuitry. HFS induced robust LTP in control and bTBI rats, with tetanic stimulus resulting
in a 166 ± 11% potentiation of fEPSP slope compared to baseline in control subjects at 60 min
post-stimulus (p < 0.03, paired Student’s t test). Despite the neuropathology revealed in our
histological assessment, mild blast exposure had no significant effect on LTP induction after 60
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min at any of the post-blast delay time points examined (Figure 3.4A). In contrast, assessment of
synaptic responses during the first 2 min following HFS revealed that post-tetanic potentiation
(PTP) was attenuated in rats after a 7-day post-blast delay (p < 0.05, ANOVA, Newman-Keuls
post hoc) (Figure 3.4B; top).
In support of this observation, short-term plasticity as a function of paired pulse ratio (PPR)
was also examined. A significant reduction in PPR was observed during the first 2 min following
paired pulsation in the control subjects (p < 0.03, Mann-Whitney test) (Figure 3.4B; bottom).
However 7 d post-blast subjects did not exhibit this form of plasticity. Thus blast exposure results
in a reduced probability of neurotransmitter release from presynaptic terminals compared to
control subjects. This reduction in synaptic response, in the absence of effects on LTP, suggests
that mild blast exposure selectively affects short term plasticity at high frequency of stimulation
and is consistent with disruption of axonal conduction, as has been proposed as an outcome of
blast injury (Baalman et al., 2013).
As another approach to assess short-term plasticity, paired pulse ratio (PPR) of synaptically
induced fEPSPs was also examined. A significant reduction in PPR was observed during the first
2 min following paired pulsation in the control subjects (p < 0.03, Mann-Whitney test) (Figure
3.4B; bottom). However 7 d post-blast subjects did not exhibit this form of plasticity. Thus blast
exposure results in a reduced probability of neurotransmitter release from presynaptic terminals
compared to control subjects.
To assess hippocampal synaptic excitability, field potential recordings were used to derive
input-output curves (Figure 3.4C). Rats that underwent a 7 d post-blast delay exhibited a
significant decrease in maximal response (p < 0.01, nonlinear regression using a polynomial
quadratic function; p < 0.03, maximal stimulation in control vs. 7 d post-blast, Mann-Whitney
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test), indicating a reduction in synaptic response intensity. To better understand this deficit, paired
pulse facilitation (PPF), was assessed at different intervals (Figure 3.4D). Interestingly, no
difference in PPF was observed across a range of inter-pulse intervals for rats subjected to different
post-blast delay periods compared to control subjects. These results indicate that while mild blast
exposure resulted in deficits of short-term plasticity and synaptic responses, they caused no
important changes to basic synaptic transmission at presynaptic terminals.
Overall, these results show subtle deficits in the neurophysiological function of
hippocampal circuitry in response to mild blast exposure. While long-term plasticity was not
significantly altered, the changes in short-term plasticity and synaptic excitability are consistent
with other reports of neurophysiological deficits following traumatic brain injury (Miyazaki et al.,
1992; Reeves et al., 2005; Colley et al., 2010), or more specifically, blast exposure (Park et al.,
2013).
Excitotoxic effects of mild bTBI
TBI causes massive neuronal depolarization resulting in large influx of ions. In response
to activation of voltage-gated Ca2+ channels, high levels of glutamate are released, triggering
excitotoxicity. Swelling of neurons, oxidative stress, and free radical production, all affect
neuronal viability, contribute to neuronal death, and are associated with TBI pathology (Cernak
and Noble-Haeusslein, 2010). Following initial trauma, a delayed and spreading process of injury
occurs. At the subcellular level, mitochondrial dysfunction and disruption in Ca2+ homeostasis are
hallmarks of TBI (Wang et al., 2006). Over-activated cellular proteases such as calpain may
contribute to injury progression (Werner and Engelhard, 2007). The effects of mild bTBI on these
parameters were examined in hippocampal lysates from blast exposed rat brain by quantitative
immunoblotting. First, levels of cleaved spectrin were assessed as a marker of calpain activity
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(Figure 3.5A). Calpain levels were significantly elevated at 3 and 7 d post-blast in comparison to
controls.
Another important calpain substrate is p35, the activating cofactor for the protein kinase
Cdk5 (Angelo et al., 2006). Calpain-dependent cleavage of p35 produces the truncated protein
p25. Cdk5/25 engenders aberrant activity and contributes to neuronal cell death (Hisanaga and
Endo, 2010). Consistent with an increase in calpain activity, as indicated by spectrin cleavage, p25
levels were significantly elevated at 3 and 7 d following mild bTBI (Figure 3.5B).
The hyperphosphorylation of the microtubule-associated protein, tau, and the resulting
formation of neurofibrillary tangles may characterize TBI (Smith et al., 2013). Furthermore,
Thr205 tau is a substrate of Cdk5/p25 (Maccioni et al., 2001). Interestingly, mild bTBI induced
acute elevations in phospho-Thr205 tau with significant increases detected at 6, 24, and 48 h after
mild bTBI (Figure 3.5C). Moreover, by 72 h, the levels were significantly below that of control
subjects. Taken together these results demonstrate that effectors of excitotoxicity are invoked by
mild blast exposure, and may underlie the pathological and neurophysiological deficits detected.
Behavioral effects of mild bTBI
To further assess the functional outcomes of mild blast injury we employed a wellestablished fear conditioning protocol (Plattner, 2014). In this behavioral paradigm, normal
subjects can predict aversive outcomes through association with a neutral context in which an
aversive stimulus was previously presented (Maren, 2001). The conditional response to the neutral
context (fear conditioning box) has long been associated with hippocampal function and injury
(Corcoran and Maren, 2001). Importantly, no changes in contextual fear response were observed
3 and 7 d following mild blast exposure (Figure 3.6A). Furthermore, mild blast-exposed rats
exhibited no effects on locomotion in fine (Figure 3.6B), ambulatory (Figure 3.6C) and total
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(Figure 3.6D) activity over a 24 h period in comparison to control subjects. Thus, the
neuropathological, neurophysiological, and biochemical effects of mild blast exposure did not
manifest in behavioral changes at the relatively early post-blast time points examined.

DISCUSSION
Here we used a bench-top model of bTBI that we developed (Turner et al., 2013b) to
explore the threshold of blast-exposure-induced brain injury. While rodent models of bTBI have
been used to demonstrate neuronal injury (Goldstein et al., 2012) and death (Turner et al., 2013b),
here we show that mild blast exposure elicited no macroscopic tissue damage or detectible
behavioral effects. However, close examination revealed axonal injury accompanied by damage
to microvasculature, with the blood brain barrier compromised at sparse foci throughout the brain.
These effects are consistent with the loss of hemodynamics, edema, and hemorrhage that
characterize more severe TBI. Interestingly, microvascular defects may characterize
presymptomatic phases of Alzheimer’s disease, suggesting a possible link between these effects
and increased incidence of neurological disease in blast exposed individuals (Dennis et al., 2009).
Numerous studies have demonstrated that neurotrauma can affect synaptic plasticity
(Bach-y-Rita, 2003; Page and Yablon, 2003; Griesbach et al., 2004), including in developing rat
brains (Li et al., 2013a). Suppression of LTP has been demonstrated in more severe models of
bTBI (Miyazaki et al., 1992; De Beaumont et al., 2012). Other traumatic brain injury models have
shown decreased hippocampal LTP levels with attenuated cognitive function (Titus et al., 2013).
In contrast, the mild blast forces used here had no detectable effect on LTP. Furthermore, the
overall functional synaptic properties were not dramatically affected by blast exposure. However,
mild blast exposure caused deficiencies in PTP following HFS and synaptic excitability. PTP may
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be mediated by long-lasting increase in presynaptic Ca2+ concentrations that elevate the release
probability of the presynaptic readily releasable pool of synaptic vesicles (Habets and Borst, 2005).
The deficiencies in this form of short-term plasticity and synaptic responsiveness may be causally
linked to the malformations of axonal processes observed histologically. While the effects
observed may be only weakly represented in evaluations of working memory or cognitive
performance, future studies, using repetitive mild blast exposures for example, may reveal latent
consequences on synaptic long-term plasticity or learning and memory.
Loss of microvascular integrity and blood brain barrier compromise are often related to
brain injuries involving excitotoxicity. Activation of Ca2+-dependent proteases such as calpain is
a predicted outcome of membrane depolarization and loss of Ca2+ homeostasis. Spectrin is
involved in actin binding and maintaining the shape of synapses. Its regulation of cytoskeletal
dynamics contributes to plasticity (Greer et al., 2013) and may be required for learning (Andres et
al., 2013). Furthermore, calpain-mediated degradation of neurofilament proteins has been
implicated in TBI (Blennow et al., 2012). Thus calpain activation and cleavage of spectrin is
consistent with deficits in axonal architecture and disruption of synaptic plasticity (Ma, 2013).
Indeed, rats exposed to bTBI can exhibit shortened axon initial segments, suggesting such
subcellular changes (Baalman et al., 2013). Moreover, spectrin cleavage in the corpus callosum
after bTBI has been suggested to attenuate overall electrophysiological responses (Park et al.,
2013) and neuronal death (Schafer et al., 2009).
Calpain-dependent conversion of p35 to p25 results in dysregulation of Cdk5, causing
relocation of the protein kinase and redirection towards aberrant substrates that mediate neuronal
injury (Plattner et al., 2006). While many of the substrates by which aberrant Cdk5 mediates
neurotoxicity remain to be delineated, one example is phospho-Thr205 tau, which increased at the
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onset of p25 generation in response to mild blast exposure. The long-term effects of bTBI include
tau hyperphosphorylation and neurofibrillary tangle accumulation (Goldstein et al., 2012; Weiner,
2013). Thus exposure to moderate blast forces may initiate subtle but still meaningful
neuropathological processes.
Preclinical studies of the effects of blast exposure in the past decade have focused
predominantly on the hippocampus as an area critical to learning and memory and neuropsychiatric
sequela (Taber et al., 2006; Cernak and Noble-Haeusslein, 2010; Budde et al., 2013; Huber et al.,
2013; Scheper and Hoozemans, 2013; Tweedie et al., 2013). Findings suggest that the exposure to
bTBI triggers early hippocampal cell damage which increases the incidence of depression and
anxiety related behaviors (Kamnaksh et al., 2012). Effects in other brain regions are also being
explored with regard to excitotoxic effects or contributions to the development of mood disorders
(Combes, 2013; Sajja et al., 2013). Taken together, the results presented here demonstrate that
mild blast exposure causes a panoply of deleterious neurological effects in the absence of major
behavioral deficits. It remains to be determined if mild blast exposures and the subclinical effects
detected here will develop into neuropsychiatric conditions with adequate periods of incubation.
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Figure 3.1. Blast pressure recording and experimental design. A. Recording of Friedlander
short-duration shock wave to which rats in this study were exposed. B. Schematic portraying
experimental design which includes time points for animal sacrifice for the neuropathology,
neurophysiology, and immunoblotting assays, or days after blast exposure for behavioral testing.
Control animals were not exposed to blast pressure.
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Figure 3.2. Mild blast exposure had no effect at the macroscopic level, but causes
microvascular injury, axonal damage, and neuroinflammation. A-C. Absence of
macroscopic tissue damage 7 d post-blast. Dorsal (A), ventral (B) and anterior-posterior coronal
4 mm brain section (C) views are shown. D. Microvascular injury and dysfunction 72 h postblast indicated by small hemorrhagic focus (center) in the corpus collosum. E. Robust reactive
astrogliosis in the same area as in D. F. Extravasation of blood plasma in a venule-like
microvessel in the left deep layer of cerebral cortex 72 h post-blast. G. Extravasation of blood
plasma in an arteriole-like microvessel in the right nucleus accumbens 48 h post-blast. H & I.
Axonal injury indicated by increased phosphorylated neurofilament immunostaining in the left
lateral septal nucleus 7 d post-blast (H); compared to control (I). J & K. Axonal injury also
indicated in thalamus 72 h post-blast (J); compared to control (K). L. Beaded, irregularly
swollen dystrophic axons (arrow) in the left lateral septal nucleus 24 h post-blast. M. Axonal
bulb (arrow) at the interface between cerebral cortex and corpus callosum 72 h post-blast. N &
O. Neuroinflammation indicated by increased astrocyte activation in the deep layer of cerebral
cortex 72 h post-blast (N); compared to the same area from control (O). P & Q.
Neuroinflammation also indicated by increased number of reactive microglia in striatum 72 h
post-blast (P); compared to the same area from control (Q). H&E staining (D,F,G). SMI 31
immunostaining (H-M). GFAP immunostaining (E,N,O). Iba1 immunostaining (P,Q). Scale
bars: 50 μm (D,E,G,H-K,N-Q); 20 μm (F,L,M).
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Figure 3.3. Mild blast exposure does not induce macroscopic changes to the hippocampus,
but does induce microscopic hippocampal pathology as indicated by axonal damage and
neuroinflammation. A. Absence of macroscopic hippocampal tissue damage 7 d post-blast. B.
Absence of overt neuronal injury in hippocampus 7 d post-blast. Insert shows no significant
pathology for CA3 field. C. Absence of FJB-positive neurons in the hippocampus 7 d post-blast.
Insert shows no degenerating neurons for CA3 field. D & E. Increased phosphorylated
neurofilament immunostaining in the hippocampal CA3 field 48 h post-blast (D); compared to
the same area from control rats (E). F. Mild swollen atrophic axon in hippocampal CA1 stratum
pyramidale 48 h post-blast. G. Axonal bulb in the hippocampal hilus 7 d post-blast (arrow). H &
I. Increased astrogliosis in the hippocampal CA1 field 72 h post-blast (H); compared to the same
area from control (I). J & K. Increased number of microglia in CA1 72 h post-blast (J);
compared to the same area from control (K). H&E staining (B). FJB staining (C). SMI 31
immunostaining (D-G). GFAP immunostaining (H & I). Iba1 immunostaining (J & K). Scale
bars: 50 μm (B-E,H,I); 20 µm (F,G); 100 μm (J,K).
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Figure 3.4. Mild blast exposure causes neurophysiological deficits in hippocampus. A.
Assessment of blast effects on LTP. B. Time-course shows plot of fEPSP slopes (percent baseline).
Each point represents average from two traces. Insets show representative traces from control
recordings (a: baseline, b: PTP, c: LTP). Horizontal arrows show PTP difference between control
and 7 d post-blast. Deficits in short-term plasticity following HFS are induced by mild blast
exposure. C. The upper panel summarizes fEPSP slopes during the first 2 min post-HFS. The
lower panel shows effects on PPR during the first 2 min post-HFS at 7 d post-blast. Input-output
curves measuring fEPSP slopes against normalized fiber volley amplitudes. A significant
reduction in maximal response was observed 7 d post-blast. Inset shows representative traces from
control recordings at different stimulation intensities. D. Paired pulse ratio at different intervals
shows no change in short-term synaptic plasticity following blast. (Mean ± SEM; n=6, *p < 0.05,
ANOVA, Newman-Keuls post hoc).
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Figure 3.5. Mild blast exposure invokes markers of excitotoxicity and neuronal injury in
hippocampus. A-C. Quantitative immunoblot analyses of hippocampal lysates from control and
blast-exposed rats at the indicated post-blast interval are shown for the calpain-cleaved form of
spectrin (A), p25, the calpain-cleaved form of the Cdk5 activator, p35 (B), and phospho-Ser205
tau (C). Data represent means ± s.e.m.; n ≤ 6; *p < 0.05, **p < 0.01, ***p < 0.005; Student’s ttest.
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Figure 3.6. Mild blast exposure has no effect on contextual fear conditioning or locomotor
activity. A. Contextual fear conditioning trials revealed no significant difference in the percent
freezing at 3 and 7 d post-blast compared to control subjects. B-D. Analysis of 24 h home cage
locomotion revealed that mild blast exposure showed no effect on ambulatory (B), fine (C), or
total locomotion (D) compared to control subjects. Data represent means  s.e.m.; n = 7; Student’s
t-test versus control.
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Chapter Four

Altering endoplasmic reticulum stress in a model of blast-induced
traumatic brain injury controls cellular fate and ameliorates
neuropsychiatric symptoms

This work is published in Front Cell Neurosci. 2014 Dec 10;8:421.
doi: 10.3389/fncel.2014.00421. eCollection 2014. PMID: 25540611
Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE,
Matsumoto RR, Huber JD, Rosen CL.
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ABSTRACT
Neuronal injury following blast-induced traumatic brain injury increases the risk for
neuropsychiatric disorders, yet the pathophysiology remains poorly understood. Blood-brainbarrier disruption, endoplasmic reticulum stress, and apoptosis have all been implicated in rodent
models of neural injury. Microvessel compromise is a primary effect of neural injury and is
postulated to cause subcellular secondary effects apoptosis. What remains unclear is how these
secondary effects progress to personality disorders in humans exposed to head trauma. To
investigate this we exposed male rats to a clinically-relevant blast model we have recently
developed. The study examined initial vascular disruption using Evan’s blue, secondary injury
mechanisms, apoptosis, and impulsive-like behavior measured with elevated plus maze. Evan’s
blue extravasation was observed immediately following blast injury, and persisted for at least 6 h.
Data showed increased mRNA abundance of stress response genes at 3 h, with subsequent
increases in cellular stress markers C/EBP homologous protein, and growth arrest and DNA
damage-inducible protein 34, at 24 h. Caspase-12 and Caspase-3 were both cleaved at 24 h
following blast injury. The endoplasmic reticulum stress inhibitor, salubrinal, was administered
(1mg/kg i.p.) to investigate its’ effects on neuronal injury and impulsive-like behavior associated
with neurotrauma. Salubrinal reduced protein expression of cellular stress markers, and diminished
Caspase-3 cleavage, suggesting apoptosis attenuation. Interestingly, salubrinal also ameliorated
impulsive-like behavior indicative of head trauma. These results suggest salubrinal to play a role
in the regulation of apoptosis and the pathology of chronic disease. These observations provide
evidence that endoplasmic reticulum stress is a promising molecular target for the attenuation of
neuronal injury after neurotrauma.
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INTRODUCTION
Blast-induced traumatic brain injury (bTBI) has been described as the ‘hallmark injury’
of recent wars in Iraq and Afghanistan (Goldstein et al., 2012). The Defense and Veterans Brain
Injury Center estimates that approximately 270,000 blast exposures have occurred over the past
decade (Farrell-Carnahan et al., 2013). Many blast exposures cause concussive or sub-concussive
brain damage and are associated with the shearing of axons (Rosenfeld and Ford, 2010) and the
compromise of brain micro-vessels (Chen et al., 2013b). Often these injuries go undetected in
soldiers and civilians due to poor understanding of the underlying mechanisms of blast injury
and the diagnostic limitations preventing the detection of pathophysiologic changes in living
patients (Stern et al., 2011).
Blast exposure can cause blood brain barrier (BBB) dysfunction (Abdul-Muneer et al.,
2013; Chen et al., 2013b) and induce short-term inflammatory cascades that promote
intracellular Ca2+ accumulation (Arun et al., 2013; Abdul-Muneer et al., 2014). Although bTBI is
considered a diffuse injury, a majority of damage from our model is localized to the prefrontal
cortex (PFC) (Turner et al., 2013b), where the brain impacts the skull on the contra coup side of
exposure (Zhu et al., 2010; Zhu et al., 2013). Ca2+ perturbations are known to cause endoplasmic
reticulum (ER) stress and trigger the unfolded protein response (UPR) (Zhang and Kaufman,
2008; Walter and Ron, 2011). Although the UPR has been reported in a model of controlled
cortical impact TBI (Farook et al., 2013), the mechanisms of cellular fate are not yet fully
elucidated.
Neuropsychiatric behaviors measured in animal models, such as impulsive-like
behaviors, are a strong indicator of damage to the rodent PFC (Bidzan et al., 2012; Johnson et al.,
2013a). Similar personality disorders are often observed in human bTBI patients as well,
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providing an important research parallel (Vaishnavi et al., 2009). We propose that our clinicallyrelevant blast model allows us to investigate the process of ER stress and how this response
relates to apoptosis and neuropsychiatric disorders.
A common downstream component of the UPR is the C/EBP homologous protein
(CHOP), which becomes upregulated during sustained cellular stress to maintain ER homeostasis
(Walter and Ron, 2011). The levels of CHOP dictate whether a cell can effectively repair itself,
or proceed to apoptosis by regulating pro- and anti-apoptotic mechanisms (McCullough et al.,
2001; Galehdar et al., 2010). Acute phase activation of the protein kinase R-like ER kinase
(PERK) UPR pathway, and its’ downstream component growth arrest and DNA damageinducible protein 34 (GADD34), helps to maintain CHOP within an ideal range to promote
cellular repair (Salminen and Kaarniranta, 2010).
Under sustained ER stress, intracellular Ca2+ accumulation can trigger apoptosis through
a separate cascade involving calpain-mediated Caspase-12 cleavage (Nakagawa et al., 2000).
This mechanism is considered separate from the UPR (Badiola et al., 2011), even though both
apoptotic cascades share Caspase-3 cleavage as a final common step in undergoing apoptosis
(Szegezdi et al., 2006). Using our model, we are interested in determining the mechanism by
which bTBI triggers apoptosis and how this relates to the pathology of chronic disease.
This study investigates acute BBB disruption, ER stress mechanisms, apoptosis and impulsivelike behavior following a single blast injury. It has been proposed that bTBI pathophysiology is
partly mediated by alterations in BBB permeability (Chen et al., 2013c), which may induce ER
stress and trigger the UPR (Begum et al., 2014). The ER stress modulator, salubrinal (SAL), has
been used to investigate downstream components of the PERK pathway (Sokka et al., 2007). Our
hypothesis is that SAL manipulation of the PERK pathway would maintain CHOP expression
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within a protective threshold. Balancing CHOP expression should regulate apoptosis and
mitigate impulsive-like behavior indicative of blast injury (Kamnaksh et al., 2011). Therefore,
treatment options should consider the UPR mechanism for the detrimental sequelae of
neuropsychiatric disorders.

METHODS
Animals
All procedures involving animals (N = 144) were approved by the Institutional Animal
Care and Use Committee of West Virginia University and were performed according to the
principles of the Guide for the Care and Use of Laboratory Animals. This work used young adult
male Sprague-dawley rats acquired from Hilltop Lab Animals (Hilltop Lab Animals, Inc.) and
weighed ~300-350g at the time of blast and sacrifice. Animals were acclimated for 1 week prior
to experimental use and were housed under 12 h light/dark conditions with food and water
available ad libitum.
Blast Overpressure Exposure
Prior to blast exposure, animals were anesthetized with 4% isoflurane (Halocarbon). The
blast was delivered to the right side of the head with the animal’s body oriented perpendicular to
the blast tube, and with the peripheral organs protected by a polyvinyl chloride pipe shield. The
animals were exposed to a mild blast (0.005” membrane; ~15 psi on incident recordings; ~50 psi
on reflected recordings), which was determined, in previous work, to produce microscopic
neuronal injury to the contra coup (left) side of the brain, with no signs of hemorrhagic injury
under gross examination (Turner et al., 2013b). Immediately following blast exposure, animals
were returned to a holding cage equipped with a homeothermic heating blanket equipped with a
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rectal thermometer to maintain body temperature at 37 °C. Once basic reflexes were restored,
animals were returned to the home cage.
Salubrinal Administration
A stock solution of SAL (Tocris) was made in 0.5% dimethyl sulfoxide (DMSO). Such a
low concentration of DMSO was chosen to avoid neurological effects (Methippara et al., 2012).
SAL was diluted to 100uM to effectively manipulate the UPR (Boyce et al., 2005). A DMSO
concentration of 0.5% was administered to control and bTBI rats 30 min prior to anesthesia. SAL
was aliquoted for each intraperitoneal injection at a dose of 1 mg/kg (Sokka et al., 2007; Liu et
al., 2014b). SAL was administered 30 min prior to anesthesia (SAL), or anesthesia followed by
blast exposure (SAL+bTBI).
Blood Brain Barrier Permeability Assessment
Animals in the BBB assessment group (N = 16) were evaluated at three time points
following blast exposure: 0.5, 6, 24 h, and control (n = 4). Following blast exposure, BBB
permeability was assessed using Evan’s Blue (EB; Sigma). EB binds to albumin and is a marker
used to detect BBB permeability (Yen et al., 2013). We had previously shown changes in BBB
permeability and tight junction protein expression with our model (Lucke-Wold et al., 2014c).
Animals were anesthetized with 4% isoflurane and maintained with 2% isoflurane throughout the
procedure. Saline containing EB (2%, 5ml/kg) was administered intravenously (femoral vein) 30
min before perfusion. The rats were then transcardially perfused with 0.9% saline for 15 min and
brains excised for raw imaging. The PFC was then dissected out and separated by hemisphere.
The samples were weighed and homogenized in 0.5 ml of 50% trichloroacetic acid (Sigma). The
samples were then incubated for 24 h at 37°C before being centrifuged at 10,000 x g for 10 min
at 4°C. The supernatant was measured by absorbance spectroscopy at 620nm. Calculations were
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based on an external standard reading and extravasated dye was expressed as ng EB / mg brain
tissue.
Quantitative Real-time Polymerase Chain Reaction
Rats (N = 48) for the gene analysis group were randomly divided into one of two groups:
time course (n = 24) and control (n = 24). The time course group consisted of six time-points
post-bTBI: 1.5, 3, 6, 12, 24, and 72 h (n = 4). The control group (anesthetized only) used rats for
all six time point from the time course study (n = 4). All animals were anesthetized with 4%
isoflurane and euthanized via decapitation in protease/phosphatase cocktail (Plattner et al.,
2006). Brains were rapidly removed with the PFC dissected out, separated by hemisphere and
flash frozen in liquid nitrogen. Total RNA was isolated in TRI-Reagent (Sigma) and was tested
for quantity and quality using a Nanodrop 2000c spectrophotometer (Thermo
Scientific). Reverse transcription was conducted using a high capacity reverse transcription kit
(Applied Biosystems). Real-time PCR analyses were performed using a 7500 Real-Time PCR
system (Applied Biosystems) in combination with TaqMan® chemistry using the following
oligonucleotide primer sets: activating transcription factor 4 (atf4) (Rn00824644_g1), CHOP
(ddit3) (Rn00492098_g1), GADD34 (ppp1R15A) (Rn00591894_m1), Glial fibrillary acidic
protein (gfap) (Rn00566603_m1) with 18s rRNA (Hs99999901_s1) used as an endogenous
control (Applied Biosystems). Changes in gene expression were determined using the (ΔΔCt)
method with a threshold cycle value of 0.2 normalized to 18s rRNA.
Western Blotting
Rats (N = 20) for the protein analysis group were randomly divided into four different
experimental groups: (1) control, (2) SAL, (3) bTBI 24 h, and (4) SAL+bTBI 24 h (n = 5).
Animals were euthanized and had tissue prepared as previously described. Protein samples were
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prepared by sonication in hot (85-95o C) 1% sodium docecyl sulfate (SDS; Sigma) as previously
described (O'Callaghan and Sriram, 2004). The protein concentration of each sample was
measured using a bicinchoninic acid (BCA) protein assay kit (Pierce). Samples were run using
30-50 μg of protein/well, depending on the primary antibody, using pre-cast Bolt® Bis-Tris Plus
gels (Life Technologies) in combination with 2X Lammeli sample buffer. Gels were run using
the Bolt® Mini tank system (Life Technologies) and transferred to polyvinylidene fluoride
membranes (Bio-Rad) using wet electrophoretic transfer cells (Bio-Rad). Membranes were
incubated with the following primary antibodies all raised in rabbit: CHOP 1:1000 (Cell
Signaling), Caspase-12 1:1000 (Cell Signaling), Caspase-3 1:750 (Cell Signaling), and GADD34
1:1000 (Pierce) overnight at 4o C. Anti-rabbit IgG horseradish peroxidase (HRP)-linked antibody
(Cell Signaling) was used as a secondary antibody at a concentration of 1:2000 with gentle
shaking for 2 h at room temperature. The rabbit monoclonal antibody β-actin (Cell Signaling)
was used as an endogenous control for all samples at a concentration of 1:10,000. Molecular
weight determination was conducted using the SeeBlue® Plus2 Pre-stained Standard (Life
Technologies). Imaging was conducted using LumiGLO chemiluminescent substrate (Cell
Signaling) according to manufacturer’s instructions. Images were converted to 8-bit and
analyzed using densitometry with background subtraction and normalized to β-actin using
ImageJ software (NIH).
Immunohistochemistry Preparation
Rats (N = 12) used for the immunohistochemistry (IHC) group were randomly divided
into three experimental groups: (1) control, (2) bTBI 24 h, and (3) SAL+bTBI 24 h (n = 4).
Histological samples were prepared as previously described (Lucke-Wold et al., 2014c). Briefly,
the animals were anesthetized by inhalation of 4% isoflurane and maintained with 2% isoflurane
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throughout the procedure. Animals were then transcardially perfused with 0.9% ice-cold saline
for 5 min followed by 10% formalin for 15 min. The brains were subsequently removed and
placed in 10% formalin solution for 24 h. Following fixation, the PFC was sectioned on a brain
block at 4mm increments. Sections were then processed with a Tissue Tek VIP 5 automatic
processor (Sakura Finetek), and embedded with Tissue Tek TEC (Sakura Finetek) as previously
described (Turner et al., 2012b). Slices (10µm) were prepared with the Leica RM2235
microtome (Leica Microsystems), mounted onto slides, and heat fixed for fluorescent staining. A
total of 46 coronal sections were prepared per animal.
Immunohistochemistry Staining
Paraffin was dissolved from slides with 5 min washes in xylene, 100% EtOH, and 95%
EtOH followed by 5 min rehydration in dH2O. The slides were then quenched with 10%
methanol and 10% H2O2 in Dulbecco’s phosphate buffered saline (DPBS) for 15 min. After
quenching, slides were rinsed three times in DPBS for 5 min each. The slides were then placed in
permeabilizing solution (1.8% L-lysine, 4% horse serum, and 0.2% Triton X-100 in DPBS) for
30 min. Slides were allowed to dry and the brain slices were circumscribed. Tissue was
incubated with primary antibody in DPBS with 4% horse serum overnight. Tissues were washed
three times in DPBS and incubated in secondary fluorescent antibody for 3 h. Tissues were then
rinsed three times in DPBS and dried overnight. Vectashield mounting media was used to fix the
coverslip (Vector Labs). When staining for co-localization, a second set of primary and
secondary antibodies were used prior to fixing the coverslip. Primary antibodies were GFAP
rabbit mAB (Dako) 1:500, CHOP mouse mAB (Cell Signaling) 1:1600, Caspase-3 rabbit
polyAB (Abcam) 1:1000, Caspase-12 mouse polyAB (Cell Signaling) 1:1000, and microtubule
associated protein 2 (MAP2) rabbit mAB (Millipore) 1:1000. Secondary antibodies were diluted
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1:100 in DPBS and included Alexa Fluor 488 goat anti-rabbit (Life Technologies), Alexa Fluor
594 goat anti-rabbit (Life Technologies), Alexa Fluor 488 goat anti-mouse (Life Technologies),
and Alexa 594 goat anti-mouse (Life Technologies). Imaging was performed with a Zeiss Axio
Imager 2 (Carl Zeiss Microscopy).
Immunohistochemistry Quantification
Corrected total cell fluorescence (CTCF) was calculated using ImageJ software (NIH).
Briefly, 12 randomly selected areas of the left PFC were outlined and measured, with fluorescent
density compared to background readings. Slides from each region were randomly selected by an
observer blinded to the experimental groups. The density was adjusted per mean area to give
corrected total cell fluorescence (Lucke-Wold et al., 2014c). For co-localization quantification,
the ImageJ plugin titled Just Another Co-localization plugin was utilized to calculate a Pearson’s
coefficient as well as an overlap coefficient for each sample (Beerten et al., 2012).
Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End Labeling
Slides for staining were prepared, sectioned and mounted as previously described. We
used an apoptosis detection kit to assess the left PFC at 24 h following blast exposure. Staining
for apoptosis was completed using the TACS 2 TdT-Dab in situ Apoptosis Detection kit
(Trevigen) according to manufacturer’s instructions. In brief, paraffin embedded slices were
deparaffinized and rehydrated with five minute incubations in xylenes, 100% EtOH, 95% EtOH,
and deionized water each. The slices were then immersed in phosphate buffered saline for 10
minutes followed by treatments with Proteinase K, quenching solution, labeling buffer, and
labeling reaction mixture. The sample was then covered in Strep-HRP solution for ten minutes,
washed, and then immersed in 3,3'-Diaminobenzidine (DAB) solution for seven minutes. The
slices were counterstained with 1% methyl green and dehydrated with 10 dips in deionized
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water, 95% EtOH, 100% EtOH, and xylenes. The slides were coverslipped using Permount™
(Sigma) mounting media and glass coverslips. For quantification of DAB staining, regions of the
PFC were randomly selected for rats from the different treatment groups. An observer blinded to
experimental group, randomly selected 100 total cells. The number of positive cells was reported
as a fraction of total cells counted.
Elevated Plus Maze
Impulsive-like behavior can be measured with increased exploratory behavior in a rodent
model of anxiety (Mosienko et al., 2012). Four groups of rats (N = 48) were subject to behavioral
analysis: control, SAL, bTBI 7 d, and SAL+bTBI 7 d (n = 12). The elevated plus maze (EPM)
was set at a height of 60 cm from the floor. The two open arms intersected perpendicular to the
two closed arms. Each arm was 50 cm x 10 cm. The closed arms were encased by black siding
30 cm tall. Each rat was placed in the middle of the elevated plus maze facing an open arm and
tracking was performed for 5 min with AnyMaze™ software (Version 4.7, Stoelting), which
pinpointed the location of the animal’s head and body continuously throughout the testing trial.
The percent time spent in the open arms, speed, closed arm entries and movement were all
recorded and quantified. Increased percent time spent in the open arms was considered a sign of
impulsive-like behavior, as previously described (Mosienko et al., 2012; Johnson et al., 2013a).
Data Analysis
Data were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc.). All data points
are shown as mean ± s.e.m. Statistical differences between control and experimental groups were
determined by using ANOVA with a Dunnett’s, Tukey’s or Bonferroni’s post-hoc tests. A twotailed Student’s t-test was used when comparing two conditions only. For DAB staining, a chisquare analysis was used to compare between groups. A power analysis was conducted for all
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experiments with an α of 0.05 and a β of 0.2 (DSS Research Power Analysis). Sample sizes were
determined by the sample effect with behavioral data being set at 0.4 and all other data being set
at 0.3. A value of p < 0.05 was considered statistically significant for all data analyzed.

RESULTS
The physical force of bTBI can shear axons (Raghupathi and Margulies, 2002), and
rupture micro-vessels (Arun et al., 2013). These primary effects can cause neurons to rapidly
depolarize and activate voltage gated Ca2+ channels, thereby increasing intracellular Ca2+
(Gurkoff et al., 2013). Studies using other models of neurotrauma have shown marked BBB
dysfunction (Abdul-Muneer et al., 2014), ER stress activation (Farook et al., 2013), and
apoptosis (Sabirzhanov et al., 2014). SAL is known to prevent the dephosphorylation of
eukaryotic initiation factor 2 alpha (eIF2α) (Boyce et al., 2005); however, this agent may directly
affect other mechanisms of ER stress (Zhang et al., 2014a) or apoptosis (Kessel, 2006). Figure
4.1 portrays how bTBI may trigger the UPR, as well as the proposed effects of SAL.
Contra Coup Vascular Disruption
The suggestion has been made previously that BBB disruption, or loss of micro-vessel
endothelium integrity, may be an inciting event for the molecular changes frequently induced
following neurotrauma (Abdul-Muneer et al., 2013; Arun et al., 2013). This may be particularly
relevant in models of blast injury in which a pressure wave, and associated surge in vascular
flow to the brain, may induce microvascular changes manifested as BBB disruption (Sosa et al.,
2013). Following BBB disruption, EB binds to albumin and diffuses into the brain in a locationspecific manner consistent with disruption (Yang et al., 2013). Recently, we have shown changes
in BBB permeability and tight junction protein expression using our blast model (Lucke-Wold et
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al., 2014c). To further address these issues, we used EB extravasation to assess the brain
vasculature of the PFC following blast exposure.
One-way ANOVA revealed a significant difference in EB absorbance in the left PFC
following blast exposure (F (3,12) = 31.350, p < 0.001). Dunnett’s post-hoc analyses revealed
bTBI significantly increased EB absorbance in the left PFC at 0.5 h (q = 8.844, p < 0.001) and 6
h (q = 3.491, p < 0.05) (Figure 4.2A). Raw images of extracted brains at varying time points
(0.5, 6, and 24 h) demonstrate BBB disruption, particularly prominent in the left PFC (Figure
4.2B). The images provide vivid proof of a contra coup style of injury following bTBI. Because
our model’s blast exposure produced no signs of hemorrhagic transformation under gross
examination at this severity (Turner et al., 2013b), we are certain that these findings indicate a
loss in BBB integrity on a microscopic scale.
Blast upregulates stress response markers
To investigate gene changes following blast exposure, we performed quantitative realtime PCR. A time course was employed to measure acute and sub-acute changes in mRNA
abundance of four stress response genes (atf4, ddit3, ppp1R15A and gfap). Atf4 encodes for
ATF4, ddit3 encodes for CHOP, ppp1R15A encodes for GADD34, and gfap encodes for GFAP.
Two-Way ANOVA revealed significant differences in left PFC atf4 mRNA abundance between
treatment, time, and interaction (p < 0.05). Blast exposure significantly increased the mRNA
abundance of atf4 in the left PFC at 3 h (t = 7.694, p < 0.001) (Bonferroni’s post-hoc analysis)
(Figure 4.3A). Two-Way ANOVA also revealed significant differences in left PFC ddit3 mRNA
abundance between treatment, time, and interaction (p < 0.05). Bonferroni’s post-hoc analysis
revealed a significant increase in left PFC ddit3 mRNA abundance at 3 h post-bTBI (t = 7.989, p
< 0.001) (Figure 4.3B). To further validate our blast model induces a contra coup form of injury
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we also measured mRNA abundance of atf4 and ddit3 in the right PFC. Indeed no differences
were observed in the right PFC for atf4 (Figure 4.3C), or ddit3 (Figure 4.3D). Left PFC mRNA
abundance for both atf4 and ddit3 quickly returned to baseline by 6 h and remained at this level
through 72 h, implying an acute phase stress response (Figure 4.3A-B).
Two-Way ANOVA revealed significant differences in the left PFC ppp1R15A mRNA
abundance between time and interaction (p < 0.05). Blast exposure significantly increased the
mRNA abundance of ppp1R15A in the left PFC at 6 h (t = 6.022, p < 0.001) (Bonferroni’s posthoc analysis) (Figure 4.3E). Two-Way ANOVA also revealed significant differences in left PFC
gfap mRNA abundance between treatment and time (p < 0.05). Bonferroni’s post-hoc analysis
revealed a significant increase in left PFC gfap mRNA abundance at 24 h post-bTBI (t = 4.081, p
< 0.01) (Figure 4.3F). Results indicate blast exposure imparts downstream upregulation of UPR
marker, GADD34, with trailing astrocyte activation at a later time point. Astrocyte activity is
indicative of neuroinflammation and early stages of cell death.
Salubrinal attenuates ER stress markers
SAL is a research tool known to inhibit the UPR in vitro (Boyce et al., 2005) and in vivo
(Sokka et al., 2007). In particular, SAL prevents the dephosphorylation of eIF2α by the
GADD34 phosphatase complex formation (Hetz et al., 2013). We used this tool prior to blast
exposure to alter ER stress and to examine any effects modulating the UPR. Western blot was
used to compare CHOP expression in the left and right PFC to further support contra coup injury
indicative of bTBI (Zhu et al., 2010; Zhu et al., 2013). A significant increase in CHOP
expression was measured in the left PFC at 24 h post-bTBI (t = 2.625, p < 0.05) (Figure 4.4A),
but not in the right PFC (t = 1.487, p > 0.05) (Figure 4.4B) (Two-Tailed Student’s t Test). A
significant difference in CHOP expression was observed with a One-Way ANOVA (F (3,12) =
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5.775, p < 0.01). At 24 h, a significant increase in CHOP expression was seen in the left PFC of
bTBI rats (t = 3.705, p < 0.05), but was attenuated in the left PFC of SAL+bTBI rats (t = 3.105, p
< 0.05) (Bonferroni’s post-hoc analysis) (Figure 4.4C). These findings indicate SAL given alone
does not alter the constitutively active form of CHOP; however, stress-activated CHOP can be
attenuated when SAL is administered prior to blast exposure.
ER stress markers Caspase-12 and GADD34 were investigated to determine if SAL had
any effects on cellular fate following blast exposure. One-Way ANOVA revealed a significant
difference in the proteolytic processing of Caspase-12 (F (3,16) = 10.230, p < 0.001) at 24 h postbTBI. Caspase-12 cleavage significantly increased in the left PFC of bTBI rats (t = 3.696, p <
0.05), as well as in the left PFC of SAL+bTBI rats (t = 3.393, p < 0.05) (Bonferroni’s post-hoc
analysis) (Figure 4.4D). A One-Way ANOVA revealed a significant difference in GADD34
protein expression (F (3,16) = 5.216, p < 0.05) following blast exposure. GADD34 protein
expression significantly increased in the left PFC of bTBI rats at 24 h (t = 3.136, p < 0.05). This
effect was mitigated when SAL was administered prior to blast exposure (t = 3.107, p < 0.05)
(Bonferroni’s post-hoc analysis) (Figure 4.4E). Findings suggest SAL may control cellular fate
through the modulation of ER stress in a bTBI model.
Salubrinal modulates ER-mediated apoptosis
CHOP, Caspase-12 and Caspase-3 are all markers of ER-mediated apoptosis (Nakagawa
and Yuan, 2000; Nakagawa et al., 2000; Tabas and Ron, 2011). Caspase-12 is initially cleaved
by ER stress through a perturbation in Ca2+ homeostasis; thereby, activating Caspase-3 and
triggering apoptosis (Bernales et al., 2012). To further confirm that bTBI increases CHOP
expression, we conducted IHC fluorescent staining in the left PFC and measured corrected total
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cell fluorescence (CTCF). We also measured CTCF for Caspase-12 and Caspase-3 in the left
PFC.
Consistent with Western blot findings, IHC analyses showed a significant difference in
CTCF for CHOP after blast exposure (One-Way ANOVA; F (2,12) = 34.390, p < 0.001).
Bonferroni’s post-hoc analyses revealed bTBI significantly increased CHOP CTCF (t = 8.099, p
< 0.001), while SAL pre-administration reduced CHOP CTCF (t = 5.592, p < 0.001) in the left
PFC at 24 h (Figure 4.5A). IHC analyses also showed that bTBI portrays a significant difference
in CTCF for Caspase-12 (One-Way ANOVA; F (2,12) = 22.03, p < 0.001), and Caspase-3 (OneWay ANOVA; F (2,12) = 12.490, p < 0.01). Bonferroni’s post-hoc analyses revealed a significant
increase in CTCF for Caspase-12 at 24 h in the left PFC of bTBI rats (t = 6.066, p < 0.001), as
well as SAL+bTBI rats (t = 5.366, p < 0.001) (Figure 4.5B). SAL also attenuated (t = 3.967, p <
0.01) the increased Caspase-3 CTCF (t = 4.615, p < 0.01) at 24 h post-bTBI in the left PFC
(Figure 4.5C). These findings suggest SAL plays an important role in the control of cellular fate
through CHOP- and Caspase-3-dependent mechanisms following blast exposure.
We employed IHC colocalization to determine cell-specific UPR activation. CHOP
displayed a moderate colocalization with the neuron-specific MAP2 in the left PFC at 24 h postbTBI (Pearson’s coefficient, r = 0.536) (Figure 4.6). CHOP displayed a weak colocalization
with MAP2 in the control (Pearson’s coefficient, r = 0.371) and SAL+bTBI groups (Pearson’s
coefficient, r = 0.233) (Figure 4.6). The results suggest blast exposure increases CHOP protein
expression in neurons of the left PFC at 24 h, and also supports the protein and gene data shown
previously for CHOP.
IHC colocalization was also used to determine if CHOP and Caspase-12 activation occur
in the same cells. We observed a very weak colocalization between CHOP and Caspase-12 in the
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left PFC of control rats (Pearson’s coefficient, r = 0.177). We discovered a moderate
colocalization between CHOP and Caspase-12 at 24 h in the left PFC of bTBI rats (Pearson’s
coefficient, r = 0.537) (Figure 4.7), as well as a moderate colocalization in the left PFC of
SAL+bTBI rats (Pearson’s coefficient, r = 0.677) (Figure 4.7). These results suggest CHOP and
Caspase-12 to be active within the same cell after blast exposure. Colocalization strengths also
suggest SAL may not have a direct effect on Caspase-12 cleavage.
Salubrinal mitigates Caspase-3 cleavage
We wanted to determine if SAL had an effect on Caspase-3 cleavage. Caspase-3 cleavage
is one of the final steps of the apoptotic cascade and is a common indicator used to assess cell
death after TBI (Clark et al., 2000). One-Way ANOVA revealed a significant difference in
Caspase-3 cleavage at 24 h post-bTBI (F (3,16) = 5.533, p < 0.01). Caspase-3 cleavage
significantly increased in the left PFC of bTBI rats (t = 3.251, p < 0.05), but was not significantly
increased in the left PFC of SAL+bTBI rats (t = 1.200, p > 0.05) (Bonferroni’s post-hoc analysis)
(Figure 4.8A). These results suggest blast exposure elicits cell death through apoptosis. The
results also suggest that ER stress plays an important role in the control of cellular fate following
blast injury.
We wanted to determine if our blast model produced cell death, and if SAL preadministration would reduce bTBI-induced cell death. To do this we employed a terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling assay that utilizes DAB to stain
cells undergoing the initial stages of apoptosis. We noticed cell membrane blebbing following
blast exposure in the left PFC, which indicates early signs of apoptosis (Clark et al., 1997). DAB
staining revealed increased apoptosis in bTBI rats compared to control rats (Figure 4.8B,C).
Interestingly, SAL+bTBI rats displayed less DAB positive staining compared to bTBI rats
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(Figure 4.8D). The ratio of positive stained cells for control = 3/100, bTBI = 26/100, and
SAL+bTBI = 3/100. χ2 = 33.456 with 2 degrees of freedom and p < 0.001.
Impulsive-like behavior ameliorated by salubrinal
We assessed the percent time spent in the open arms of the EPM to measure changes in
impulsive-like behavior (Mosienko et al., 2012). Track plots from the Anymaze™ analysis were
included for each experimental group to visually support the behavioral changes (Figure 4.9A).
A One-Way ANOVA exhibited a significant difference in the percent time spent in the open
arms at 7 d post-bTBI (F (3,44) = 4.250, p < 0.05). Tukey’s post-hoc analysis revealed a
significant increase in the percent time spent in the open arms between bTBI rats and SAL alone
rats (q = 3.816, p < 0.05). SAL given prior to bTBI significantly reduced the percentage of time
spent in the open arms compared to the 7 d post-bTBI group (q = 4.657, p < 0.05) (Tukey’s posthoc analysis) (Figure 4.9B). No significant differences were observed between groups in speed
(p > 0.05) (Figure 4.9C), closed arm entries (p > 0.05) (Figure 4.9D), or total movement (p >
0.05) (Figure 4.9E) (Tukey’s post-hoc analysis). Overall, these results indicate blast exposure
may increase impulsive-like behavior, and that ER stress modulation may play a role in the
manipulation of this type of behavior.

DISCUSSION
Data from the current study provides evidence that blast exposure disrupts the BBB and
increases PERK-mediated ER stress in the left PFC. Impulsive-like behavior, a neuropsychiatric
symptom associated with PFC damage (Johnson et al., 2013a), was demonstrated by rats exposed
to bTBI through their increased exploration in the open arms of the EPM. IHC results confirm
bTBI increases the expression of neuronal apoptosis. ER stress modulation, influences cellular
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fate and ameliorates impulsive-like behavior indicative of blast exposure. Overall, these results
suggest a possible mechanistic link between ER stress, apoptosis and neuropsychiatric disease.
Previous groups have shown that disruptions in the BBB by various insults such as ischemic
stroke and epilepsy can cause increased micro-vessel permeability (Kaya and Ahishali, 2011).
The external forces of TBI can cause rapid depolarization of neuronal cell membranes;
thereby, activating voltage gated Ca2+ channels and increasing intracellular Ca2+ levels (Gurkoff
et al., 2013; Begum et al., 2014). Until recently, it was unknown to what extent blast injury
disrupts the BBB. A mild exposure (~15psi on incident recordings) from our clinically-relevant
blast model previously exhibited no signs of brain hemorrhage under gross examination (Turner
et al., 2013b). A new study showed BBB disruption at 6 h following a mild intensity blast (~17.8
psi) in Sprague-Dawley rats (Abdul-Muneer et al., 2013). Our results indicate a more acute
disruption in BBB permeability shown at 0.5 h, which is an earlier documentation of BBB
disruption following bTBI. The rapid increase in permeability from blast injury is thought to
result from an intracranial pressure spike (Chen et al., 2013c), and may be an important primary
effect driving cellular stress (Arun et al., 2013).
Increased intracellular Ca2+ triggered ER stress and activated the UPR in other models of
neuronal injury (Osada et al., 2009). Similarly, mild neurotrauma was shown to activate other
adaptive arms of the UPR in mice (Rubovitch et al., 2011a). The UPR is unique in that
depending on the time and duration of the response, different arms of the pathway are activated
(Rubovitch et al., 2011a). If the UPR lasts too long, a switch from neuroprotection to apoptosis
occurs (Nakagawa et al., 2000; Urra et al., 2013). Apoptosis is not purely detrimental to the
damaged brain considering the heightened energy demands following neurotrauma. By limiting
energy expended on severely damaged cells, the brain can preserve function to surviving cells.
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Blast-induced CHOP elevation, along with increased Caspase-12 and Caspase-3
cleavage, suggests a neuronal shift from the repair response to apoptosis. Modulation of the ER
stress response with SAL has been shown to attenuate CHOP expression (Zhang et al., 2014a)
and limit apoptosis in other models of neuronal injury (Sokka et al., 2007; Nakka et al., 2010).
SAL’s effects on Caspase-12 remain controversial where some studies claim SAL mitigates
Caspase-12 cleavage (Liu et al., 2012), while other studies claim SAL promotes cleavage (Gao et
al., 2013). Furthermore, it is important to note that Caspase-12 is regulated through a calpaindependent process (Nakagawa and Yuan, 2000) independent from the PERK-mediated UPR
(Badiola et al., 2011). In our bTBI model, we show that SAL mitigates CHOP expression and
reduces Caspase-3-mediated cell death with no effect on Caspase-12 cleavage. This suggests that
SAL may not have a direct effect on Caspase-12 cleavage, but still plays a role in the control of
cellular fate. Our findings, along with the findings of others, provide evidence for new ways to
examine cellular stress and apoptosis in models of neuronal injury.
Neurotrauma is also intimately associated with post-injury changes in behavior
(Schroeter et al., 2007). Blast exposure increases impulsive-like behavior in adult male Sprague
Dawley rats as shown in the EPM data. This finding may correlate with acute behavioral findings
seen in soldiers following head injury (Menon et al., 2010). Interestingly, SAL attenuated the
percentage of time spent in the open arms of the EPM following bTBI. These findings suggest
that SAL may have a modulatory effect on impulsive-like behavior indicative of PFC damage
through modulation of ER stress. While significant advances have been made in understanding
the acute pathophysiology of blast exposure, it remains unclear how bTBI leads to the
development of neuropsychiatric disorders (Tweedie et al., 2013).
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Emerging evidence indicates that the UPR may be one potential mechanism linking acute
neuronal injury and chronic disease pathology (Scheper and Hoozemans, 2013). In various
models of neurodegenerative disease, evidence of PERK-mediated ER stress activation has been
implicated (Costa et al., 2012; Ho et al., 2012; Nijholt et al., 2012). Moreover, experimental
work using other models of neurotrauma have shown elevated UPR markers (Farook et al., 2013;
Begum et al., 2014) and behavioral deficits (Goldstein et al., 2012; Petraglia et al., 2014c). Based
on our findings, the elevation of UPR markers concurrently with Caspase-3 cleavage suggests
neuronal apoptosis, which has been implicated as an early indicator of chronic disease pathology
(McKee et al., 2009). As such, our study provides a correlative link between blast-induced UPR
activation and neuropsychiatric disorder development. Future studies, likely using genetically
altered animals, or additional pharmacologic inhibitors, are required to examine the precise role
of ER stress in the development of chronic disease following neurotrauma. Similarly,
investigating PERK-mediated ER stress in pathologic clinical specimens will further clarify the
potential role of the pathway in neuropsychiatric disease development.
Long-term studies utilizing both a single and repetitive injury model are warranted in
order to examine not only chronic disease processes associated with ER stress but also the effect
of repetitive injury on the activation of the ER stress response. Finally, the contribution of the
other two adaptive arms of the UPR following blast injury remains to be elucidated. All three
adaptive arms of the UPR share CHOP as a signal mediator and is of particular interest due to the
overlapping nature of the pathways and the potential for modulation of signaling in a biphasic
manner. We are also interested in the role of axonal shearing as a result of blast exposure. We
have shown previously that a majority of damage from our blast model occurs in the corpus
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callosum (Turner et al., 2013b). This is considered another primary effect of blast exposure and
warrants future investigation using our model.
Blast exposure disrupts the BBB and triggers ER stress in the left PFC. Rats exposed to
blast exhibit more impulsive-like behavior and display markers of neuronal apoptosis. When
bTBI rats were given the ER stress modulator, SAL, markers of apoptosis and impulsive-like
behavior were both attenuated. The cells that survive the initial primary injury of bTBI are those
that we seek to protect from secondary injury mechanisms. Future studies linking ER stress to
chronic disease are ongoing and could provide new molecular targets for treatment following
blast injury.
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Figure 4.1. Schematic shows primary and secondary effects of blast injury. Blast-induced
traumatic brain injury (bTBI) can burst brain microvessels and shear axons. Both primary effects
lead to increased intracellular calcium levels which triggers a variety of secondary effects
including endoplasmic reticulum (ER) stress. ER stress activates the unfolded protein response
(UPR) which consists of three separate adaptive arms that play a time-dependent role in
maintaining cellular homeostasis. Following neural injury the protein kinase-like ER kinase
(PERK)-mediated UPR is considered the acute phase adaptive arm. This mechanism, along with
a link to ER-mediated apoptosis, is displayed with the proposed effects of salubrinal (SAL)
included.
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Figure 4.2. Blood brain barrier disruption observed in the contra coup brain after bTBI.
(A) Blood Brain Barrier (BBB) disruption as evidenced by increased Evan’s Blue absorbance in
the left prefrontal cortex (PFC) at 0.5 h post-bTBI (***p < 0.001 vs. Ctrl) and 6 h post-bTBI (*p
< 0.01 vs. Ctrl) (values represent mean ± s.e.m.) (n = 4). (B) Raw images of Evan’s Blue bound
albumin in the left brain parenchyma at acute time points post-bTBI.
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Figure 4.3. Blast exposure upregulates stress response genes atf4, ddit3, ppp1R15A and gfap.
Real-time quantitative PCR time course showed a significant increase in mRNA abundance in
the left PFC post-bTBI of stress response genes (A) atf4 (activating transcription factor 4)
(ATF4) at 3 h (***p < 0.001 vs. Ctrl at 3 h) and (B) ddit3 (CHOP) at 3 h (***p < 0.001 vs. Ctrl
at 3 h). No real differences were observed in mNRA abundance in the right PFC for (C) atf4 (p >
0.05) and (D) ddit3 (p > 0.05). A significant increase in mRNA abundance was also observed in
the left PFC for UPR gene (E) ppp1R15A (GADD34) at 6 h (***p < 0.001 vs. Ctrl at 6 h), and
astrocyte activation marker (F) gfap (GFAP) at 24 h (**p < 0.01 vs. Ctrl at 24 h) (values
represent mean ± s.e.m.) (n = 4).
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Figure 4.4. SAL attenuates ER stress markers in the contra coup PFC after bTBI (A)
Immunoblots show a significant increase in CHOP expression at 24 h post-bTBI in the left PFC
(*p < 0.05 vs. Ctrl). (B) No significant differences were observed in the right PFC (p > 0.05 vs.
Ctrl). (C) CHOP expression was significantly increased at 24 h post-bTBI compared to SAL
administered alone (*p < 0.05 vs. SAL). SAL administration prior to blast exposure attenuated
CHOP expression (#p < 0.05 vs. bTBI). (D) A significant increase in Caspase-12 cleavage was
observed at 24 h in bTBI rats (*p < 0.05 vs. SAL), as well as in SAL+bTBI rats at 24 h (*p <
0.05 vs. SAL). (E) GADD34 protein expression was significantly increased at 24 h post-bTBI
(*p < 0.05 vs. SAL). SAL administration prior to blast exposure attenuated GADD34 protein
expression (#p < 0.05 vs. bTBI) (values represent mean ± s.e.m.; normalized to β-actin) (n = 45).

108

Figure 4.5. SAL modulates fluorescence of apoptosis markers after bTBI. Column of panels
display immunofluorescence of apoptosis markers: CHOP (green), Caspase-12 (red) and
Caspase-3 (red) (top to bottom). Row of Panels are separated by experimental group: CTRL,
bTBI and SAL+bTBI (left to right). All images are from the left PFC region and display the blue
nuclear counterstain 4',6-diamidino-2-phenylindole (DAPI). Images are displayed at 20x; arrows
demarcate insets at 40x. (Scale bars = 50µm). (A) Immunohistochemistry (IHC) shows bTBI
augmented CHOP fluorescence in the left PFC at 24 h (***p < 0.001 vs. Ctrl). SAL
administration prior to bTBI attenuated CHOP fluorescence at 24 h (###p < 0.001 vs. 24 h) (B)
IHC shows bTBI increased Caspase-12 fluorescence in the left PFC at 24 h (***p < 0.001 vs.
Ctrl). SAL+bTBI rats also displayed increased Caspase-12 fluorescence at 24 h (***p < 0.001
vs. Ctrl) (C) IHC also shows bTBI augmented Caspase-3 fluorescence in the left PFC at 24 h
(***p < 0.001 vs. Ctrl). SAL administration prior to bTBI mitigated Caspase-3 fluorescence at
24 h (##p < 0.01 vs. 24 h) (values represent mean ± s.e.m.) (n = 4; 12 randomly selected areas
from left PFC).
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Figure 4.6. SAL reduces CHOP and MAP2 colocalization after blast exposure. Column of
panels display immunofluorescence of UPR marker CHOP (green), neuron-specific marker
MAP2 (red), nuclear counterstain DAPI (blue), and those three markers merged (yellow) (left to
right). Row of panels are separated by experimental group: CTRL, bTBI and SAL+bTBI (top to
bottom). All images are from the left PFC region with colocalization determined by levels of
yellow in merged images. Images are displayed at 20x; arrows demarcate insets at 40x. (Scale
bars = 50µm).
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Figure 4.7. CHOP and Caspase-12 colocalize regardless of SAL administration prior to
bTBI. Column of panels display immunofluorescence of UPR marker CHOP (green), Caspase12 (red), nuclear counterstain DAPI (blue), and those three markers merged (yellow) (left to
right). Row of panels are separated by experimental group: CTRL, bTBI and SAL+bTBI (top to
bottom). All images are from the left PFC region with colocalization determined by levels of
yellow in merged images. Images are displayed at 20x; arrows demarcate insets at 40x. (Scale
bars = 50µm).
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Figure 4.8. SAL reduces apoptosis in the left PFC following blast exposure. (A) Caspase-3
cleavage increased in the left PFC of bTBI rats at 24 h (*p < 0.05 vs. SAL), but was not
increased in SAL+bTBI rats at 24 h (p > 0.05 vs. SAL) (values represent mean ± s.e.m.;
normalized to β-actin) (n = 5). (B,C) Evidence of increased cell membrane blebbing, an indicator
of early apoptosis, was observed at 24 h in the left PFC of bTBI rats compared to control rats.
(D) Membrane blebbing was reduced in the left PFC of SAL+bTBI rats. Images displayed at
20x; arrows demarcate insets at 63x. (Scale bars = 30µm) (n = 4).
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Figure 4.9. SAL ameliorates impulsive-like behavior indicative of PFC damage after Blast.
(A) A motion capture track plot of one animal from each experimental group during a single
elevated plus maze (EPM) trial using AnyMaze Software™. (B) Percentage of time spent in the
open arms of the EPM was significantly increased in bTBI rats compared to SAL only rats at 7 d
(*p < 0.05 vs. SAL). SAL administration prior to bTBI decreased the percent time spent in the
open arms of the EPM (#p < 0.05 vs. bTBI) (values represent mean ± s.e.m.) (n = 12). No
significant differences were observed between groups for (C) Speed, (D) Closed-Arm Entries, or
(E) Movement within the EPM trials (5 min).
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Chapter Five

Salubrinal reduces oxidative stress, neuroinflammation and
impulsive-like behavior in a rodent model of traumatic brain injury

This work has been submitted for publication in Brain Research (2016)
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ABSTRACT
Traumatic brain injury is the leading cause of trauma related morbidity in the developed
world. TBI has been shown to trigger secondary injury cascades including endoplasmic
reticulum stress, oxidative stress, and neuroinflammation. The link between secondary injury
cascades and behavioral outcome following neurotrauma is poorly understood and warrants
further investigation. Using our validated rodent blast injury model, we examined the secondary
injury cascades following single injury and how these effects may contribute to risk-taking
behavior after repetitive blast. We targeted these pathways with the cellular stress modulator,
salubrinal, and investigated its role in decreasing neuroinflammation and risk-taking behavior
after blast injury. Single blast increased multiple markers associated with secondary injury
cascades including janus-N-terminal kinase phosphorylation, nuclear factor kappa beta activity,
inducible nitric oxide synthase protein expression, pro-inflammatory markers, and superoxide
levels at 24 hours post-injury. After repeat blast, we observed elevated neuroinflammation and
neurodegeneration, in addition to risk-taking behavior measured on the elevated plus maze.
Salubrinal administration attenuated secondary injury cascades acutely, and prevented risktaking behavior following repetitive blast. Overall, these results suggest a link between
secondary injury cascades and risk-taking behavior that can be modulated by salubrinal
administration. Overlapping components of cellular stress were targeted by salubrinal and
provide a novel approach to treat neuroinflammation and neuropsychiatric symptoms following
neurotrauma.
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INTRODUCTION
An estimated 3.2 million Americans are currently living with disabilities from traumatic
brain injury (TBI) (Zaloshnja et al., 2008). Risk-taking behavior is one of the most common
neuropsychiatric symptoms associated with brain injury and results from damage to the frontal
cortex (Schwarzbold et al., 2010; Adhikari et al., 2011; Logsdon et al., 2014; Michael et al.,
2015). Risk-taking behavior is a key finding in patients diagnosed with chronic traumatic
encephalopathy (CTE) and presents early in disease progression (Banks et al., 2014; Rebetez et
al., 2015). CTE is a progressive tauopathy that develops in patients with a history of
neurotrauma. The diagnosis of CTE is increasing but prospective studies are limited (Stein et al.,
2014). Currently, no therapies for risk-taking behavior are available for patients diagnosed with
progressive neurodegenerative disease.
The underlying mechanistic causes linking neurotrauma to subacute neuropsychiatric
symptoms are still poorly understood (Lucke-Wold et al., 2014b). Neuroinflammation has
emerged as a possible contributory factor to behavior change (Faden et al., 2015). Preclinical
models have shown that TBI is associated with a significant inflammatory burden (Kumar et al.,
2014). Furthermore, it has been shown that neuroinflammation can persist years after injury in
the brains of retired athletes (Coughlin et al., 2014). Recent clinical evidence ties
neuroinflammation to neurobehavioral dysfunction (Cho et al., 2013; Wu et al., 2014). We
propose that by targeting neuroinflammation, we can possibly improve behavior after TBI. In
this paper, we investigate how cellular stress modulation may contribute to changes in the
inflammatory burden and neurobehavioral dysfunction in a rodent model of blast TBI.
The endoplasmic reticulum (ER) stress mechanisms have been shown to play a
significant role in acute and chronic disease pathology following TBI (Zhang et al., 2012; Abdul-
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Muneer et al., 2014; Begum et al., 2014; Lucke-Wold et al., 2015b). We recently showed that
markers of ER stress were increased in the brains of athletes diagnosed with CTE (Lucke-Wold
et al., 2015c). Janus-N-terminal kinase (JNK) is a common downstream component of ER stress
(Urano et al., 2000), which is activated following TBI (Otani et al., 2002; SzmydyngerChodobska et al., 2010). JNK is also a known tau kinase (Tran et al., 2012). Simultaneous to ER
stress activation, oxidative stress occurs and generates free radicals, which play a role in cell
death and disease pathology following TBI (Toklu and Tumer, 2015). Free radicals damage
cellular membranes, increase carbonyl formation, and can contribute to cell death and
neurobehavioral dysfunction (Ferguson et al., 2010).
ER stress may also cause a direct increase in oxidative stress acutely following injury due
to accumulated unfolded proteins (Chaudhari et al., 2014). ER stress and oxidative stress have
both been associated with increased neuroinflammation after TBI (Deslauriers et al., 2011;
Bellezza et al., 2014; Hayashi, 2015). Integral to the process of neuroinflammation is activation
and nuclear translocation of nuclear factor kappa B (NFB) (Bracchi-Ricard et al., 2013). NFκB
is known to promote pro-inflammatory cytokines, such as, tumor necrosis factor alpha (TNF)
and interleukin 1 beta (IL-1) (Algattas and Huang, 2014). These inflammatory cytokines can
signal changes that damage neuronal cell membranes and intracellular organelles (Abdullah and
Bayraktutan, 2014). NFκB activity is also known to promote inducible nitric oxide synthase
(iNOS) (Algattas and Huang, 2014), which may, under persistent conditions, contribute to
neurodegeneration and neurobehavioral dysfunction (Jayakumar et al., 2014). Therefore,
neuroinflammation may be a promising target for improving TBI outcome.
Salubrinal (SAL) is a modulator of cellular stress known to inhibit protein phosphatase 1
(Boyce et al., 2005). SAL has been shown to be neuroprotective in models of stroke (Nakka et
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al., 2010) and TBI (Logsdon et al., 2014; Dash et al., 2015). In the present study, we investigated
the effects of SAL on oxidative stress and neurodegeneration following blast exposure. We also
measured SAL’s effects on neuroinflammation in the frontal cortex. Moreover, we examined
whether SAL ameliorated risk-taking behavior, a neurobehavioral dysfunction associated with
damage to the frontal cortex (Schwarzbold et al., 2010; Adhikari et al., 2011; Logsdon et al.,
2014). Modulating intracellular stress may positively influence the extracellular inflammatory
milieu leading to improved outcomes following brain injury.

METHODS
Animals
Fifty-one (51) male Sprague-Dawley rats (Hilltop Lab Animals) at 2-3 months of age
were used in this study. Rats were acclimated for 1 week prior to use and housed under 12 hour
light/dark conditions with food and water available ad libitum. Animal experiments were
performed according to the principles of the Guide for the Care and Use of Laboratory Animals.
The West Virginia University Animal Care and Use Committee approved all procedures
involving rats.
Salubrinal
SAL (Tocris Biosciences) was dissolved in 0.5% DMSO and delivered via intraperitoneal
(i.p.) injection at a dose of 1 mg/kg (Sokka et al., 2007; Liu et al., 2014b).
Blast overpressure exposure
Blast exposure was induced as previously described (Turner et al., 2013b). Blast pressure
with a 0.005” membrane (15 psi incident wave; 50 psi reflected wave) was determined, from our
previous work, to exhibit neural injury markers with no mortality (Turner et al., 2013b; Logsdon
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et al., 2014; Lucke-Wold et al., 2014c). Following blast exposure, rats were returned to a holding
cage equipped with a homeothermic heating pad. Once basic reflexes were restored, rats were
returned to their home cage.
Experimental groups
A detailed timeline shows the course of injury and treatment for each group of rats
(Figure 5.1). Rats were randomly assigned to one of three treatment groups. Group 1 rats served
as sham controls (anesthetized with 4% isoflurane). Following anesthesia, rats were injected with
vehicle (0.5% DMSO; i.p.) 5 minutes after being placed on blast table. Group 2 rats served as
our experimental control group, in which anesthetized rats were oriented similarly to sham rats
and subsequently exposed to blast. Rats were injected with vehicle 5 minutes after each blast
exposure. Group 3 served as our experimental group. Rats received blast exposure as group 2,
but SAL (1 mg/kg; i.p.) was administered 5 minutes after each blast exposure (Rubovitch et al.,
2015).
There was two blast TBI subgroupings: a single blast TBI (sTBI) and a repeated blast
TBI (rTBI). Rats in the rTBI group received a blast every other day over two weeks, for a total of
six blast injuries. This repetitive schedule was determined by our previous work that showed
markers of ER stress activation (Lucke-Wold et al., 2015b), and from other TBI models that
showed markers of neuroinflammation and neurodegeneration (Mouzon et al., 2012; Mouzon et
al., 2014).
Twenty-four (24) sTBI rats were randomly divided into the three treatment groups and
euthanized for biochemical analysis at 24 hours post-blast (n=4 rats per group), and
immunohistochemistry (IHC) at 72 hours post-blast (n=4 rats per group). Twenty-seven (27)
rTBI rats were randomly divided into the three treatment groups and were subject to behavioral
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testing 72 hours after the repetitive blast schedule (n=9 rats per group). Four rTBI rats from each
experimental group were euthanized for IHC after behavioral testing was complete.
Tissue preparation
Rats used for biochemical analysis were euthanized and their brains were rapidly
removed in an ice-cold HaltTM protease/phosphatase inhibitor cocktail mix (Thermo Scientific).
The striatum was dissected out from each hemisphere, flash frozen in liquid nitrogen, and stored
at −80 °C for later measurement of carbonyl and reactive oxygen species (ROS) levels. The
frontal cortex was dissected out from each hemisphere, flash frozen in liquid nitrogen and stored
at −80 °C for later measurement of protein expression and mRNA abundance. Rats used for IHC
were anesthetized with 4% isoflurane and perfused transcardially with ice-cold saline. Following
perfusion, brains were removed, flash frozen in isopentane (−60 °C) and stored at −80 °C for
IHC preparation.
Carbonyl measurement
For carbonyl measurement, striatal tissue samples from sTBI rats (n=4 rats per group)
were assayed using an OxyBlot Protein Oxidation Detection kit (Millipore). Striatal tissues from
each treatment group were sonicated in 6% sodium docecyl sulfate (SDS). Control samples were
mixed with derivation control solution and experimental samples were mixed with 2,4dinitrophenylhydrazine. Samples were incubated for 15 minutes followed by addition of
neutralization solution. Samples were loaded (20 ul per well) and electrophoresed on a 10%
acrylamide gel and immunoblotted as outlined in the Western blot methods below.
ROS measurement
For ROS detection, striatal tissue from sTBI rats were homogenized and cells were
isolated by incubation in collagenase at 2 mg/ml for 30 minutes. Cells were separated by enzyme
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digestion and manual disruption by repeated pipetting. Cells were strained through a 70 um
nylon cell strainer followed by centrifugation at 400 x g for 5 minutes. Pellets were resuspended
to a concentration of 1.0 x 106 cells/ml in Dulbecco's Modified Eagle Medium (DMEM).
Total ROS and superoxide levels were detected using a Total ROS/Superoxide Detection kit
(Enzo Life Sciences) according to manufacturer’s instructions. In brief, 100 μl of suspended cells
were added to each well of a dark-sided 96 well plate with a clear bottom. Cells were incubated
overnight at 37°C in DMEM. The following day, media was removed and 100 μl of
ROS/Superoxide Detection Solution was added to each well and incubated in the dark for 1
hour. Detection of total ROS (green) and superoxide (red/yellow) fluorescence was detected at
an excitation wavelength of 488/520 nm and an emission wavelength of 550/610 nm,
respectively. Data were collected using Gen5 software (BioTek). Concentrations were
determined based on a known standard curve.
Western blot
Protein samples from sTBI and rTBI rats were prepared in 1% SDS and Western blot
analysis was performed as previously described (Lucke-Wold et al., 2014c). Primary antibodies
(and dilution factors) were rabbit anti-pJNK monoclonal antibody (mAB) (Thr183/Tyr185)
(1:500), rabbit anti-binding immunoglobulin protein (BiP) mAB (1:1000), rabbit anti-JNK mAB
(1:1000) (Cell Signaling); mouse anti-NFκB p65 polyclonal antibody (pAB) (1:200), rabbit antiiNOS pAB (1:200) (Santa Cruz). A rabbit anti-β-actin mAB (1:10,000) (Cell Signaling) was
used as an endogenous control to normalize protein loading. Secondary antibodies were
IRDye® 800CW (goat anti-rabbit) and IRDye® 680RD (goat anti-mouse) (LI-COR
Biosciences). Images were collected using the Odyssey Classic Infrared Imaging System (LICOR Biosciences). Images were converted to gray scale, and detected bands were quantified
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using Image Studio Lite Software (LI-COR Biosciences). Bands were normalized to β-actin
values to measure relative intensity.
Quantitative real-time polymerase chain reaction
RNA samples from sTBI and rTBI rats were prepared in TRIzol® reagent (Life
Technologies) and confirmed for quality (1.8-2.1 absorbance ratio). Reverse transcription was
conducted and real-time PCR analyses were performed on cDNA using the following
oligonucleotide primer sets: TNFα (Rn01525859_g1), IL-1β (Rn00580432_m1), and 18s rRNA
(Hs99999901_s1; endogenous control) (Life Technologies). Changes in mRNA abundance were
determined by the ΔΔCt method with a threshold cycle value of 0.2 normalized to 18s rRNA.
Histology
Whole brains from sTBI and rTBI rats were mounted on a Leica CM3050S cryostat
(Leica Microsystems) set to −20 °C. Coronal sections of the frontal cortex were sliced at a
thickness of 20 μm and mounted onto glass slides for IHC staining as previously described
(Lucke-Wold et al., 2015b). Briefly, brain slices were circumscribed, and incubated overnight
with primary antibodies: iNOS (Santa Cruz), glial fibrillary acidic protein (GFAP), C/E
homology protein (CHOP), BiP, and pJNK (Cell Signaling). The next day, an Alexa Flour®
secondary antibody (Invitrogen) was applied to slides for 3 hours, and coverslip mounted with
Vectashield® 4',6-diamidino-2-phenylindole (DAPI) nuclear counterstain (Vector) . If staining
for colocalization, a second set of primary and secondary antibodies were applied prior to fixing
the coverslip. Fluorojade B (FJB) (Millipore), and ROS (Enzo Life Sciences) staining was
performed in accordance with manufacturer’s instructions.
Fluorescent imaging was performed using a Zeiss Axio Observer Z1. For fluorescent
staining, 10 cells per slide were randomly selected, outlined, and measured with ImageJ software
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(NIH) by an observer blinded to experimental group. Density was adjusted per mean area to give
corrected total cell fluorescence normalized to background. Co-localization quantification with
the Just Another Co-localization plugin for ImageJ was used to determine overlap coefficient or
Pearson’s coefficient. Overlap coefficient was calculated using k^2 = k1*k2 with values adjusted
to threshold.
Elevated plus maze
Risk-taking behavior was assessed in rTBI rats using the Elevated plus maze (EPM). The
EPM was set at a height of 60 cm above the floor. The two open arms intersected perpendicular
to the two closed arms. Each arm was 50 cm x 10 cm. The closed arms were encased by black
siding 30 cm tall. Each rat was placed in the middle of the EPM facing an open arm and tracking
was performed for 5 minutes using AnyMaze™ software (Stoelting), which pinpointed the
location of the rat’s head and body continuously throughout the testing trial.
Statistical analysis
Data were analyzed using a one-way analysis of variance (ANOVA) followed by
Newman-Keul's post hoc tests for between groups comparison. For colocalization studies,
Pearson’s coefficient was obtained for control sections. Overlap coefficient was obtained for
experimental groups to determine the extent of same-cell protein expression. Sample sizes were
determined using a power analysis with an α of 0.05, a β of 0.2, and a sample effect of 0.4 for
behavioral data and 0.3 for all other data (DSS Research Power Analysis). P < 0.05 was
considered significant.

RESULTS
SAL reduces oxidative stress after sTBI
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Figure 5.2A shows a significant difference in carbonyl levels between groups after sTBI
(F(2,9) = 10.21; P < 0.01). A significant increase in carbonyl levels was measured in sTBI rats as
compared to control rats (q = 6.26; P < 0.01). SAL administration significantly reduced carbonyl
levels (q = 4.23; P < 0.05) when compared to vehicle-treated sTBI rats.
Figure 5.2B shows a significant difference in superoxide levels between experimental
groups after sTBI (F(2,9) = 7.68; P < 0.05). A significant increase in superoxide levels was
measured in sTBI rats when compared to control rats (q = 4.92, P < 0.05). SAL administration
significantly reduced superoxide levels as compared to vehicle-treated sTBI rats (q = 4.68, P <
0.01). Figure 5.2C shows no difference in total ROS levels (F(2,9) = 0.16; P > 0.05).
SAL attenuates neurodegeneration after sTBI
Figure 5.3A shows a significant difference in corrected total cell fluorescence for GFAP
at 72 hours post-sTBI (F(2,29) = 35.23; P < 0.001). A significant increase in GFAP fluorescence
was observed in sTBI rats compared to control rats (q = 10.07, P < 0.001). SAL administration
significantly reduced GFAP fluorescence when compared to vehicle-treated sTBI rats (q = 7.58,
P < 0.001).
Figure 5.3B shows a significant difference in corrected total cell fluorescence for FJB at
72 hours post-sTBI (F(2,29) = 7.43; P < 0.01). A significant increase in FJB fluorescence was
observed in sTBI rats compared to control rats (q = 5.18, P < 0.05). SAL administration
significantly reduced FJB fluorescence when compared to vehicle-treated sTBI rats (q = 3.32; P
< 0.05).
SAL mitigates neuroinflammation after sTBI
Figure 5.4A indicates a significant difference between experimental groups in JNK
phosphorylation after sTBI (F(2,9) = 9.04; P < 0.01). A significant increase in JNK
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phosphorylation at 24 hours was observed in sTBI rats as compared to control rats (q = 5.79; P <
0.01). SAL administration significantly attenuated JNK phosphorylation when compared to
vehicle-treated sTBI rats (q = 4.31; P < 0.05). No difference in total JNK protein expression was
observed at 24 hours post-sTBI (P > 0.05).
Figure 5.4B shows no significant difference in BiP expression between experimental
groups (F(2,9) = 0.93; P > 0.05).
Figure 5.4C shows a significant difference in NFκB p65 expression between
experimental groups at 24 hours after sTBI (F(2,9) = 4.67; P < 0.05). NFκB p65 expression was
significantly increased in sTBI rats compared to control rats (q = 4.101; P < 0.05). SAL
administration significantly reduced NFκB p65 expression when compared to vehicle-treated
sTBI rats (q = 3.24; P < 0.05).
Figure 5.4D shows a significant difference in iNOS expression at 24 hours after sTBI
(F(2,9) = 6.81; P < 0.05). A significant increase in iNOS expression was measured in sTBI rats
compared to control rats (q = 4.92; P < 0.05). SAL administration significantly reduced iNOS
expression when compared to vehicle-treated sTBI rats (q = 3.97; P < 0.05).
Figure 5.4E shows a significant difference in IL-1β mRNA abundance at 24 hours postsTBI amongst the treatment groups (F(2,9) = 5.62; P < 0.05). A significant increase in IL-1β
mRNA abundance was measured in sTBI rats compared to control rats (q = 4.13; P < 0.05). SAL
administration significantly reduced IL-1β mRNA abundance when compared to vehicle-treated
sTBI rats (q = 4.08; P < 0.05).
Figure 5.4F shows a significant difference amongst the treatment groups in TNFα mRNA
abundance at 24 hours post-sTBI (F(2,9) = 5.54; P < 0.05). A significant increase in TNFα mRNA
abundance was measured in sTBI rats compared to control rats (q = 4.49; P < 0.05). SAL
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administration significantly reduced TNFα mRNA abundance when compared to vehicle-treated
sTBI rats (q = 3.47; P < 0.05).
ER stress and neuroinflammation markers colocalize
Figure 5.5A shows IHC colocalization (yellow) of ER stress marker CHOP (green) with
ER stress marker BiP (red). Pearson’s coefficient revealed a low correlation in vehicle controls (r
= 0.21), a high correlation in rTBI + Vehicle (r = 0.82), and a low correlation in rTBI + SAL (r =
0.20).
Figure 5.5B shows IHC colocalization (yellow) of ER stress marker CHOP (green) with
ER stress marker pJNK (red). Overlap Pearson’s coefficient revealed no correlation in vehicle
controls (r = 0.00), a medium correlation in rTBI + Vehicle (r = 0.61), and no correlation in rTBI
+ SAL (r = 0.00).
SAL attenuates neuroinflammation after rTBI
Figure 5.6A shows IHC colocalization (yellow) of ER stress marker CHOP (green) with
neuroinflamation marker iNOS (red). Overlap Pearson’s coefficient revealed a low correlation in
vehicle controls (r = 0.17), a medium correlation in rTBI + Vehicle (r = 0.65), and a low
correlation in rTBI + SAL (r = 0.22).
Figure 5.6B shows a significant difference in corrected total cell fluorescence for GFAP
at 72 hours post-rTBI (F(2,29) = 6.62; P < 0.01). A significant increase in GFAP fluorescence was
observed in rTBI rats compared to vehicle-control rats (q = 4.69, P < 0.01). A significant
increase in GFAP fluorescence was also observed in rTBI + SAL rats compared to vehiclecontrol rats (q = 4.99, P < 0.05).
SAL ameliorates risk-taking behavior after rTBI
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Figure 5.7A shows a significant difference in open arm time at two weeks post-rTBI
amongst the treatment groups (F(2,24) = 4.72; P < 0.05). A significant increase was measured in
the time that the rTBI rats spent in the open arms of the EPM compared to control rats (q = 4.09;
P < 0.05). Interestingly, SAL administration significantly attenuated the open arm time when
compared to vehicle-treated rTBI rats (q = 3.31; P < 0.05). Figure 5.7B shows no difference in
the total distance the rats travelled between the experimental groups (F(2,24) = 2.54; P > 0.05).
Track plots from Anymaze™ were overlaid for each subject to provide a clear visual
representation of the rats’ behavior during the EPM trials (Figure 5.7C-E).
Mechanism of blast injury
Figure 5.8 shows a proposed detailed schematic of the injury cascade following blast
injury. We propose blast TBI may cause vascular disruption and blood extravasation into the
brain parenchyma can damage plasma membranes and trigger secondary injury cascades (Uranga
et al., 2009; Liu et al., 2013; Nisenbaum et al., 2014). The secondary injury cascades may
contribute to neurodegeneration and neurobehavioral dysfunction.

DISCUSSION
Blast TBI models cause a primary injury due, in part, to acceleration-deceleration forces
to the rat’s head (Goldstein et al., 2012). The current study shows an initiation of secondary
injury cascades including oxidative stress and ER stress following primary injury in addition to
glial reactivity and neurodegenerative changes. We also show these cellular stress responses
occurred concurrent with increases in neuroinflammatory markers after blast TBI.
Neuroinflammation is a common secondary effect of brain injury and has been demonstrated in a
variety of rodent TBI models (Abdul-Muneer et al., 2013; Cho et al., 2013; Abdul-Muneer et al.,

127

2014; Algattas and Huang, 2014; Roth et al., 2014), and has been linked clinically to single and
repetitive head injuries (Aungst et al., 2014; Webster et al., 2015). While previous studies have
shown an association between ER stress and neuroinflammation, what remains unknown is
whether regulation of these responses would affect neurodegeneration and improve
neurobehavioral outcome (Fenn et al., 2015). Additionally, ER stress activation has been
proposed to directly increase oxidative stress particularly in the striatum (Malhotra and
Kaufman, 2007). Using the ER stress modulator SAL, we show a potential link between these
pathways. Moreover, how brain injury contributes to neuroinflammation and subsequent
neurobehavioral dysfunction has not yet been elucidated. Using SAL as a modulator, we also
offer compelling evidence that acute cellular stress cascades, not only closely link to subacute
neuroinflammation, but also subsequent behavioral alteration.
An important secondary injury cascade often increased following TBI and intimately
linked to ER stress is oxidative stress (Cho et al., 2013). We report an increase in oxidative stress
damage in the striatum following blast exposure, as evidenced by increased carbonyl and
NADPH-oxidase (NOX)-mediated superoxide levels. Superoxide production is a consequence of
TBI mainly through activation of the NOX system (Brennan et al., 2009; Zhang et al., 2012;
Loane et al., 2013). A previous report indicated that NOX and superoxide levels were elevated at
6 hours after blast TBI and persisted for 72 hours (Ansari et al., 2014). Additionally, NOX-4
mediated oxidative stress perpetuates damage to neuronal membranes leading to cell death
(Zhang et al., 2012). A late-onset symptom of CTE is motor dysfunction similar to Parkinson’s
disease that indicates cell death and damage to the striatum (Stern et al., 2011). In a future study
we will investigate late-onset motor disturbance associated with the striatal damage reported
herein. We will further elucidate whether repeat or single injury is necessary for motor deficits.
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Persistent damage to the cell from oxidative stress can trigger a measurable increase in
JNK phosphorylation (Quan et al., 2015), and NFκB activity [39, 40], affecting
neuroinflammation. An increase in both pJNK and NFκB p65 expression were demonstrated in
this study. JNK can signal NFκB translocation to the nucleus, which may upregulate proinflammatory mediators such as iNOS, TNF and IL-1 (Algattas and Huang, 2014; Ruan et al.,
2015). In line with this ensuing injury cascade following blast, we found increased levels of proinflammatory markers: NFB, iNOS, TNF and IL-1. These pro-inflammatory markers are
thought to cause a sudden oxidative burst that overwhelms antioxidant defense cascades leading
to further damage of surrounding brain tissue (Liao et al., 2013). We show repetitive blast TBI
causes a subacute increase in iNOS fluorescence, suggesting a persistent inflammatory response.
Consequently, while neuroinflammation is a necessary response to brain injury (Finnie, 2013),
unabated, persistent neuroinflammation can lead to irreversible neurodegeneration and poor
injury outcome.
Furthermore, we recently showed that ER stress is an important secondary injury
response activated after blast TBI (Logsdon et al., 2014), and human CTE (Lucke-Wold et al.,
2015c). ER stress can also lead to neurobehavioral dysfunction following TBI (Dash et al., 2015;
Lucke-Wold et al., 2015b). We show ER stress markers CHOP and pJNK fluorescence to be
increased following repetitive injury. Similar to oxidative stress, the ER stress response has
significant cross talk with neuroinflammatory pathways through JNK signaling (Prell et al.,
2014). A recent study suggests crosstalk between JNK phosphorylation and NFB activity after
inflammatory challenge with an ER stressor (Ruan et al., 2015).
We show, for the first time, that SAL administration post-injury attenuates iNOS protein
expression and JNK phosphorylation. This is in agreement with a recent study where SAL

129

administration reduced NFB and microglia activation in a model of Alzheimer’s disease
(Huang et al., 2012). SAL also improved chronic motor performance in a model of spinal cord
injury (Ohri et al., 2013). In a future study, we will investigate if SAL improves motor
performance long-term following TBI. Further investigation is needed to see if acute modulation
of cellular stress pathways will lead to long-term behavioral improvements. Docosahexaenoic
acid, another less-specific ER stress modulator, improved cognitive performance following TBI
(Begum et al., 2013; Lucke-Wold et al., 2015b). Based on the results of this study and the
supporting background information, we propose a novel mechanism of action for the beneficial
properties of SAL through downstream regulation of NFB activity. In support of this claim, we
demonstrated that SAL administration after blast attenuated pJNK, NFB, iNOS, TNFα, and IL1β expression.
SAL also decreased markers of glial reactivity after single blast exposure, suggesting a
protective effect at the blood-brain barrier as previously reported (Logsdon et al., 2014).
Surprisingly, SAL had no influence on glial reactivity following repetitive blast exposure,
possibly due to a priming effect of persistent neuroinflammation (Ma et al., 2014). The repetitive
injury schedule may have reduced the measured glial reactivity at 72 hours compared to a single
blast exposure. Results suggest that astrocyte activation may not contribute to the subacute
neurobehavioral dysfunction observed with our repetitive TBI model.
Abnormal behavioral symptoms can be a manifestation of persistent neuroinflammation,
and are of particular clinical relevance for patients suffering multiple mild head injuries
(Sominsky et al., 2015). We showed that rTBI rats displayed risk-taking behavior in the EPM 72
hours following the last blast. Interestingly, SAL administration reduced risk-taking behavior
when administered after each blast exposure.
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At 72 hours following the last blast, IHC results suggest that repetitive blast exposure
increases markers of ER stress and neuroinflammation in the frontal cortex. The results also
suggest SAL administration reduced CHOP expression. The Pearson’s coefficient values suggest
CHOP colocalized with BiP, pJNK and iNOS in the frontal cortex at 72 hours post-rTBI.
Colocalization strengths also suggest SAL may have an effect on ER stress and
neuroinflammation within the same cells. These markers have been postulated to cause the
neuronal demise responsible for neurobehavioral dysfunction. Consequently, and most
importantly, we suggest that SAL may mitigate subacute markers of neuroinflammation and
thereby reduce risk-taking behavior mediated by the frontal cortex after repetitive brain trauma.
These findings have broad reaching implications regarding the importance of targeting
cellular stress acutely post-injury in order to reduce subacute neuroinflammation and ameliorate
neurobehavioral dysfunction. We showed that ER stress modulation after blast injury decreases
acute superoxide formation in the striatum, attenuates neuroinflammatory markers in the frontal
cortex, and ameliorates sub-acute risk-taking behavior in rats. In doing so, we map a unique
interconnection between intracellular stress cascades and neuroinflammation. Further pre-clinical
studies are warranted to determine the role of oxidative stress, ER stress and neuroinflammation
at subacute time points following brain injury and how these pathways contribute to
neurobehavioral dysfunction.
In summary, cellular stress and neuroinflammation are intrinsically interconnected and
play an important role in injury progression following TBI. We show that blast exposure induced
markers of oxidative stress, which is known to contribute to the exacerbation of ER stress and
neuroinflammation. Furthermore, we show that ER stress may be linked neuroinflammation
through the JNK-mediated NFB pathway. Surprisingly, SAL reduced markers of oxidative
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stress and ER stress; thereby, reducing markers of neuroinflammation post-blast. The likely
mechanism is reduction of JNK phosphorylation. Most importantly, SAL ameliorated risk-taking
behavior when administered after each repetitive blast exposure. Secondary injury modulation
with key multi-target pharmaceutics offers a promising approach to reduce the long-term
neuropsychiatric symptoms associated with head injuries.
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Figure 5.1. Experimental design
Detailed experimental timeline showing: rTBI (repetitive blast) animals at top; sTBI (single
blast) animals at bottom. SAL (Salubrinal); ROS (Reactive oxygen species); WB (Western blot);
PCR (Polymerase chain reaction); IHC (Immunohistochemistry).
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Figure 5.2. SAL reduced markers of oxidative stress after single blast
(A) A significant increase in protein carbonyl levels was measured at 24 hours post-sTBI (**P <
0.01 vs Vehicle); SAL treatment significantly attenuated carbonyl levels (#P < 0.01 vs sTBI).
(B) A significant increase in superoxide levels was measured at 24 hours post-sTBI (*P < 0.05
vs Vehicle); SAL treatment significantly attenuated superoxide levels (##P < 0.01 vs sTBI). (C)
No significant differences were observed in total ROS levels (P > 0.05). One-way ANOVA,
Newman-Keul’s post hoc. Mean ± S.E.M. n = 4.
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Figure 5.3. SAL attenuated markers of neurodegeneration after single blast
(A) We observed a significant increase in GFAP (green) fluorescence at 72 hours post-sTBI
(***P < 0.001 vs Vehicle); SAL significantly reduced GFAP fluorescence (###P < 0.001) (n =
4). GFAP images include nuclear counterstain DAPI (blue). (B) We observed a significant
increase in FJB (green) fluorescence at 72 hours post-sTBI (*P < 0.05 vs Vehicle); SAL
significantly reduced FJB fluorescence (#P < 0.05). One-way ANOVA, Newman-Keul's post
hoc. Mean ± S.E.M. n = 4. Images are displayed at 20x; insets at 63x. (Scale bars = 30µm).
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Figure 5.4. SAL mitigated markers of neuroinflammation after single blast
(A) We measured a significant increase in JNK phosphorylation at 24 hours post-sTBI (**P <
0.01 vs Vehicle); SAL significantly mitigated JNK phosphorylation (#P < 0.05 vs sTBI +
Vehicle). (B) No significant differences were observed in BiP expression at 24 hours post-sTBI
(P > 0.05). (C) We measured a significant increase in NFκB p65 expression at 24 hours postsTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated NFκB p65 expression (#P < 0.05 vs
sTBI + Vehicle). (D) We revealed a significant increase in iNOS protein expression at 24 hours
post-sTBI (*P < 0.05 vs vehicle); SAL significantly mitigated iNOS expression (#P < 0.05 vs
sTBI + Vehicle). (E) We measured a significant increase in IL-1β mRNA abundance at 24 hours
post-sTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated IL-1β abundance (#P < 0.05 vs
sTBI + Vehicle). (F) We measured a significant increase in TNFα mRNA abundance at 24 hours
post-sTBI (*P < 0.05 vs Vehicle); SAL significantly mitigated TNFα abundance (#P < 0.05).
One-way ANOVA, Newman-Keul's post hoc. Mean ± S.E.M. n = 4.
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Figure 5.5. BiP and pJNK colocalized with CHOP after repetitive blast
Columns are separated by experimental group: Vehicle, rTBI + Vehicle, and rTBI + SAL (left to
right). All panels display nuclear counterstain DAPI (blue). (A) BiP (red) merged with CHOP
(green). (B) pJNK (red) merged with CHOP (green). Colocalization determined by levels of
yellow in each image (Overlap coefficient; r values). All images are from the frontal cortex
region. Images are displayed at 20x; Insets displayed at 63x. (Scale bars = 30µm).
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Figure 5.6. SAL reduced iNOS fluorescence, but not GFAP, after repetitive blast
Columns are separated by experimental group: Vehicle, rTBI + Vehicle, and rTBI + SAL (left to
right). All panels display nuclear counterstain DAPI (blue). (A) iNOS (red) merged with CHOP
(green). Colocalization was determined by levels of yellow in each image (Overlap coefficient; r
values). Arrows demarcate iNOS fluorescence. (B) We observed a significant increase in GFAP
(green) fluorescence at 72 hours post-rTBI (**P < 0.01 vs Vehicle); we also observed a
significant increase in GFAP post-rTBI with SAL administration (*P < 0.05 vs Vehicle). Oneway ANOVA, Newman-Keul's post hoc. Mean ± S.E.M. n = 4. All images are from the frontal
cortex region. Images are displayed at 20x; Insets displayed at 63x. (Scale bars = 30µm).
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Figure 5.7. SAL ameliorated risk-taking behavior after repetitive blast
(A) A significant increase was observed in the time that the rats spent in the open arms of the
EPM at 72 hours post-rTBI (*P < 0.05 vs Vehicle); SAL significantly reduced the time spent (#P
< 0.05 vs rTBI + vehicle). (B) No significant differences were observed in the total distance
moved among rats in each group (P > 0.05) One-way ANOVA, Newman-Keul's post hoc. Mean
± S.E.M. n = 9. (C, D, E) Track plots from Anymaze™ were overlaid for each subject to provide
a clear visual representation of the rats’ behavior during the EPM trials.
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Figure 5.8. Blast injury cascade with SAL mechanism of action
Schematic of blast injury cascade and salubrinal mechanism of action. TBI = Traumatic Brain
Injury; ER = Endoplasmic Reticulum; IRE1α = Inositol requiring enzyme 1 alpha; BiP = Binding
immunoglobulin protein; NFκB = Nuclear factor kappa beta; JNK = Janus n-terminal kinase;
iNOS = inducible Nitric oxide synthase; TNFα = Tumor necrosis factor alpha; IL-1β =
Interleukin 1 beta.
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Chapter Six

The quest to model chronic traumatic encephalopathy: a multiple
model and injury paradigm experience

This work is published in Front Neurol. 2015 Oct 20;6:222.
doi: 10.3389/fneur.2015.00222. eCollection 2015. PMID: 26539159
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ABSTRACT
Chronic neurodegeneration following a history of neurotrauma is frequently associated
with neuropsychiatric and cognitive symptoms. In order to enhance understanding about the
underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model preclinical approach must be established to account for the different injury paradigms and
pathophysiologic mechanisms. We investigated the development of tau pathology and
behavioral changes using a multi-model and multi-institutional approach, comparing the preclinical results to tauopathy patterns seen in post-mortem human samples from athletes
diagnosed with chronic traumatic encephalopathy (CTE). We utilized a scaled and validated
blast-induced traumatic brain injury model in rats and a modified pneumatic closed-head impact
model in mice. Tau hyperphosphorylation was evaluated by western blot and
immunohistochemistry. Elevated plus maze and Morris water maze were employed to measure
impulsive-like behavior and cognitive deficits respectively. Animals exposed to single blast
(~50 PSI reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the
contralateral hippocampus at 1 month compared to controls. Animals exposed to repeat blast (6
blasts over 2 weeks) had increased AT8 and AT270 in the contralateral hippocampus at 1 month
post-injury compared to controls. In the modified controlled closed-head impact mouse model,
no significant difference in AT8 was seen at 7 days, however a significant elevation was detected
at 1 month following injury in the ipsilateral hippocampus compared to control. Elevated plus
maze data revealed that rats exposed to single blast and repeat blast spent more time in seconds
exploring the open arms compared to controls. Morris water maze testing revealed a significant
difference between groups in acquisition times on days 22-27. During the probe trial, single
blast and repeat blast rats spent less time in seconds exploring where the platform had been
located compared to controls. This study provides a multi-model example of replicating tau and
behavioral changes in animals and provides a foundation for future investigation of CTE disease
pathophysiology and therapeutic development.

142

INTRODUCTION
Current limitations in understanding CTE pathophysiology are unlikely to be addressed in
a clinical population in the near future due to the challenges associated with establishing longterm, prospective cohort studies in such a population. Preclinical rodent models serve to fill this
gap in knowledge for various disorders and could allow for further investigation of the molecular
mechanisms responsible for CTE, as well as testing the potential of diagnostic and therapeutic
approaches under development.

Few preclinical models of CTE have been proposed that

sufficiently demonstrate both the requisite tauopathy and behavioral changes attributed to CTE
(DeFord et al., 2002; DeRoss et al., 2002; Uryu et al., 2002; Creeley et al., 2004; Longhi et al.,
2005; Friess et al., 2009; Blaylock and Maroon, 2011; Shitaka et al., 2011; Fujita et al., 2012b;
Goldstein et al., 2012; Mouzon et al., 2012; Turner et al., 2012a; Genovese et al., 2013; Hawkins
et al., 2013; Klemenhagen et al., 2013; Mannix et al., 2013; Aungst et al., 2014; Bailes et al., 2014;
Donovan et al., 2014; Lucke-Wold et al., 2014a; Mannix et al., 2014; Mouzon et al., 2014;
Petraglia et al., 2014b; Petraglia et al., 2014a; Brody et al., 2015).
The purpose of this paper is to present two preclinical models that successfully reproduce
some neuropathological and behavioral changes consistent with CTE-like phenotypes, and discuss
future directions for CTE animal modeling. Brody and colleagues (Brody et al., 2015) present
several unanswered questions that we expand upon in our accompanying review such as the role
of 1) inter-injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5)
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the likelihood and/or
progression of CTE development. We recently reported that endoplasmic reticulum stress might
be a contributing factor linking acute neurotrauma to behavioral deficits (Logsdon et al., 2014).
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The quest for elucidating CTE pathophysiology development is ongoing with the goal of targeting
specific injurious cascades a key priority in order to prevent the emergence of clinical symptoms.
In this work we present novel models of neurotrauma-induced neurodegeneration in both
mice and rats following exposure to single or repetitive brain injury, respectively. These models
replicate both the tauopathy and some of the behavioral changes implicated in CTE in the clinical
population. We believe the blast model is particularly relevant clinically due to utilization of a
scaled, short-duration blast exposure. This is a striking contrast to long-duration blasts utilized in
numerous studies that may more closely approximate an atomic blast than a blast from an
improvised explosive device (Bass et al., 2012; Panzer et al., 2012; Turner et al., 2013b; Panzer et
al., 2014). Park and colleagues show that by having the animal outside of the tube, the wave is
directed towards the skull causing neurologic injury without extensive lung injury (Park et al.,
2011). Extended duration waves generated from long blast tubes are based on lung based scaling.
When the animals are placed within the tube, the impulse exposure to the skull might not be
representative of human exposure (Cho et al., 2013). The modified closed-head injury in
unanesthetized animals described previously by Petraglia and colleagues offers the benefit of
injuring awake animals, more closely replicating the clinical picture seen in athletes than most
other TBI models (Petraglia et al., 2014b; Petraglia et al., 2014a). Further studies are required to
address injury paradigms that do or do not contribute to CTE development but utilization of these
models appears promising in not only modeling CTE but also identifying therapeutic targets based
upon other recently published work by our groups (Logsdon et al., 2014; Lucke-Wold et al.,
2014c).

METHODS
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Animals and Human Samples
All experiments involving animals were approved by either the Institutional Animal Care
and Use Committee of West Virginia University or that of the University of Rochester and were
performed based upon principles of the Guide for the Care and Use of Laboratory Animals. Fifty
six (56) young-adult male rats (300-350 grams) were acquired from Hilltop Laboratories
(Scottdale, PA). All blast procedures were performed at West Virginia University. Twelve (12)
young-adult male C57BL/6J mice were acquired from Jackson Laboratories (Bar Harbor, ME) and
used for modified controlled cortical impact at the University of Rochester. All animals were
allowed to acclimate upon arrival for 1 week prior to any experimentation. At all times animals
were provided food and water ad libitum and maintained on a 12 hour light-dark cycle. Human
samples were from deceased professional athletes that were previously diagnosed with chronic
traumatic encephalopathy (Omalu et al., 2010b). The tissue was collected from the entorhinal
cortices.
Experimental Groups
Fifty six (n = 56) rats were divided into three primary experimental groups for behavior –
anesthetized controls (n = 24), a single blast injury (n = 16), and repeat blast injuries (n = 16).
Each of these groups was sacrifed at 1 month following the final blast or sham-injury and after
undergoing functional assessment. Elevated-plus maze was done at 7 days post-blast (n = 24; 8
controls, 8 single blast, and 8 repeat blast) and the Morris water maze started at 21 days post-blast
(n = 32; 16 controls, 8 single blast, and 8 repeat blast). Following behavioral analysis, rats from
the EPM group were divided into two separate groups with one utilized for immunohistochemistry
(n = 10; 4 controls, 3 single blast, and 3 repeat blast) and the other for western blotting (n = 14; 4
controls, 5 single blast, and 5 repeat blast). Twelve (12) mice were divided into three primary
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experimental groups – anesthetized controls (n = 4), single injury with sacrifice at one week (n =
4), and single injury with sacrifice at one month (n = 4). All mice were utilized for western blotting
techniques at time of sacrifice. An experimental schematic can be seen in Figure 1.
Traumatic Brain Injury
Briefly, all blast injuries administered to rats as part of this work were of moderate intensity
(~50 PSI peak reflected overpressure) as determined previously and completed under isofluranebased anesthesia (Turner et al., 2013b; Logsdon et al., 2014; Lucke-Wold et al., 2014c). Blast
exposure occurred on the right side of the animal and was only administered to the head and neck
region. The rat was outside of the blast tube and a rigid barrier protected the remainder of the
animal. Blast waves were of a short-duration (~2 ms) to ensure clinical relevance based on
elucidated scaling parameters (Figure 2A). The scaling parameters are based on impulse dynamic
measurements, which are more representative of human blast than closed models based on duration
(Needham et al., 2015).
Mice were utilized in a manner previously described (Petraglia et al., 2014b; Petraglia et
al., 2014a). Briefly, mice were placed, unanesthetized, into a rodent restraint bag/cone and
immobilized on top of a foam bed of known spring constant. A helmet was secured to the head
using an elastic band, allowing for administration of a diffuse impact through force distribution.
Impacts were delivered using a modified controlled cortical impact device that was adjusted to
include an altered tip of vulcanized rubber (Figure 2B).
Western Blot
Animals were anesthetized and sacrificed by rapid decapitation. Brains were extracted and
immediately placed in a lysate buffer with protease and phosphatase inhibitors as described
elsewhere (Logsdon et al., 2014). Brains were dissected and tissue flash frozen and stored at -80
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°C prior to blotting. Hippocampal protein samples were dissolved in 0.5 mL of 1% sodium
dodecyl sulfate (SDS) prior to sonication and protein assay. Pre-cast 10% 12-well gels (Life
Technologies, Carlsbad, CA) were loaded with 30 μg of protein per well and run with 2X Lammeli
buffer. Wet transfer was performed using nitrocellulose membranes (Bio-Rad, Contra Costa, CA)
at 60 volts for 2.5 hours. Primary antibodies against AT8 (Pierce; Rockford, IL), AT270 (Pierce;
Rockford, IL), CP13 (kindly supplied by Dr. Peter Davies), and PHF-1 (kindly supplied by Dr.
Peter Davies) were utilized and detected utilizing the corresponding secondary. Membranes were
imaged using a LI-COR fluorescent scanner (LI-COR; Lincoln, NE) and images converted to gray
scale. Analysis was performed using background subtraction (Odyssey Processing Software, LICOR) and values normalized to β–actin levels, resulting in a normalized intensity value.
Immunohistochemistry
For immunohistochemistry preparation, animals were anesthetized using isoflurane and
transcardially perfused with ice-cold physiologic saline followed by 10% formalin for a total of 10
minutes. Brains were extracted and placed in fresh 10% formalin for a minimum of 24 hours prior
to blocking and subsequent paraffin embedding. Sections were prepared in 6 μm thickness using
a Leica RM2235 microtome (Leica Microsystems, Wetzlar, Germany). Staining was performed
using standard protocols used within the field and previously by our laboratory, using the
antibodies described above as well as thioflavin for detecting neurofibrillary tangles (McKee et
al., 2010; Goldstein et al., 2012; Stern et al., 2013).
Behavioral Assessments
Learning and memory was assessed using the Morris water maze. Spatial acquisition trials
began at Day 21 after the final blast exposure (in both single and repeat injury paradigms). The
pool utilized was ~180 cm in diameter and filled with water at ambient temperatures (18-21 °C).
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A platform (10 cm x 10 cm) was submerged 2.5 cm below the surface of the water. A series of
objects was placed in the environment around the pool to provide visual cues for the animal during
trials. The training paradigm (spatial acquisition) consisted of 6 days with a total of 4 trials
occurring each day per animal. Animals were placed into the maze from four different locations
each day (4 trials) with a total of 2 minutes (maximum) allowed per trial. Upon finding the
platform, animals were allowed 15 seconds for acquisition to occur. If unsuccessful in finding the
platform, animals were placed on the platform at the conclusion of 2 minutes by the investigator.
On the probe trial day (platform removed), animals were placed in the maze at a novel location
and allowed to explore the maze for 1 minute. Data was acquired using AnyMaze™ video tracking
software (Stoelting Co., Wood Dale, IL) throughout all studies and allows for acquisition of
latency, distance, and speed data to be analyzed across maze regions/quadrants.
Impulsivity was determined, at 7 days after the final blast, as previously described using
an elevated-plus maze and measuring exploratory behavior (Mosienko et al., 2012; Johnson et al.,
2013a; Logsdon et al., 2014). The apparatus was placed at a height of 60 cm from the floor and
consisted of two open and two closed arms, with open arms opposing one another and intersecting
perpendicularly with the opposed closed arms. Each arm was 50 cm long by 10 cm wide. Open
arms were surrounded by clear plastic edging ~1.5 cm high. Closed arms were encased with black
walls 30 cm tall, creating a 3-sided and comforting enclosure for the rodent. At the start of each
5-minute trial, animals were placed in the middle of the intersecting arms facing an open arm prior
to release. Animals were allowed to explore the apparatus for the duration of the trial. AnyMaze™
software was utilized to record the animals’ position, distance traveled, and entry pattern into
various arms throughout the trial. An increased percentage of time spent in the open arms was
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considered a sign of impulsive behavior (Mosienko et al., 2012; Johnson et al., 2013a; Logsdon et
al., 2014).
Statistical Analysis
An observer blinded to experimental condition performed all data acquisition. One-way
Analysis of Variance (ANOVA) was used for statistical analysis of all tests except spatial
acquisition trials of the Morris water maze and immunohistochemical comparisons in which a twoway, repeated measures ANOVA and students t-test were utilized, respectively. Bonferroni posthoc comparison was used to determine differences between experimental groups on two-way
ANOVA with repeated measures for spatial acquisition. For all other comparison’s, a Tukey’s
post-hoc was utilized. Analysis was completed using GraphPad Prism 5.0 (GraphPad Software,
Inc.; La Jolla, CA). A p <0.05 was considered statistically significant for all data analyzed.

RESULTS
Neurotrauma induces tau hyperphosphorylation in both blast and closed-head injury models
To elucidate the effect of neurotrauma on the development of CTE-like neuropathology,
animals were exposed to sham-injury, single-injury (either blast or modified closed-head), or
repeat-injury (blast). Animals were first assessed for tau phosphorylation, using AT8 and AT270
antibodies, believed to be the initial precursor of neurofibrillary tangle development. AT8 forms a
single band in rats and a double band in mice (Hawkins et al., 2013). Conversely, AT270 forms a
double band in rats, but only a single band in mice (Green et al., 2007). The number of bands is
indicative of calpain dependent phosphorylation, which is regulated uniquely between rats and
mice (Medeiros et al., 2012). Increased phosphorylation of tau was observed after blast exposure
and modified closed-head injury but the location of the increase was model-dependent.

149

Specifically, tau phosphorylation was observed in the contralateral hemisphere in rats exposed to
repeat blast injury but only in the ipsilateral hemisphere, and only with the AT8 antibody, in mice
receiving a single modified closed-head injury.
In rats exposed to blast, no significant difference in tau phosphorylation was observed in
the ipsilateral hippocampus after blast injury for AT8 (Fig. 3A) or AT270 (Fig. 3E). A significant
difference was observed in AT8 (F2,11 = 16.64, p < 0.001) and AT270 (F2,9 = 4.37, p < 0.05) levels
in the contralateral hippocampus of rats exposed to blast injury. At one month following a single
blast, a significant increase in tau phosphorylation recognized by AT8 increase was measured
compared to control (q = 3.96, p < 0.05) (Fig. 3B). A significant increase in phosphorylation
detected by AT8 was also observed after repeat blast (q = 8.12, p < 0.001) (Fig. 3B).
In the modified closed-head injury model utilized on the mice, a significant difference was
observed in tau phosphorylation AT8 (F2,9 = 4.93, p < 0.05) in the ipsilateral hippocampus. At
one-month following injury, AT8 expression was elevated in comparison to sham-injury (q = 4.34,
p < 0.05) (Fig. 3C). No significant difference was observed at 7-days post-injury on the ipsilateral
side or between any groups or time points on the contralateral side (Fig. 3D).
At one-month following repetitive blast exposure, a significant increase phosphorylation
recognized by the AT270 antibody was measured in the contralateral hippocampus of rats
compared to anesthetized control animals (q = 4.03, p < 0.05) (Fig. 3F). No significant differences
were observed in tau phosphorylation recognized by AT270 in either ipsilateral (Fig. 3G) or
contralateral (Fig. 3H) hippocampus of mice receiving modified closed-head injury.
Hyperphosphorylation of tau following neurotrauma occurs in perivascular brain regions
Clinical case series documenting patients with CTE have demonstrated the deposition of
neurofibrillary tangles (NFTs), an end product of tau hyperphosphorylation, in perivascular
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regions, which is a distinct difference from other tauopathies such as Alzheimer’s disease (AD).
Possible mechanisms leading to NFTs in perivascular regions include the disruption of the bloodbrain barrier (BBB), leading to punctate microhemorrhages, red blood cell breakdown, oxidative
stress, and finally, persistent neuroinflammation. We observed a significant difference in tau
hyperphosphorylation within perivascular regions of the contralateral hippocampus in rats exposed
to repeat blast in comparison to control when identified with both AT8 (t = 4.46, p < 0.001) and
AT270 (t = 11.47, p < 0.001) at 1-month post-injury (Fig. 4). These findings were consistent with
prior reports of CTE in humans and from our collection of post-mortem human samples with
documented CTE.
Neurotrauma is associated with conformational changes in tau that are recognized precursors
of neurofibrillary tangle formation
Following hyperphosphorylation, tau is purported to undergo conformational changes
associated with subsequent insolubility and deposition/precipitation in the form of neurofibrillary
tangles.

Following neurotrauma in rats and mice, we found an elevation in markers of

conformational change of the tau molecule based on immunoblotting with PHF-1 and CP13. After
blast exposure, markers of tau conformational change were observed in the contralateral
hemisphere of rats, while after the impact procedure in mice, the markers were found ipsilaterally.
No significant differences in markers of tau conformation change were observed in the ipsilateral
hippocampus after blast injury for neurofibrillary precursor PHF-1 (Fig. 5A) or CP13 (Fig. 5E).
A significant difference was observed in PHF-1 (F(2,11) = 7.92, p < 0.01) and CP13 (F(2,9) =
6.03, p < 0.05) levels in the contralateral hippocampus of rats exposed to blast injury. At one
month following a single blast, a significant increase in PHF expression was measured compared
to control (q = 4.76, p < 0.05) (Fig. 5B).
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A significant difference was observed in PHF-1 (F(2,9) = 7.18, p < 0.05) levels in the
ipsilateral hippocampus of mice exposed to injury. At one month following modified impact, a
significant increase in PHF-1 expression was measured compared to control (q = 5.17, p <
0.05)(Fig. 5C). No significant differences were observed in PHF-1 expression in the contralateral
hippocampus of mice exposed to cortical impact (Fig. 5D).
At one month after repetitive blast exposure, a significant increase in CP13 expression was
measured in the contralateral hippocampus of rats compared to control (q = 4.73, p < 0.05)(Fig.
5F). A significant difference was observed in CP13 (F(2,9) = 21.70, p < 0.001) levels in the
ipsilateral hippocampus of mice exposed to injury. At one month following impact, a significant
increase in CP13 expression was measured compared to control (q = 9.28, p < 0.001)(Fig. 5G).
No significant differences were observed in CP13 expression in the contralateral hippocampus of
mice exposed to cortical impact (Fig. 5H).
Similar findings were seen using immunohistochemistry when comparing repeat-injured
animals to sham-injured animals at 1 month post-injury. Specifically, a significant difference was
seen on PHF-1 staining (t = 6.06, p < 0.001) and CP-13 staining (t = 3.88, p < 0.01)(Fig. 6). Again,
the distribution of the staining was notable for being perivascular in nature, a finding shared across
the clinical specimens diagnosed with CTE as seen in Fig. 7. We show that PHF, AT8, and a
thioflavin stained neurofibrillary tangle are increased perivascular in human CTE specimens. CP13 is increased in a perivascular distribution following repeat blast in a rat.
Neurotrauma produces cognitive impairments
Cognitive deficits have long been associated with the neuropathological diagnosis of CTE
in the clinical population, particularly amongst the population diagnosed with CTE at a later age
in life. Similarly, cognitive impairments in both learning and memory have been associated with
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neurotrauma but have not been presented in the context of a corresponding tauopathy in both a
single and repeat blast injury paradigm. In cohorts of animals subjected to either sham-, single-,
or repetitive-injury, spatial acquisition (learning) was assessed 3 weeks after the injury in singleinjury animals and the final injury in repeat-injury paradigms (Days 21-27 post-injury). Blast
injury exposure was associated with worsened performance in the Morris water maze as evident
by latency to find the platform in seconds when analyzed using a two-way repeated measures
ANOVA. Post-hoc tests revealed significant differences between anesthetized controls and singleinjury animals during spatial acquisition on Days 22-24, and Day 26 (Day 21: t = 1.38, p > 0.05;
Day 22: t = 3.70, p < 0.01; Day 23: t = 4.12, p < 0.001; Day 24: t = 4.38, p < 0.001; Day 25: t =
2.17, p > 0.05; Day 26: t = 3.20, p < 0.01). Similarly, post-hoc tests demonstrated a significant
impairment in acquisition between anesthetized controls and repetitively injured animals on Days
22-26 (Day 21: t = 0.66, p > 0.05; Day 22: t = 5.01, p < 0.001; Day 23: t = 4.16, p < 0.001; Day
24: t = 4.72, p < 0.001; Day 25: t = 3.69, p < 0.01; Day 26: t = 3.76, p < 0.01). Notably, no
differences were seen between single- and repeat-injured animals during the course of acquisition
trials, despite the notable difference in tau pathology at this time presented earlier (Fig. 8). The
differences in latency to platform between blast-injured animals and anesthetized control animals
is apparent as well based on visualization of the track plots recorded during data acquisition (Fig.
9). Clearly different swimming patterns emerge with blast-injured animals exhibiting what
appears to be more thigmotaxis (circling around the outer edge of the pool) than anesthetized
control animals that reached statistical significance between controls and repeat-injured animals
on Day 23 (q = 3.58, p < 0.05), although this data point did not reach significance on Days 21 and
26 based on automated measurements generated using AnyMaze™ (Fig. 8).
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Memory, as measured during the probe test (time spent in area surrounding the nowremoved platform) conducted on Day 27, again demonstrated deficits in animals subjected to blastinduced neurotrauma when analyzed using a one-way ANOVA (F2,29 = 20.01, p < 0.0001). Posthoc tests showed significant differences between sham and single injury animals (t = 6.44, p <
0.05) as well as between sham and repetitively injured animals (t = 8.00, p < 0.05) but no difference
between single injury and repeat injury paradigms (Fig. 8). These findings were confirmed
visually using track plots generated during data acquisition (Fig. 9). Anesthetized control animals
exhibit a greater preponderance of pool crossings and swimming behavior within the region near
the platform in contrast to blast-injured animals (Fig. 9).
Impulsivity is increased following neurotrauma
Clinically, impulsive behavior has been described extensively in those with a history of
repetitive neurotrauma and the context of CTE. To make an analogous comparison between our
animal model of blast-induced traumatic brain injury and clinically reported symptoms, the
elevated-plus maze was utilized to measure impulsive-like behaviors based upon the percentage
of time spent in the open-arms of the maze. Significant differences between groups were observed
when analyzed using a one-way ANOVA (F2,32 = 5.03, p < 0.05). Post-hoc tests revealed a
significant difference between sham and single injury animals (q = 3.53, p < 0.05) as well as
between sham and repetitively injured animals (q = 4.21, p < 0.05). No difference was seen
between single and repeat injury paradigms with regards to percentage of time spent in the open
arms of the apparatus (Fig. 10). While not statistically significant, a trend towards a greater
distance traveled in the open arms was observed with increasing levels of neurotrauma, evidence
consistent with the percentage of time spent in the open arms (Fig. 10). Conversely, a trend was
also present regarding distance traveled in the closed arms with animals subjected to neurotrauma
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traveling less distance (Fig. 10). Post-hoc tests revealed no statistical significance when comparing
sham to single injury groups but significance was reached when comparing sham to repetitivelyinjured animals (F2,33 = 3.06 ; q = 3.47, p < 0.05).

DISCUSSION
While the clinical literature has been inundated with reports of CTE in athletes and soldiers
alike, few experimental tools exist for investigating disease pathophysiology, establishing
diagnostic criteria, and discovering preventative or therapeutic agents.

For these reasons,

preclinical models of CTE are highly desirable. In this work we demonstrate two preclinical
models capable of generating some biochemical and behavioral hallmarks of CTE, namely
tauopathy and impulsive-like behavior. Furthermore, this work illustrates the utility of two distinct
models and injury paradigms, namely blast exposure versus a more traditional modified closedhead injury, and repeat versus single injury paradigms respectively. Likewise, the fact that this
work was completed in two different species and builds upon prior work by both West Virginia
University and the University of Rochester laboratories validates the use of both mice and rats in
the preclinical modeling of neurotrauma related neurodegeneration (Logsdon et al., 2014; Petraglia
et al., 2014b; Petraglia et al., 2014a). The modified closed-head injury represents a helmeted
design with controlled placement of the impact likely accounting for ipsilateral deficit. The
tauopathy development period following modified controlled impact was not previously elucidated
therefore warranting the 7-day time point. Petraglia and colleagues show that astrocyte activation
and cell death occurs at 7 days post modified controlled impact (Petraglia et al., 2014a). We
previously reported that tauopathy following blast in rats does not develop until weeks after injury
and is on the contralateral side due to coup/contra-coup injuries (Lucke-Wold et al., 2015c).
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The potential utility of these, as well as other preclinical models of neurotrauma related
neurodegeneration, is highly promising for investigation of disease pathophysiology, particularly
as related to biochemical endpoints associated with CTE. To fully develop a CTE model,
transgenic rodents will be needed that include amyloid, tau, and TDP43 pathology. The quest for
elucidating the underlying mechanisms behind CTE development is ongoing. In previous work,
we have shown blast causes substantial blood brain barrier disruption (Lucke-Wold et al., 2014c),
endoplasmic reticulum stress activation (Logsdon et al., 2014), and oxidative stress (Lucke-Wold
et al., 2015a). We show in this work the induction of hyperphosphorylated tau, conformational
changes in tau, and more advanced precursors of NFT formation with the usage of CP13 and PHF1 antibodies. AT8 binds to serine 199 and 202 as well as threonine 205. AT270 binds to threonine
181, PHF binds to serine 396 and 404, and CP13 binds to serine 202. Serine 396 and 202 are only
exposed after tau undergoes conformational change (Lucke-Wold et al., 2014b). These changes
are the ultimate result of tau hyperphosphorylation and protein misfolding/aggregation, and are
likely related to dysregulation of the tau kinase/phosphatase system. Peclinical modeling of
neurotrauma related neurodegeneration will allow for the elucidation of how and when these
kinases and phosphatases become dysregulated, and will allow for increased understanding of the
disease process. Additionally, these studies will provide targets for direct or indirect therapeutic
development. Similarly, preclinical models may prove instrumental in identification of diagnostic
and prognostic tests for establishing a diagnosis of CTE and tracking disease progression. There
is a clinical need for a rapid, cheap, and reliable diagnostic test to predict severity of CTE.
Currently neuropathological examination remains the gold standard for diagnosis with some
studies purporting the use of PET-based imaging for diagnosis (Small et al., 2013; Gandy and
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DeKosky, 2014; Mitsis et al., 2014). It is possible that development and validation of these
techniques, and others such as diffusion tensor imaging and magnetic resonance spectroscopy may
be accelerated through the application to preclinical models. The current limitation is that
advanced imaging is expensive, cumbersome, and requires expertise from subspecialty
radiologists.
Despite this work illustrating what we believe represents a clear step forward in the study
of neurotrauma related neurodegeneration, it is clear that further study is warranted. Pre-clinical
models must be utilized to more fully characterize behavioral, biochemical, imaging, and
electrophysiological/functional changes associated with the development of CTE. Future studies
will likely address the development of behavioral/functional deficits in relation to biochemical
changes temporally and assess the chronicity of changes based on the number, severity, and
inter-injury interval of neurotrauma-related events. The development of better transgenic models
is critical as the field moves forward. Performing studies such as these will allow for the
questions raised in our accompanying review be addressed. Specifically, what is the role of the
1) inter-injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5)
mechanism of impact, 6) genetics, 7) gender, and 8) effect of environment on the likelihood
and/or progression of CTE development.
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Figure 6.1. Schematic showing experimental design and behavioral experiments. Time of
sacrifice for biochemical experiments is also shown.
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Figure 6.2. Schematic representation of the two injury models utilized within this work. (A)
Experimental setup utilized at West Virginia University for the study of blast-induced
neurotrauma. The shock tube consists of a high-pressure driver section (nitrogen gas filled) and a
low-pressure driven section (ambient air filled). When the membrane dividing the chambers
ruptures, the blast wave is formed and released, encountering the rat from the right side of the
cranium. (B) Depiction of the model utilized at the University of Rochester in un-anesthetized
mice. An electromagnetic impactor used in CCI was modified with a rubber tip and a specially
designed helmet was placed on the mouse as previously described.
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Figure 6.3. Blast and closed-head injury models both induced tau hyperphosphorylation. (A)
Immunoblots show no significant difference in tau phosphorylation at serine sites 199/202 and
threonine site 205 (AT8) at one month after single and repeat blast exposures in the ipsilateral rat
hippocampus. (B) A significant increase in AT8 expression was measured after single (*p<0.05
vs. CTRL) and repeat blast exposure (***p<0.001 vs. CTRL) in the contralateral rat hippocampus.
(C) AT8 expression was significantly increased at one month after closed-head injury in the
ipsilateral mouse hippocampus (*p<0.05 vs. CTRL). (D) No significant differences were observed
in AT8 expression in the contralateral mouse hippocampus. (E) Immunoblots show no significant
difference in tau phosphorylation at threonine site 181 (AT270) at one month after single and
repeat blast exposure in the ipsilateral rat hippocampus. (F) A significant increase in AT270
expression was measured at one month after repeat blast exposure (*p<0.05 vs. CTRL) in the
contralateral rat hippocampus. (G) No significant differences were observed in AT270 expression
in the ipsilateral mouse hippocampus, (H) or the contralateral mouse hippocampus after closedhead injury. One-way ANOVA Tukey’s post-hoc analysis (values represent mean ± s.e.m.;
normalized to β–actin) (n=3-5).
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Figure 6.4. Tau hyperphosphorylation is seen in microfoci throughout the contralateral
superficial cortex. AT8 was significantly increased at 1 month post repetitive blast (t = 4.455, p
< 0.001). AT270 was also significantly increased following repetitive blast (t = 11.47, p < 0.001).
AT270 was increased in a circular distribution. Tau hyperphosphorylation is an indicator of
progressive pathology. Values were calculated using a student’s t-test comparing the mean
difference between groups.
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Figure 6.5. Blast and closed-head injury models both induce conformational changes in tau
proteins. (A) Immunoblots show no significant difference in markers of tau conformational
change at serine site 396/404 (PHF) at one month after single and repeat blast exposure in the
ipsilateral rat hippocampus. (B) A significant increase in PHF expression was measured after
single (*p<0.05 vs. CTRL) and repeat blast exposure (*p<0.05 vs. CTRL) in the contralateral rat
hippocampus. (C) PHF expression was significantly increased at one month after closed-head
injury in the ipsilateral mouse hippocampus. (D) No significant differences were observed in PHF
expression in the contralateral mouse hippocampus. (E) Immunoblots show no significant
difference in markers of tau conformational change at serine site 202 (CP13) at one month after
single and repeat blast exposure in the ipsilateral rat hippocampus. (F) A significant increase in
CP13 expression was measured at one month after repeat blast exposure (*p<0.05 vs. CTRL) in
the contralateral rat hippocampus. (G) A significant increase in CP13 expression was measured
at one month after closed-head injury in the ipsilateral mouse hippocampus (***p<0.001 vs.
CTRL). (H) No significant differences were observed in CP13 expression in the contralateral
mouse hippocampus after closed-head injury. One-way ANOVA Tukey’s post-hoc analysis
(values represent mean ± s.e.m.; normalized to β–actin) (n=3-5).
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Figure 6.6. Tau conformational markers were increased throughout the contralateral
superficial cortex. PHF was significantly increased at 1-month post repetitive blast (t = 6.055, p
< 0.001). CP-13 staining was also significantly increased following repetitive blast (t = 3.883, p <
0.01). CP-13 was increased in a perivascular distribution. Tau conformational change is required
for the formation of neurofibrillary tangles. Values were calculated using a student’s t-test
comparing the mean difference between groups.
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Figure 6.7. Tauopathy is seen in a perivascular distribution. PHF and AT8 were increased
adjacent to longitudinal microvessels in human patients diagnosed with chronic traumatic
encephalopathy. A neurofibrillary tangle stained with thioflavin was seen adjacent to a cut vessel
lumen in the brain of a retired professional football player. Similarly, CP-13 was increased next to
a cut vessel lumen in the contralateral cortex 1 month following repeat blast in the rat. Arrows
indicate tauopathy while arrow heads point out vessels.
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Figure 6.8. Blast-induced brain injury produces deficits in learning and memory in rats. (A)
Spatial acquisition trials conducted on Days 21-26 post-injury revealed deficits in learning in
single-injury animals on Days 22-24 and 26 in comparison to control. Repeat-injury was
associated with deficits on Days 22-26 in comparison to control. No differences were seen
between single- and repeat-injury paradigms. (B) The probe test on Day 27 revealed a statistically
significant difference in time spent near the prior platform location between injured animals (single
or repeat) and control animals. No difference was seen between single- and repetitively-injured
rats. (C) Animals exposed to neurotrauma exhibited a trend towards increased thigmotaxis during
spatial acquisition procedures but this finding did not reach statistical significance.
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Figure 6.9. Track plots acquired across spatial acquisition and probe testing in rats. (A-D)
Track plots generated from anesthetized control animals on Day 21, Day 23, Day 26, and during
the probe test. (E-H) Track plots generated from single-injured animals on Day 21, Day 23, Day
26, and during the probe test post-injury. (I-L) Track plots generated from repetitively-injured
animals on Day 21, Day 23, Day 26, and during the probe test post-injury. Injured animals appear
to spend more time exhibiting thigmotaxis behaviors (circling edge of pool) on later days and in
the probe trial fail to spend as much time as the anesthetized control animals within the probe
region and the direct area surrounding the probe region.
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Figure 6.10. Blast-induced brain injury in rats produces an increase in impulsive behavior
based on the elevated-plus maze. (A) A significant difference (p<0.05 vs. CTRL) was seen
between anesthetized control animals and both single and repeat blasts with regards to the
percentage of time spent in the open arm of the elevated-plus maze. No difference was measured
between single and repeat-injury paradigms. (B) While not reaching statistical significance, a
trend towards greater distance traveled in open arms was seen with neurotrauma, a finding
consistent with the documented increase in time spent in the open arms. (C) Animals subjected to
neurotrauma appeared to travel less distance in the closed arms of the maze, although this finding
did not reach statistical significance. (D) Track plot showing little exploration of the open arm by
control animals. (E) Track plot showing increased exploration of the open arms of the elevatedplus maze by single-injured animals. (F) Track plot showing increased exploration of the open
arms of the elevated-plus maze by repetitively injured animals.
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Chapter Seven
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for Future Discovery

This work is published in Front Neurol. 2015 Oct 26;6:223.
doi: 10.3389/fneur.2015.00223. eCollection 2015. Review. PMID: 26579067
Turner RC*, Lucke-Wold BP*, Logsdon AF*, Robson MJ, Lee JM, Bailes JE,
Dashnaw ML, Huber JD, Petraglia AL, Rosen CL.

168

ABSTRACT
Despite the extensive media coverage associated with the diagnosis of chronic traumatic
encephalopathy (CTE), our fundamental understanding of the disease pathophysiology remains in
its infancy. Only recently have scientific laboratories and personnel begun to explore CTE
pathophysiology through the use of preclinical models of neurotrauma. Some studies have shown
the ability to recapitulate some aspects of CTE in rodent models, through the use of various
neuropathologic, biochemical, and/or behavioral assays. Many questions related to CTE
development however remain unanswered. These include the role of impact severity, the time
interval between impacts, the age at which impacts occur, and the total number of impacts
sustained. Other important variables such as the location of impacts, character of impacts, and
effect of environment/lifestyle and genetics also warrant further study. In this work we attempt to
address some of these questions by exploring work previously completed using single and
repetitive injury paradigms. Despite some models producing some deficits similar to CTE
symptoms, it is clear that further studies are required to understand the development of
neuropathological and neurobehavioral features consistent with CTE-like features in rodents.
Specifically, acute and chronic studies are needed that characterize the development of tau-based
pathology.
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INTRODUCTION
Corsellis described the original case series of chronic traumatic encephalopathy (CTE) in
boxers (Corsellis et al., 1973). The disease consisted of brain atrophy, dilated ventricles, a cavum
septum pellucidum, and pallor of the substantia nigra. Chronic traumatic encephalopathy was
reintroduced into the medical lexicon by Dr. Bennet Omalu in 2005 (Omalu et al., 2005). Omalu
described a progressive tauopathy that was seen in the brains of deceased football players. In recent
years, McKee, Goldstein, and Stern have defined clinical and pathologic features of the disease.
These include behavioral disturbances such as impulsivity, depression, and lack of oversight
(Corsellis et al., 1973; Mez et al., 2013). Pathologic criteria include neurofibrillary tangles in a
perivascular distribution and within superficial cortical areas with occasional amyloid and TDP43 protein aggregations (Baugh et al., 2014). Stern recently expanded the CTE criteria further by
describing young vs. old onset based on symptom manifestation (Stern et al., 2013). Interestingly,
blast traumatic brain injury has been linked to CTE following a single exposure, where athletes
develop the disease following repetitive head injury (Lucke-Wold et al., 2014b).
CTE has been defined as a slowly progressive disease that takes years to decades to
develop, often providing a significant latent period between when the neurotrauma occurs and
when symptoms develop. A few cases involve athletes/soldiers as early as late teen’s to early
twenties (Omalu et al., 2011a; Tartaglia et al., 2014). The reason for the discrepancies in age of
presentation observed is currently unknown but is likely due to the age at which impacts were
sustained and the severity of the injury. Prior studies have shown that children with TBI have
inadequate development of social cognition (Ryan et al., 2014) and that adolescents can develop
post-traumatic headaches. Very rarely however do either of these groups experience symptoms of
CTE (Dubrovsky et al., 2014). Early behavioral symptoms of CTE usually do not appear until the
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mid-thirties, and cognitive impairment does not begin until the early sixties (Baugh et al., 2014).
Recent evidence suggests that neurotrauma may be linked to other neurodegenerative diseases
such as Alzheimer’s disease (AD) as well (Johnson et al., 2010).
CTE and AD, despite both being tauopathies, have generally been viewed as separate
diseases. Each disease has distinct clinical presentations and unique clinical risk values. This view
has gradually been changing with some reports showing that CTE can develop within the context
of AD. The relationship between these two conditions however is poorly understood. Prior studies
have indicated that TBI is a risk factor for development of cognitive impairment and AD
(Guskiewicz et al., 2005), but whether the conditions are additive or synergistic remains unclear
(Weber, 2007). Recent evidence suggests that neurotrauma may both increase the likelihood of
disease development and accelerate the development of AD (Barnes et al., 2014). Notably, the
wealth of AD pathology observed in preclinical neurotrauma models supports the idea of disease
acceleration (Tran et al., 2011). In addition to AD, some groups have presented a possible link
between CTE and a variant of amyotrophic lateral sclerosis that has been termed ‘chronic traumatic
encephalomyelopathy’ (CTEM) (McKee et al., 2010). Therefore, it is clear that neurotrauma may
have many lasting deleterious consequences, including the potential for increased risk and
accelerated development of neurodegenerative diseases such as AD, CTE, and CTEM. While the
data on these studies is preliminary in nature and not prospective, these findings demonstrate the
need for further investigation with both preclinical models and clinical trials.
The Quest for the Ideal Model
The search for ideal preclinical models to study CTE remains an area of ongoing
investigation with a relative paucity of prior studies. Of those published previously, the majority
of studies fail to recapitulate the extensive neuropathologic and neurobehavioral aspects of injury
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(Goldstein et al., 2012; Ojo et al., 2015). Post-mortem identification of neurofibrillary tangles are
a key diagnostic marker used clinically (Baugh et al., 2012). Therefore, the development of
hyperphosphorylated tau in animals following injury must be an important component in
establishing a CTE model. Tau hyperphosphorylation appears to correlate with the emergence of
neuropathologic

and

neuropsychiatric

deficits

representative

of

neurotrauma

related

neurodegeneration (Petraglia et al., 2014a). By modeling CTE in rodents, we can better understand
disease development and discover potential therapeutic avenues. Similarly, little justification is
given to injury severity, number of impacts, interval between impacts, and age at which the impacts
occur. Few studies have also evaluated secondary mechanisms of injury. In the following sections,
we discuss the advancements and shortcomings of prior research while highlighting areas in need
of further investigation.
What are the proper controls for studying CTE?
One of the challenges in creating a preclinical model for CTE is the establishment of proper
controls comparing sham to TBI animals (Weber, 2007). Specifically, sham animals must undergo
the exact same procedure each day of the injury paradigm. They must be anesthetized for the same
duration as injured animals. The age of the animal must also be considered. Control animals should
be the same age as experimental animals at time of sacrifice. This is an important consideration in
designing extended studies with behavioral assays. Biochemical time courses also require control
animals for each time point. Numerous questions must be addressed in planning experiments while
considering the implications of each decision in terms of experimental question addressed and
potential complications (Figure 1).
Utilizing Available Tools For Studying CTE
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One of the current weaknesses of clinical investigation of CTE is that the disease remains
a neuropathological diagnosis. Some advancement has been made in ligand-based PET imaging.
The imaging was used in a cohort of patients with an extensive history of neurotrauma, but the
modality is not readily available (Small et al., 2013). Consequently, clinical observations are
largely retrospective in nature and it is nearly impossible to investigate disease onset and
progression. These clinical shortcomings can be readily addressed through the use of adequately
designed preclinical models.
The first step in creating a preclinical model of CTE is to choose a model that can be used
to generate a combination of biochemical and behavioral changes post-injury consistent with the
CTE-like

phenotype.

Specifically,

tauopathy

or

a

precursor

of

tauopathy

(tau

hyperphosphorylation), must be present. The changes in tau must be inducible in genetically
unaltered animals and then must be verified with transgenic rodents. Behavioral changes must be
induced by neurotrauma. These changes should persist or worsen at chronic time points postinjury. Assessment of behavior should include tests capable of evaluating behavioral symptoms
reported in clinical CTE cases. In particular, tests for cognition, depressive-like behavior, and
impulsive-like behavior should be used. Cognition can be measured using Morris water maze
(MWM) whereas depressive-like behavior can be assessed with the forced swim test or tail
suspension test. Impulsivity can be elucidated with the elevated-plus maze (EPM).
Once a model is established, biochemical, electrophysiological, and advanced imaging
techniques can be employed to assess neural injury. Biochemical mechanisms of potential interest
include those related to cell survival/death, regulation of tau phosphorylation/dephosphorylation
(kinases/phosphatases),

bioenergetics,

and

propagation

of

tau-based

changes.

Electrophysiological studies can be performed to identify effects of injury and CTE development
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both on individual synapses and larger tracts such as the Schaffer collaterals within the
hippocampus. Imaging modalities such as magnetic resonance imaging (MRI), functional MRI
(fMRI), spectroscopy (MRS), and PET studies have the unique advantage of being able to be
performed longitudinally with multiple assessments of the same animal at different time points.
Taken together, integration of biochemical, behavioral, electrophysiological, and imaging
modalities may provide insight into the mechanisms and time course of CTE development. This
approach will also allow for more definitive evidence to be gathered. This evidence will provide a
stepping-stone in addressing key questions about the effect of inter-injury interval, injury severity,
and number of cumulative injuries necessary for the development of CTE. The answers garnered
from this potential work may then influence the design of clinical trials that dictate return-to-play
decisions. Baseline monitoring may become required in sports arenas and battlefields with high
incidences of neurotrauma. The monitoring may assist in detecting cumulative subthreshold injury
levels and be used to decrease the overall level of concussions.
Implications for Modeling CTE: Results from Prior CTE Modeling Studies
Perhaps one of the most promising studies, with regards to demonstrating CTE-like disease
in a rodent model, was performed by Luo, et al. In this study, the authors developed a closed head
model of neurotrauma utilizing an electromagnetic stereotaxic impact device. The authors showed
that enhanced force of injury or using repeat injury increased GFAP-tagged luciferase.
Intriguingly, when this same repeat injury paradigm was applied to wild-type mice, spatial learning
and memory deficits were observed 2 to 6 months after injury and were accompanied by increased
hyperphosphorylated tau and astrogliosis (Luo et al., 2014). The gliosis response in human CTE
has not been well characterized, but the findings by Luo and colleagues show that GFAP was
increased near areas of tauopathy. Similar findings have been seen by Petraglia and colleagues
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who performed a rigorous investigation of the behavioral effects of both single and repetitive
closed head injury in wild-type mice (Petraglia et al., 2014b). The authors found that a single
injury, in un-anesthetized animals, produced notable short-term abnormalities in behavior similar
to a post-concussive state. Repetitive injury (42 impacts total: 6 impacts per day over 7 days)
produced chronic deficits, particularly with regards to depressive-like and risk-taking behaviors as
well as spatial learning and memory (Petraglia et al., 2014b). This same group published a recent
follow-up study demonstrating the presence of hyperphosphorylated tau, a precursor of
neurofibrillary tangle (NFT) development, in repetitively injured animals (Petraglia et al., 2014a).
The model produces several of the same behavioral symptoms reported by patients suspected of
having CTE. We recently show that endoplasmic reticulum stress contributes to tauopathy and
CTE-like behavioral deficits following repeat blast injury (Lucke-Wold et al., 2015c).
Other studies, conducted by Mouzon and colleagues report both behavioral and
neuropathologic changes following repetitive neurotrauma in mice.

Specifically, 5 injuries

administered 48 hours apart, produced durable cognitive deficits, learning disabilities, diminished
rotarod performance, and changes in anxiety-like behavior on elevated-plus maze. Notably, these
behavioral changes occurred in conjunction with persistent neuroinflammatory changes and
disruption of white matter integrity. No changes in A and tau phosphorylation were seen at the
chronic time points of 6 and 12 months post-neurotrauma, likely because rodents don’t naturally
develop neurofibrillary tangles (Mouzon et al., 2014). Rodents do however demonstrate acute tau
changes due to phosphorylation and cleavage following injury (Huber et al., 2013). Liu and
colleagues found that tau hyperphosphorylation was increased in rats acutely post-injury and
triggers caspase activation in rat cortices (Liu et al., 2011). The activation of cell death can lead to
circuit dysfunction and behavioral deficits (Abisambra and Scheff, 2014). Goldstein and
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colleagues show that tauopathy contributes to mitochondrial dysfunction and microtubule injury
that ultimately leads to apoptosis. In this study, they found that tau modulation is a potential avenue
for therapeutic intervention (Kondo et al., 2015). We recently report that caspase activation was
increased in human CTE brains near sites of neurofibrillary tangle formation (Lucke-Wold et al.,
2015a).
Other repeat-injury studies have investigated changes in tau and amyloid post-injury with
the goal being to more clearly elucidate the relationship between TBI and neurotrauma related
neurodegeneration. One report showed an increase in neuronal tau immunoreactivity (Kanayama
et al., 1996) and another showed elevated amyloid precursor protein (APP) (Dobrowolska and
Gibson, 2005; Weber, 2007) at a variety of time points post-injury. A final study by Zhang and
colleagues showed that monoacylglycerol lipase can lead to behavioral deficits and tauopathy
characteristic of a CTE-like phenotype (Zhang et al., 2015). These findings were further verified
in other studies using transgenic models of amyloidosis and tauopathy in which repetitive injury
paradigms produced elevated amyloid and tau levels with increased deposition. Single injury
however failed to produce changes above control levels (Uryu et al., 2002; Conte et al., 2004).
Using a T44 tau Tg mouse line, Yoshiyama and colleagues sought to study dementia pugilistica
(DP), a condition sharing many features with modern day CTE, but with several key differences.
DP by definition occurs only in boxers and has more severe gross anatomical changes that are not
always present in CTE. The Yoshiyama group found that 4 impacts per day given once a week
for 4 weeks produced only modest neuropathology with only 1 mouse demonstrating CTE or DP
characteristics out of a total of 18 Tg mice and 24 wild-type mice (Yoshiyama et al., 2005; Weber,
2007). The affected mouse displayed neuropathologic changes that included heightened tau
burden, the presence of neurofibrillary tangles, and cognitive deficits (Yoshiyama et al., 2005).
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While it remains unclear why only one mouse developed such pathology, neuropathological
findings from this one animal demonstrated that iron deposition was increased and associated with
blood-brain barrier disruption. Iron deposition, associated with degradation of heme, activates
oxidative stress-related pathways. Importantly, this oxidative stress is then associated with
accelerated neurofibrillary tangle formation in these perivascular locales (Yoshiyama et al., 2005).
Notably, even single injury paradigms have been shown to produce tauopathy in a variety
of injury models including blast (Goldstein et al., 2012), fluid percussion (Hawkins et al., 2013),
and controlled cortical impact, findings consistent with prior clinical reports (Begum et al., 2014;
Rubenstein et al., 2014). Goldstein and colleagues demonstrated that tauopathy following single
blast injury was associated with hippocampal-dependent learning and memory deficits at subacute
and chronic time points. These changes were also associated with electrophysiological alterations
in long-term potentiation (Goldstein et al., 2012). Therefore, even a single mild to moderate injury
may induce neurodegeneration and neurological deficits leading to impaired cognition and
disrupted synaptic transmission (Goldstein et al., 2012). Single injury has also been shown to
contribute to blood brain barrier disruption (Glushakova et al., 2014). This is a significant finding
considering the numerous concussive and subconcussive injuries occurring in athletics and on the
battlefield.

Other studies using single injury models have also demonstrated activation of

numerous pathological processes and behavioral changes associated with neurodegeneration.
Modeling neurotrauma related neurodegeneration is a key component in the search for a model of
CTE (Smith et al., 1995; Logsdon et al., 2014; Lucke-Wold et al., 2014c). While the importance
of repeat injury in CTE modeling cannot be overstated, some single injury studies have led to
advances in the ability to detect phospho-tau in serum at weeks to months post-injury. These
advances indicate the potential role of biomarkers in monitoring and understanding disease
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pathophysiology (Rubenstein et al., 2014). The development of animal based models that exhibit
similar characteristics of CTE will afford researchers the opportunity to characterize the acute and
chronic effects of injury on the phosphorylation of tau in controlled experimental conditions. In
vitro models may even be beneficial in elucidating changes at the cellular level (Zander et al.,
2015). Evaluating imaging modalities, potential biomarkers, such as phosphorylated tau, and
proposed therapeutics in a controlled context will promote advancement towards clinical
applications and could be instrumental for monitoring and understanding disease pathophysiology
in the future.
Implications for Modeling CTE: Learning from Past Shortcomings with TBI Models
Despite these notable advancements in CTE modeling as outlined above, the vast majority
of repeat injury studies fail to address the role of injury severity, inter-injury interval, and the total
number of impacts needed to reproduce a CTE-like state (Prins et al., 2010; Goddeyne et al., 2015).
Most studies simply describe features of TBI without relating the findings to neurodegeneration
(Loane and Kumar, 2015). Furthermore, because CTE is a neuropathologic diagnosis, any study
claiming to serve as a model of CTE must demonstrate the hallmark neuropathologic changes (tau
hyperphosphorylation and neurofibrillary tangles) and show that these changes persist at delayed
time points and coexist with behavioral deficits. Few studies have looked at amyloid, tau, or
TDP43 accumulation following injury.
One of the most common omissions from repetitive injury paradigms is the lack of
consideration for inter-injury interval. Work by Longhi and colleagues directly explored this issue,
demonstrating that in a mouse model of closed-head injury (CHI), mice had a period of
vulnerability estimated between 3 and 5 days where the effect of injuries was additive and
produced deficits in cognition. When the inter-injury interval was lengthened to 7 days, these
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deficits were not present (Longhi et al., 2005). While the focus of that study was elucidating
differences in the inter-injury interval, other groups employing a repeat injury paradigm should
consider how the inter-injury interval may relate to their findings. Inter-interval design will be an
important consideration in developing CTE models. Attempting to provide a clinical context for
these decisions would be desirable, with the interval between severe concussive-type impacts
ideally being longer than that between mild subconcussive-type impacts. This would expand
scientific insight for “return-to-play” guidelines that require players to be asymptomatic following
a diagnosed concussion prior to returning to contact sports. These types of questions have
generally not been considered in preclinical work, with most studies using brief inter-injury
intervals, often ranging from minutes to 24 hours with poor justification for timing (Creeley et al.,
2004; Shitaka et al., 2011; Genovese et al., 2013; Klemenhagen et al., 2013; Petraglia et al., 2014b;
Wang et al., 2014).
Another important limitation related to interpretation of injury severity and
neuropathologic outcome, is the sensitivity of detecting neuropathology using current scientific
approaches. Shitaka and colleagues demonstrated previously that silver staining was more reliable
for detecting axonal injury and pathology in comparison to routine histological analysis,
assessment of neuronal cell loss, and amyloid precursor protein (APP) immunohistochemistry
(Shitaka et al., 2011). It may be increasingly important, particularly in studies of repetitive
subconcussive impacts, to utilize measures of high sensitivity for injury detection. Silver staining,
which has been shown repeatedly to exhibit a higher degree of sensitivity in detecting axonal injury
than many immunohistochemical techniques; electron microscopy; or other markers with these
characteristics may prove promising (Shitaka et al., 2011). It has not yet been determined if
neurofibrillary tangles accumulate around sites of axonal shearing.
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Key Questions Going Forward
Improving experimental models will enhance the quest for developing therapeutic agents that can
be used to prevent and treat CTE. The search for a model of CTE raises a number of questions
that are important clinically. These questions include issues such as length of the inter-injury
interval, the number and severity of impacts, and the age at time of impacts, as well as the
mechanism of impact, the gender of the patient, and what role genetic predisposition may play in
the development of neurodegenerative disease following neurotrauma.

Another important

question that must be addressed is does a history of neurotrauma and potential presence of CTE
accelerate the development of Alzheimer’s disease?

Furthermore, how can the period of

susceptibility following neurotrauma be identified most readily? In the following sections we
attempt to address these questions based upon available evidence. We also provide suggestions for
handling shortcomings going forward. Studies upon which these sections are based are referenced
in Tables 1-6 for quick reference.
Inter-Injury Interval
The effect of inter-injury interval on outcome following TBI has only recently been
investigated. Studies have explored a variety of intervals ranging from 2 minutes apart (in vitro)
to a few hours (in vivo) to as long as 30 days apart (in vivo). Using a novel approach assessing
vasoreactivity in TBI, Fujita and colleagues demonstrated that administration of seemingly mild
injuries at brief intervals (3 hours apart) produced dramatic declines in vasoreactivity and axonal
pathology. When the inter-injury interval was lengthened to 5 hours, the magnitude of these
changes was diminished substantially with complete dissolution of changes in both pathology and
vasoreactivity at 10 hours (Fujita et al., 2012b).
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Other studies that have investigated longer inter-injury intervals have identified periods of
susceptibility following an initial impact at periods ranging from 24 hours to a few weeks (Meehan
et al., 2012; Mannix et al., 2013; Bolton and Saatman, 2014; Weil et al., 2014). Bolton and
colleagues demonstrated with a CHI model that a single impact produced extensive gliosis
bilaterally in the hippocampi and entorhinal cortices. Repeat injury after 24 hours produced a
more severe injury consisting of hemorrhage in the entorhinal cortices as well as heightened
measures of neurodegeneration, gliosis, and neuroinflammation (Bolton and Saatman, 2014).
When the experimental paradigm was changed such that impacts were given with a 48-hour interinjury interval, the histopathology resembled that of a single impact suggesting enhanced
susceptibility when a second impact was administered within 24 hours (Bolton and Saatman,
2014).
Mannix and colleagues performed one of the most rigorous investigations of the effect of
inter-injury interval on outcomes associated with TBI. These studies included measures of both
cognition and neuropathology related to the development of neurodegenerative diseases such as
CTE and AD. In this study, the investigators showed that animals who received daily or weekly
injuries with weight-drop had persistent cognitive deficits up to 1 year post-injury (Mannix et al.,
2013). This was in contrast to when animals were injured biweekly or monthly, which failed to
produce deficits at such a chronic time point (Mannix et al., 2013). Notably, the cognitive deficits
seen in the daily- and weekly-injured animals did not correlate with elevations in tau
phosphorylation or amyloid-β when measured by ELISA nor brain volume loss when measured
by MRI (Mannix et al., 2013). This finding may indicate that in addition to inter-interval time,
injury severity must be considered. Tauopathy is essential for modeling CTE therefore an
appropriate inter-injury interval might be best characterized in transgenic animals. Weight drop
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produces variable injury based on the height of the drop. A more severe TBI can produce cognitive
deficits but may not be representative of the concussive and subconcussive injuries associated with
CTE. A mild TBI with a transgenic animal will likely produce the most relevant deficits.
Meehan and colleagues performed a similar study with primarily behavioral assays. The
investigators subjected mice to a CHI via weight-drop for a total of 5 impacts at various intervals.
These intervals included daily, weekly, and monthly intervals. Mice receiving 5 impacts total at
daily or weekly intervals were impaired in the MWM compared to sham animals (Meehan et al.,
2012). This was not the case when injuries were delivered at monthly intervals, as these animals
exhibited no impairment in the MWM (Meehan et al., 2012). Interestingly, at one month postinjury, the daily- or weekly-injured animals still exhibited deficits in the MWM and this deficit
persisted in daily-injured animals out to 1 year (Meehan et al., 2012). This finding may represent
why football lineman who experience daily subconcussive injuries appear more likely to develop
CTE based on the clinical cases reported. It is still necessary to establish if tauopathy is the driving
mechanism behind behavior. The findings confirm and expand upon the inter-interval studies
completed by Longhi and colleagues (Longhi et al., 2005). Longhi reported that shorter interinterval injuries produce worse outcomes, which is in agreement with the Mannix and Meehan
findings. These studies were consistent with findings in higher phylogenetic species as well,
specifically piglets. Friess and colleagues showed that a 24-hour inter-injury interval produced
more severe deficits and higher mortality rates than when the interval was extended to 7 days
(Friess et al., 2009). Finally, Kanayama and colleagues demonstrated a graded response in
locomotor activity. Both shorter inter-injury intervals as well as greater number of total injuries
were associated with worse outcome (Kanayama et al., 1996).
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Weil and colleagues explored the effect of altering the inter-injury interval in relation to
recovery from TBI. They used a clear clinical-minded approach and utilization of metabolic
imaging (PET). This group showed that injuries separated by only 3 days were associated with
worse neuropathology and an inability to mount the typical hypermetabolic response with regards
to glucose utilization following TBI. This worse outcome was not seen following either a single
injury or repeat injuries with an extended inter-injury interval of 20 days (Weil et al., 2014).
Similarly, a brief inter-injury interval of 3 days was associated with elevated IL-1β and TNFα gene
expression when compared with other experimental groups (Weil et al., 2014).
The longest interval between injuries used in preclinical studies, to the best knowledge of
the authors, was 30 days. The additional injury had no additive effect on anxiety (EPM),
depression (FST), and cognitive function (MWM) when compared to animals receiving only one
injury (Mychasiuk et al., 2014). These findings indicate that either the window of vulnerability
following the first injury was avoided or that the response to the first injury may protect the animal
from subsequent injuries, a concept known as preconditioning (Mychasiuk et al., 2014). The
progression towards tauopathy was not well characterized in this work.
In vitro studies have shown similar findings to the in vivo studies described above. Shorter
inter-injury intervals between mechanical stretching resulted in an elevation in S-100β protein
release and increased cellular permeability identified with propidium iodide staining (Weber,
2007). Similarly, a ‘subthreshold’ level of stretch did not produce any overt cellular damage or
death when repeated at 1-hour intervals but did cause neuronal loss and neuron-specific enolase
(NSE) release when performed at incredibly short intervals (every 2 minutes) (Slemmer and
Weber, 2005; Weber, 2007). Remarkably, this rapid and repetitive ‘subthreshold’ stretch that
produced changes in neurons, failed to produce an increase in S-100β protein release,indicating a
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differential response between neurons and glia to neurotrauma severity and interval (Slemmer and
Weber, 2005; Weber, 2007).
In contrast to the above studies, one group showed that repeat injury, when administered
in different anatomical locations within the brain, failed to result in heightened damage when an
inter-injury interval was 3 days. It did however increase tissue vulnerability with a 7-day interval
as evident by increased hemorrhage (Donovan et al., 2012; Donovan et al., 2014). The authors of
the study therefore argue that the period of susceptibility likely depends on not only the time
interval between injuries, but also the anatomic location of injury (Donovan et al., 2012; Donovan
et al., 2014). Importantly, this study utilized an open injury model (controlled cortical impact), a
scenario that is only seen in a subset of clinical neurotraumas.
In summary, these studies demonstrate a period of vulnerability following initial injury in
which sustaining a second brain injury may result in an additive effect. Additive injury is not
clearly apparent when the brain is allowed a more extensive recovery period. Interestingly, this
vulnerability may not solely be due to initial axonal pathology but may also be the result of
cerebrovascular reactivity and the inability to utilize glucose effectively (Fujita et al., 2012b; Weil
et al., 2014). This concept of a varied cellular response to TBI is consistent with findings from in
vitro studies that demonstrate a varied response amongst glia and neurons (Slemmer et al., 2004;
Slemmer and Weber, 2005; Weber, 2007).
Number of Impacts
The prevailing theory for ‘mild’ neurotrauma is that repetitive injuries are associated with
more short- and long-term detrimental effects than a single injury alone (Laurer et al., 2001;
Mouzon et al., 2012; Bolton and Saatman, 2014). This concept has been applied regardless of
injury severity (concussive versus subconcussive) with emerging evidence indicating that even
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subthreshold impacts are cumulatively detrimental (Fujita et al., 2012b; Bailes et al., 2013). In
this section we explore the effect of repeat injury through analysis of studies employing both repeat
and single injury paradigms.
One of these studies, conducted by Mouzon and colleagues, showed that when rodents are
exposed to 5 total injuries with an interval of 48 hours, these animals exhibit both impaired learning
and memory at extended time points (Mouzon et al., 2014). These findings are in contrast to single
injured animals that display only learning deficits but no retention impairment at the same time
points (Mouzon et al., 2014). This study closely parallels the clinical findings documented by
Guskiewicz and colleagues in which former athletes with a history of repetitive concussions
experience memory-related issues at a rate 5 times higher than those without a history of
concussion (Guskiewicz et al., 2005; Mouzon et al., 2014).
Other work that investigated various iterations of impacts (0, 1, 3, 5, and 10) demonstrated
that while a single injury does not produce deficits in MWM performance in comparison to shaminjured animals, repetitive injury does in fact produce deficits and these deficits may exhibit a
dose-dependent relationship. When mice were given 10 concussive weight-drop injuries, those in
which the weight was dropped from a height of 42 inches performed worse than those injured from
a height of 38 inches. Therefore, this work demonstrates the potential for both injury number and
injury severity in contributing to neurological dysfunction (Meehan et al., 2012). Luo and
colleagues utilized a GFAP-driven luciferase mouse line and a repetitive closed head injury model
to investigate cumulative decline. The investigators showed that there appeared to be a linear
increase in GFAP luminescence from 1 to 3 injuries but that this response appeared to reach a
plateau by 5 injuries (Luo et al., 2014). In addition to the increase in GFAP fluorescence with
repetitive injuries, mice receiving three injuries demonstrated less freezing time than sham animals
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in both cued and contextual fear conditioning (Luo et al., 2014). This was in contrast to single
injury animals that did not differ from sham-injured animals in cued or contextual memory (Luo
et al., 2014). Consequently, this data demonstrates that an increase in injury number is associated
with an increasing severity of injury markers (based on protein expression of GFAP) as well as
functional deficits (fear conditioning). Others employing both single and repeat injury paradigms
have shown that while single injury may not induce pathological findings, repeat injury, of the
same severity, does. This was particularly notable in work by Uryu and colleagues in which
repetitive injury produced an increase in Aβ deposition in Tg2576 animals, whereas no increase
was observed in single injury paradigms in these same animals (Uryu et al., 2002). Likewise,
Kanayama and colleagues demonstrated that repeat injury paradigms induced tau
hyperphosphorylation, a precursor to NFT formation, in conditions such as CTE and AD
(Kanayama et al., 1996).
The observed findings in closed-head, repeat injury models, were also consistent with those
found in open-head injury using a craniectomy and controlled cortical impact. In work by
Donovan and colleagues, the investigators showed that repeat injury induces progressive and
evolving changes that are not observed in single injury paradigms (Donovan et al., 2014). The
basis of many of the memory and cognitive changes following repeat TBI, may be explained by
electrophysiological alterations in synaptic transmission. In work by Aungst and colleagues,
repetitive TBI was found to prevent the induction of long-term potentiation (LTP) 28-days postinjury due to alterations in the NMDA receptor. This is in stark contrast to single injury paradigms
that revealed the ability to induce LTP in both hemispheres, with the contralateral hemisphere
exhibiting less LTP than the ipsilateral hemisphere. The impairments in excitatory
neurotransmission following repeat injury were accompanied by extensive neuroinflammation and
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neurodegeneration as well as behavioral/functional impairments (Aungst et al., 2014).
Specifically, repeat injury produced deficits more severe than single injury when measured at oneweek intervals out to a month. Importantly, even single injury produced deficits at chronic time
points post-injury when compared to sham animals, indicating long-term effects of TBI (Aungst
et al., 2014).
Povlishock and colleagues expanded the concept of subthreshold injury. In these studies,
the investigators showed that administering a single weight-drop injury from 1.0 m resulted in
neither axonal nor microvascular change. With repeat injury of short inter-injury intervals (hours),
significant axonal and microvascular pathology was observed (Fujita et al., 2012b). This work
was the first to assess microvascular reactivity to acetylcholine (ACh) following repetitive
subthreshold brain injury. This work demonstrates the clear danger of subthreshold impacts when
sustained in a repeated and rapid fashion. It also illustrates the role of the microvasculature in
neuronal injury, showing that the neurovascular unit is essential for neuronal homeostasis.
Importantly, work regarding the number of impacts has been extended higher up the
phylogenetic tree to rabbits and piglets (Olsson et al., 1971; Raghupathi et al., 2004). In rabbits,
repeated loading with loads of up to 1.5 atm failed to produce an additive concussive response
over a single load. A multi-loading paradigm at higher loads however caused respiratory arrest
(Olsson et al., 1971). In piglets, multiple less severe injuries induced neuropathological findings
similar to a severe load based on the density of injured axons as well as number and distribution
of foci (Raghupathi et al., 2004).
In vitro studies have reported similar findings to the in vivo studies. Weber and colleagues
applied a mild stretch to hippocampal neuronal cultures that produced low-grade injury when
applied at a single time. When this injury was repeated, the cells exhibited cumulative damage
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with two injuries inducing an increase in neuron-specific enolase (NSE) (Slemmer et al., 2004;
Slemmer and Weber, 2005; Weber, 2007).
Notably, the group led by Mychasiuk and colleagues provides evidence contrary to the
widely held belief that an increased number of impacts are associated with detrimental findings on
behavioral or histological measures.

With a 30-day inter-injury interval, rodents receiving

multiple injuries performed similar to single-injury animals on measures of anxiety, depression,
and cognitive ability. Therefore, they propose that receiving head injury at an early age may prime
the brain to be less susceptible to the effects of a later neurotrauma, a theory known as ‘preconditioning’ (Mychasiuk et al., 2014). DeRoss, et al also showed that while one concussive
impact resulted in diminished performance in 85% of animals, less deviation was seen with
subsequent impacts. The number of impacts has an inverse relationship with animal performance
in the water maze (DeRoss et al., 2002). Again, the mechanism behind these findings is not
entirely clear as those animals sustaining multiple injuries also received additional exposure to the
water maze, allowing for enhanced training/learning of the maze (DeRoss et al., 2002). Therefore,
while repetitively injured animals did better than single-injured animals in the maze, this is likely
a product of increased training rather than a protective response but this cannot be said with
absolute certainty.
Severity of Impacts
The effect of injury severity on likelihood of neurodegenerative disease development is not
entirely clear, although some clinical reports indicate that more severe injury results in a greater
predisposition for AD development (Plassman et al., 2000; Uryu et al., 2002). What is known
from preclinical studies using an array of animal models is that there is a dose-dependent increase
in neural injury markers and cognitive deficits with more severe injury (DeFord et al., 2002;
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Manley et al., 2006; Long et al., 2009; Budde et al., 2013; Turner et al., 2013b; Luo et al., 2014).
Similarly, repetitive ‘mild’ injuries may produce a phenotype more consistent with a single more
severe injury (DeFord et al., 2002).
How ‘mild’ TBI contributes to the likelihood of developing CTE remains unclear.
Emerging evidence from preclinical studies raises concern about lasting effects of subthreshold
injuries when sustained in a rapid and repetitive fashion. These repetitive injuries contribute to
vascular reactivity and subsequent axonal degeneration in vivo (Fujita et al., 2012b). Some studies
suggest that severity of injury may dictate the rest period required to minimize cumulative
cognitive deficits, although further studies are required to validate these findings (Meehan et al.,
2012).
Similarly, preclinical studies, even those in which only a mild force is imparted to a thinned
cranium, indicate that a substantive inflammatory response is produced quickly after injury (Roth
et al., 2014). This response is associated with heightened vascular permeability, also seen
clinically, as well as microglial response (Roth et al., 2014). It is these mechanisms, both primary
and secondary, that may contribute to neurodegenerative disease post-neurotrauma.
In vitro studies may be of further use in addressing the role of injury severity, particularly
in subconcussive/subthreshold-type studies, as levels of injury and subsequent cellular responses
can be monitored rapidly and performed over a greater number of iterations at a lower cost in
comparison to in vivo studies. In fact, a number of injury paradigms and mechanisms have been
investigated successfully in this manner including fluid pulse-induced shear stress, repetitive
stretching, and other mechanical deformation procedures, both in vitro and ex vivo (LaPlaca and
Thibault, 1998; Mukhin et al., 1998; Sieg et al., 1999; Slemmer et al., 2004; Slemmer and Weber,
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2005; Morrison et al., 2006). The in vitro shearing studies found a significant amount of axonal
beading and glial death (LaPlaca et al., 2005).
Age at Time of Impacts
Age is the biggest risk factor for the development of neurodegenerative disease and has
been associated with poor outcomes following TBI in a variety of clinical and preclinical reports
(Hamm et al., 1991; Maughan et al., 2000; Hoane et al., 2004; Anderson et al., 2009; Wali et al.,
2011; Mehan and Strauss, 2012; Timaru-Kast et al., 2012; Turner et al., 2012d; Turner et al., 2014).
Similarly, neurotrauma has been associated with an increased risk of neurodegenerative disease
development with regards to AD (Plassman et al., 2000; Van Den Heuvel et al., 2007; Magnoni
and Brody, 2010; Sivanandam and Thakur, 2012), PD (Bower et al., 2003), and CTE (Omalu et
al., 2005; Omalu et al., 2006; McKee et al., 2010; Omalu et al., 2010b; Omalu et al., 2010a; Omalu
et al., 2010c; Gavett et al., 2011; Omalu et al., 2011a; Omalu et al., 2011b; Goldstein et al., 2012;
Stern et al., 2013; Montenigro et al., 2014; Omalu, 2014). One of the primary questions currently
in the field is how the age at which the patient sustains the neurotrauma pertains to the
development, or lack thereof, of CTE.
Similar findings have been observed in preclinical studies. Mychasiuk and colleagues
showed that TBI during brain development leads to worse outcomes than TBI affecting the mature
brain (Mychasiuk et al., 2015). Preclinical work has also shown that young animals experience
less edema than middle-aged animals following TBI (Kasturi and Stein, 2009). The increased
edema is associated with an increase in lesion size in aged rodents experiencing TBI (Kumar et
al., 2013). TBI in aged rodents is also more likely to increase sensorimotor and cognitive decline
(Hoane et al., 2004). TBI in youth may ultimately be more detrimental for social development,
whereas severe injury in the elderly results in rapid cognitive decline due to increased edema and
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therefore, lesion size. In regards to human TBI, it is unclear if the elderly would have a more
progressive form of the disease similar to rodent studies or if the disease would develop in the
normal manner. It is also important to consider that males <35 years old are the most likely to
have repetitive TBIs, a group associated with heavy participation in sports and now the military
(Theadom et al., 2014). Future preclinical studies should therefore continue to investigate TBI
secondary mechanisms in both young and aged animals with particular attention paid to addressing
repetitive injury paradigms and the development of CTE-like features, both behaviorally and
biochemically.
Mechanism of Impact
CTE has been diagnosed in athletes sustaining direct impacts as a result of participation in
warfare, football, wrestling, and soccer (Omalu et al., 2005; Omalu et al., 2006; McKee et al.,
2010; Omalu et al., 2010b; Omalu et al., 2010a; Omalu et al., 2010c; Gavett et al., 2011; Omalu et
al., 2011a; Omalu et al., 2011b; Goldstein et al., 2012; Stern et al., 2013; Montenigro et al., 2014;
Omalu, 2014). The mechanism of injury is different between blast and athletic concussions, but
how these mechanisms relate to injury progression remains to be elucidated. For blast, primary to
quaternary injury must be considered (Kobeissy et al., 2013). Other important questions include
what is the influence of linear versus rotational impacts? What is the effect of direct impacts such
as a football tackle versus indirect impacts such as primary blast exposure? Furthermore, how can
comparisons most accurately be made across these various impacts? Are accelerometers and
recording systems (such as the HITS system) the best method for understanding and comparing
these impacts? What role does high-speed videography and subsequent kinematic analysis play?
Each of these questions remains to be answered and may provide further insight into understanding
the role that impact type plays in CTE development.
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Biochemical Mechanisms
Interestingly, glymphatic clearance has recently been shown to play a role in injury
progression. Iliff and colleagues showed increased tauopathy accumulation in aquaporin knockout mice following traumatic brain injury due to disrupted glymphatic clearance (Iliff et al., 2014).
It has yet to be determined how the primary injury mechanism causes the disruption to glymphatic
channels. Cernak proposed an interesting theory about low-frequency stress waves transmitting
kinetic energy through tissue (Cernak, 2015). This mechanism may account for the dysfunction of
the aquaporin channels. The energy transfer may also injure other cellular components such as
axons or vessels. Chodobski and colleagues have shown that kinetic transfer of energy can account
for blood brain barrier disruption (Chodobski et al., 2011). Blood brain barrier disruption postinjury can trigger increased neuroinflammation. Agoston and colleagues showed that blast
traumatic brain injury, in particular, causes persistent neuroinflammation, which leads to
behavioral deficits (Kovesdi et al., 2012). The neuroinflammation can also contribute to posttraumatic epilepsy and tauopathy (Salazar and Grafman, 2015). Investigating how tauopathy
spreads is a topic warranting further investigation (Koliatsos and Xu, 2015). Furthermore,
Kobeissy and colleagues highlight in their recent review that underlying neuronal damage can
cause lasting neuropsychiatric deficits such as post-concussion syndrome and post-traumatic stress
disorder (Kobeissy et al., 2013).
Role of Genetics
Genetics and lifestyle choices may play a role in likelihood of sustaining a TBI and also
the outcome following a TBI. Little to no evidence currently exists regarding lifestyle choices
associated with TBI and only recently has genetic contribution to CTE been addressed.
Specifically, it is well known in the human literature that the APO4 allele is associated with worse
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outcome following TBI (Ponsford et al., 2011). APO4 and APO3 have also been implicated in
the development of both CTE and AD (Weber, 2007; Saulle and Greenwald, 2012). The
mechanism by which APO4 worsens outcome following TBI is poorly defined (Mannix et al.,
2013), but targeted replacement of the allele in mice has allowed focused research into cholesterol
metabolism and may lead to insights in the field of traumatic brain injury and subsequent
neurodegeneration (Laskowitz and Dawson, 2014). Notably, a study by Maroon and colleagues
recently demonstrated that there was no significant difference between ApoE4 carriers in a
population of patients afflicted with CTE when compared to the general population, suggesting
that perhaps ApoE may not represent a significant risk factor for CTE development, even in
individuals exposed to neurotrauma (Maroon et al., 2015).
Other genetic influences have also been observed but are currently limited to preclinical
evidence. Rare genetic alterations such as mutation of the CACNA1A calcium subunit gene have
also been shown to lead to poor TBI outcomes in human patients (Kors et al., 2001). Recent preclinical studies have shed light on other potential genetic factors that may influence TBI outcomes.
Decreases in micro RNA 23a and 27a increase apoptosis following TBI in rodents (Sabirzhanov
et al., 2014). Deficient caveolin expression can exacerbate neuroinflammation post-TBI (Niesman
et al., 2014). The knock-in mouse APP696swe has accelerated deposition of A following TBI
(Yoshiyama et al., 2005). Emerging evidence also suggests dysfunctional mitochondrial genes
following TBI such as Fas, Apaf1, and Chp. Interestingly, these genes become more dysfunctional
and mutated with time after mild TBI (Sharma et al., 2012). TBI can also induce DNA
fragmentation leading to an upregulation of p53, a critical regulator of cell cycle (Lu et al., 2000).
On the other hand, upregulation of insulin growth factor expression prior to TBI is associated with
neuroprotection (Carlson et al., 2014). Similarly, genetic regulation of aquaporin 4 channels can
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reduce edema formation following TBI in rodent models (Ke et al., 2001). Surprisingly, disruption
or the PARP1 gene offers protection against TBI hypoxia (Hagberg et al., 2004). Studying genetic
risk factors for TBI is an area of growing importance and requires further investigation.
Understanding factors that lead to increased or decreased TBI severity may also allow the
development of novel pharmaceutics for the prevention of neurodegenerative disease.
An emerging area is the role of epigenetic modulation following TBI. Epigenetic markers
are now being used preliminarily to predict recovery following injury (Lipsky and Lin, 2015).
VandeVord and colleagues show enhanced methylation of DNA in the rat hippocampus following
blast traumatic brain injury (Bailey et al., 2015b). These epigenetic changes are mediated by
HDACs and DNMTs (Bailey et al., 2015a). Interestingly, the methylation changes are cumulative
with repetitive injury (Haghighi et al., 2015). HDAC has been shown to contribute to GSK3
activation, which is a known tau kinase. When HDAC is inhibited white matter damage is reduced
(Wang et al., 2015). Epigenetic regulation has been tied to the development of post-traumatic stress
disorder clinically (Almli et al., 2015). Targeting epigenetic regulation may therefore be a viable
target in preventing tauopathy and behavioral deficits following traumatic brain injury.
Influence of Gender
The influence of gender on outcome after TBI remains controversial, particularly in light
of the few cases of CTE diagnosed in women. Some studies claim that females have better
outcomes following neural injury (Bramlett and Dietrich, 2001) while others report no change
(Kadyan et al., 2004; Bruce-Keller et al., 2007), or worse outcome (Farace and Alves, 2000b).
Estrogen treatment has shown improved outcomes in rodent models of neural injury (Simpkins et
al., 1997; Suzuki et al., 2007; Jia et al., 2009; Li et al., 2011), including TBI (Gatson et al., 2012;
Day et al., 2013). Female rodents exhibit better outcomes after neural injury as evidenced by
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increased neurotrophin production (Gatson et al., 2012), decreased neuroinflammation (Brown et
al., 2009), and better performance on motor tasks (Wagner et al., 2004b). Clinical evidence shows
that female patients exhibit lower oxidative damage after TBI (Wagner et al., 2004a), which could
be the result of a higher estrogen circulation following injury. Gender differences should be
considered when conducting clinical trials for TBI therapy.
Interestingly, Dixon and colleagues found that TBI in female humans reduces estradiol in
the CSF (Garringer et al., 2013). The reduction of estradiol may have unique long-term effects
because it is not yet known if this is transient or permanent. The limited amount of data about
women with TBI has restricted the comparisons of injury between genders (Bell and Pepping,
2001). The majority of traumatic brain injuries in women are subdural hematomas from falls.
Elderly women with subdural hematomas tend to fair worse than the general TBI population as a
whole (Farace and Alves, 2000a). Menopause may therefore dampen the neuroprotective
physiologic properties mediated by estrogen post-injury. TBI in elderly women is also linked with
earlier onset Alzheimer’s disease (Nemetz et al., 1999). Hormonal changes may also be a
contributing factor to CTE, but this has yet to be verified. It is clear based on the limited preclinical and clinical data that further investigation into the gender differences surrounding TBI
outcome is warranted.
Effect of Environment
Another area of investigation required for elucidation of factors influencing the likelihood
and/or severity of CTE development following neurotrauma includes the effect of environment.
Areas of particular interest include social support, diet, use of supplements, and use of drugs or
anabolic steroids.
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Good social support has been shown to decrease the likelihood of developing a
postconcussional disorder following acute head injury (McCauley et al., 2001). Strong family
support is linked to better outcomes (Khan et al., 2003). Another important feature of environment
is diet. While the effect of diet is well understood with regards to general health, there are limited
studies relating diet and mental health, particularly in the context of traumatic brain injury. A
preclinical study conducted by Mychasiuk and colleagues showed that high-fat diet in conjunction
with TBI resulted in cumulative deficits on assessments of motor function, short-term working
memory, and produced depressive-like effects compared to animals with normal diet and TBI
(Mychasiuk et al., 2014). Similarly, administration of dietary supplements such as Vitamin E and
DHA have been shown to improve outcomes from TBI in numerous studies (Conte et al., 2004;
Wu et al., 2004; Mills et al., 2011b; Mills et al., 2011a; Bailes and Patel, 2014). The suggestion
has been made previously, based on evidence that some cases of diagnosed CTE occurred in former
athletes with a history of anabolic steroid use, that anabolic steroid use may predispose these
athletes to CTE development. While this question has not been completely resolved in terms of
studying markers of CTE, preliminary studies found no difference in amyloid precursor protein
(APP) expression post-TBI regardless of when anabolic steroids were used (Mills et al., 2012).
Preconditioning
Any neural injury model has the potential to be complicated by the concept of
preconditioning. Preconditioning at the most basic levels refers to neuroprotection for a given
injury induced by a prior stimulus/injury. The concept of preconditioning has been well
documented in a variety of neural injury models ranging from ischemic stroke to TBI (Weber,
2007). Initial stimuli that serve a protective effect in a subsequent injury include but are not
limited to brief periods of ischemia, chronic exposure to moderate heat or heat acclimation, and
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subthreshold or mild injury (Weber, 2007). The proposed mechanism is that neuronal antioxidant
machinery is upregulated with subthreshold injury thereby increasing the cells ability to respond
to free radical production during subsequent injuries (Hu et al., 2008) Whether preconditioning
serves a protective phenomenon in the development of CTE is unclear, but the general clinical
consensus is that any brain injury no matter how small may be detrimental long-term,
minimizing any potential benefit of the preconditioning phenomenon (Bailes et al., 2013;
Talavage et al., 2014). This is in contrast to preclinical literature demonstrating that sustaining
repetitive mild injury prior to a single severe injury protects the animal from the most deleterious
effects of the severe injury (Allen et al., 2000). In other words, animals receiving repetitive mild
injury prior to a severe injury do better than animals receiving a single severe injury (Allen et al.,
2000). Similar findings have been observed in vitro in which subthreshold stretch prevented
more deleterious injury when a threshold stimulus was given (Slemmer and Weber, 2005). The
concept of preconditioning versus additive injury is captured pictorially in Figure 2.
Summary
In conclusion, understanding CTE as a disease remains in its infancy and current studies
remain largely speculative in nature without prospective clinical investigation. The required
clinical studies to advance the field mandate extensive financial resources and time. Preclinical
studies represent the most promising mechanism for studying many of the basic biologic questions
about CTE, as discussed above. While these studies are continuing to evolve, numerous groups
have reported exciting findings. Better modeling has allowed more extensive biochemical and
behavioral characteristics to be defined. Now that our laboratory and others have established CTE
models, options for translational investigation of CTE pathophysiology abound. In this work we
discussed numerous avenues for addressing translational questions, namely the role of 1) inter-
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injury interval, 2) number of impacts, 3) impact severity, 4) age at time of impacts, 5) mechanism
of impact, 6) genetics, 7) gender, and 8) effect of environment on the development of CTE. We
also highlighted some of the challenges of CTE modeling and specific requirements for successful
models. By improving our understanding about CTE mechanisms, we believe that significant
strides can be made not only in understanding CTE but also potentially developing prevention and
therapeutic-related approaches. A companion manuscript describes our collective experience in
modeling CTE, both neuropathologically and behaviorally.

198

Figure 7.1. Schematic representation of factors influencing injury outcomes, particularly in
repetitive injury paradigms. Initial evidence indicates that longer inter-injury intervals, less
severe initial injury, a younger age, and female gender may serve as protective effects in repeat
paradigms. In contrast, shorter intervals, increased severity, older age, and male gender may be
associated with worse outcomes.
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Figure 7.2. Methodological challenges associated with repeat injury in comparison to single
injury paradigms include balancing equal age at time of exposure versus age at sacrifice.
Two possibilities are shown depending on the variable the experimenter wants to control in future
work.
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Table 7.1. Chronic traumatic encephalopathy TBI models
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Table 7.2. Shock tube TBI models

202

Table 7.3. Weight-drop TBI models
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Table 7.4. TBI models not using craniotomy
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Table 7.5. TBI models using craniotomy
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Table 7.6. Other in vivo TBI models
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Table 7.7. In vitro and ex vivo TBI models
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Chapter Eight

GENERAL DISCUSSION
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SUMMARY
A tremendous need for traumatic brain injury (TBI) therapy is driving the focus of research.
With over 250,000 TBI hospitalizations per year, the neuropsychiatric symptoms and cognitive
deficits that develop after neurotrauma are detrimental to patients and even those around them.
An estimated 60 billion dollars in annual healthcare costs are spent to treat the behavioral
sequelae of TBI. This staggering cost warrants a desperate need for an effective treatment for
TBI. Much like Stroke, pre-clinical therapeutic success has not translated into the clinic. Over
the past few decades, the lack of clinical relevance in pre-clinical TBI models has prevented
effective treatment options from enduring the rigor of clinical trials.
Historically, our lab has focused on making neural injury models more clinicallyrelevant. For instance, our aged model of embolic stroke was better recapitulating clinical
ischemic stroke in a more relevant pre-clinical sub-population. We wanted to do the same for the
sub-population of patients who sustain non-penetrating head trauma. As such, we developed a
clinically-relevant model of blast-induced TBI for young Sprague-dawley rats. To develop our
model we needed to understand the physical characteristics behind a blast wave and how to scale
human exposure to rodent exposure. We scaled our model for rat exposure based on lung
leathality curves and could gauge blast exposure from mild to severe. We could produce gross
macroscopic hemorrage and mortality with the severe blast exposure, and microscopic neural
injury and no mortality using the mild blast exposure. Because 75% of all TBI hospitalizations
are mild in nature, and because mild TBI is often undiagnosed, we used the mild blast exposure
for the rest of our experiments in order to encompass a larger clinical population and to explore
underlying mechanism of symptom onset.
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A relatively new disease has been classified in patients in particular who have sustained
head injuries and has been called Chronic Traumatic Encephalopathy (CTE). CTE is commonly
reported in soldiers and athletes due to their susceptibility to multiple head injuries during their
careers. Impulsivity and memory loss are two symptoms common amongst patients diagnosed
with CTE. The cause of the disease is largely unknown and warrants further examination. New
advanced imaging modalities have allowed clinicians to gain a better understanding of disease
progression, but the pathophysiology of CTE is still in its infancy.
After model validation, we sought to characterize the temporal and regional profile of the
blast injury. In addition, we wanted to evaluate rodent behaviors associated with the symptoms
observed in patients with CTE. Furthermore, we investigated the neurophysiological response in
brain slice recordings at various time points after TBI. Once we could determine where, when
and to what extent, neural injury occurred, then we could correlate our biochemical and
physiological findings to the behavioral changes associated with CTE. After blast injury, we
discovered microscopic pathology which suggested damage to the neurovascular unit (NVU) in
the hippocampus and cortex. We also revealed a sustained increase in biochemical markers of
cell death such as DNA fragmentation and apoptosis after blast. A subtle deficit in short term
plasticity was also observed at more chronic time points after TBI, and suggested a decreased
probability of neurotransmitter release. Spatial memory deficits were also oberved using the
Morris water maze at chronic time points after blast injury. Interestingly, we also observed an
increase in the phosphorylation of Tau protein, which has been heavily linked to CTE. These
results were merely a characterization, and more concrete follow-up studies were necessary to
elucidate potential mechanisms that may lead to tau phosphorylation and subsequent CTE
development.
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Tau is a microtubule stabilizing protein found in axons. When neural injury occurs, tau
can become dissociated from axonal microtubules and become insoluble. Insoluble tau exposes
multiple phosphorylation sites that are targets of many tau kinases. When tau becomes
hyperphosphorylated, it changes its conformation and can bind to and aggregate with additional
tau proteins to form an oligomer. Oligomeric tau is toxic to neurons and is thought to contribute
to neurodegenerative diseases such as CTE. Therefore, we wanted to first determine the extent of
tauopathy occurring in rodents exposed to our TBI model.
CTE is a progressive neurodegenerative disease and has been labeled as a tauopathy due
to the extent of tau protein aggregation observed in post-mortem samples of those with the
disease. Tau phosphorylation and aggregation are considered hallmarks of CTE development.
We observed an increase in marker of tau phosphorylation and conformational change in rats
exposed to single and repetitive blast. We also revealed that rats subject to repetitive blast injury
displayed behavioral deficits associated with the neuropsychiatric symptoms observed in patients
with CTE. Interestingly, Tau changes and cell death markers were discovered in brain regions
that correlated to the observed behavioral deficits.
CTE, like many other neurodegenerative diseases have some vascular component to their
pathophysiology. CTE shows a perivascular tau distribution in clinical samples, so we wanted to
evaluate damage to the NVU in rodents. We observed an acute increase in Evan’s blue
extravasation in the frontal cortex and the hippocampus. We also observed astrocyte and
microglia activation in the same regions, which suggested damage to the NVU. The link between
damage to the NVU and neurobehavioral dysfunction following TBI is poorly understood.
Interestingly, we also observed tau changes in brain regions where the damage to the NVU was
revealed. We believe the primary effects of blast injury can result from damage to the NVU can
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trigger secondary injury cascades, which if go untreated, can eventually lead to neuronal cell
death.
The overarching goal of this study was to elucidate a link between damage to the NVU
and the development of tauopathies and cell death. This link would provide us with novel targets
for pharmaceutical intervention to ameliorate the behavioral sequelae of CTE. Recently
secondary injury cascades, such as endoplasmic reticulum (ER) stress and neuroinflammation,
have been hypothesized to be early indicators for the development of tauopathy. We revealed a
robust increase in markers of ER stress and neuroinflammation within the frontal cortex after
TBI. Interestingly, we observed impulsive-like behavior in rats after TBI, which is indicative of
damage to the frontal cortex. These findings support the literature and provides a new
perspective to the link between vascular injury and neurodegeneration.
After characterization of secondary injury cascades, we investigated the role of ER stress
modulation in mediating neuroinflammation, cell death and neurobehavioral dysfunction
following TBI. ER stress modulation attenuated markers of neuroinflammation and neuronal cell
death. Moreover, ER stress modulation ameliorated impulsive-like behavior and improved
working memory in rats after TBI. These results suggest that the ER stress response may be the
missing link between primary injury and tauopathy development. Elucidation of these
mechanisms will provide new therapeutic options to reduce neuronal cell death after injury and
hopefully reduce the symptoms of neurodegenerative diseases, such as CTE.

FUTURE DIRECTIONS
Because we can’t predict, or prevent a TBI from occurring, and because it is difficult to
treat neurodegenerative disease once they have been diagnosed, our only option to this point is to
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target and treat secondary injury cascades. Future studies should aim to causally link secondary
injury cascades to tauopathy in order to elucidate new drug targets for improving TBI outcome.
In order to implement an effective treatment strategy we need to intervene early after injury to
avoid neurodegeneration and inevitable cell death. Therapeutic strategy could be biphasic in
nature and contain an early intervention of ER stress modulation, followed by a prolonged
suppression of neuroinflammation for optimal results. Developing effective treatment for TBI
may be more than just finding novel targets, but also determining the rights times to intervene.
Better modeling has allowed for more extensive biochemical and behavioral
characteristics to be defined. Now that our laboratory has established a potential CTE model,
options for translational investigation of CTE pathophysiology become available. We have
revealed damage to the NVU, tau pathology, and neurobehavioral dysfunction in rats exposed to
our TBI model. Bridging the gap between these effects remains the key to therapeutic success.
Therefore, we investigated secondary injury cascades, such as ER stress and neuroinflammation,
as potential CTE mechanisms for novel therapeutic intervention. By improving our
understanding about CTE mechanisms, significant strides can be made to develop novel
therapeutic strategies to reduce the neuropsychiatric burdens of patients exposed to neurotrauma.
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